Can multiple or large fibroids harm my baby?

Most pregnancies with fibroids do not result in serious fetal harm. Fibroids are associated at a population level with some complications, including preterm birth, breech presentation, placenta praevia, placental abruption and postpartum haemorrhage, but the individual risk depends more on size, location, placental relationship, symptoms and other maternal or fetal conditions than on fibroid count alone. [1,2] The useful response is a precise anatomical and obstetric plan—not a prediction that a complication will occur.

Do fibroids always increase the risk of miscarriage?

No. Many women with one or several fibroids have an ongoing healthy pregnancy. Research about miscarriage is influenced by fibroid type, cavity distortion, maternal age, fertility treatment and other factors, and it cannot be applied as an automatic personal forecast. [1,2] A submucosal or cavity-distorting fibroid may be more relevant before pregnancy than a fibroid on the outer uterine surface. During pregnancy, bleeding or pain still requires assessment rather than being attributed to fibroids automatically.

Will my fibroids keep growing throughout pregnancy?

Not necessarily. Fibroid size may increase, remain stable, become compressed or appear different as the uterus expands. Change is often not linear, and measurements can vary with scan angle, operator, fetal position and fibroid shape. [1] A change in diameter alone does not determine treatment or birth route. Later imaging should focus on clinically important relationships such as placenta, cervix, lower uterine segment, fetal growth and presentation.

Can diet, supplements or herbal remedies shrink fibroids during pregnancy?

No pregnancy diet or supplement has been shown to shrink fibroids safely. Nutrition is valuable because it can protect haemoglobin, iron reserve, protein intake, hydration, bowel function, maternal weight and recovery. Restrictive diets, detoxes, castor oil, concentrated green-tea or EGCG products, unregulated herbs and high-dose vitamins may create risk without treating the fibroid. Supplements should be used only for a documented need or a recognised pregnancy indication.

What is red degeneration?

Red degeneration is one possible cause of acute fibroid pain during pregnancy and is thought to involve reduced blood supply and tissue change within a fibroid. [1] It may cause localised pain and tenderness, sometimes with nausea, vomiting or a mild temperature. It is not safe to diagnose every episode of pain as degeneration because placental abruption, labour, urinary disease, torsion, appendicitis, uterine-scar complications and other emergencies can present with pain.

Which pain medicines can I take for fibroid pain?

Paracetamol or acetaminophen is generally the first-line option when used appropriately under pregnancy guidance. [7] Anti-inflammatory medicines such as ibuprofen, diclofenac, naproxen and indomethacin should not be self-started. The FDA advises avoiding NSAIDs at around 20 weeks or later unless specifically recommended by a healthcare professional, limiting any necessary use between 20 and 30 weeks, and generally avoiding them after 30 weeks. [6] Severe pain may require prescribed short-term treatment, fetal assessment and reassessment of the diagnosis.

Should I stay on bed rest because I have large fibroids?

Routine prolonged bed rest is not a treatment for fibroids and has not been shown to prevent miscarriage, preterm birth or fibroid complications. Short-term rest may be reasonable during severe acute pain, but activity should increase again as symptoms allow. Prolonged immobility can worsen constipation, muscle loss and thrombosis risk. The plan should instead address pain, hydration, nutrition, mobility, bleeding, contractions, fetal movements and the specific condition being monitored.

Do I need scans at every visit?

No universal scan schedule applies to every fibroid pregnancy. Some women need only routine antenatal care plus selected reassessment of strategically important fibroids. Others need growth, placental, cervical, presentation or scar-focused imaging because fundal height is unreliable or a specific risk is present. A scan should answer a defined question and have a named reviewer. Repeatedly measuring every fibroid without linking the result to care can create anxiety without improving safety.

Can fibroids cause fetal-growth restriction or low amniotic fluid?

Fibroids do not automatically cause fetal-growth restriction or low fluid. Growth assessment may be appropriate when fundal height is unreliable, the uterus is markedly distorted, the placenta is strategically related to a fibroid or another recognised growth risk exists. [11,12] When fetal-growth restriction is diagnosed, management should follow the established growth and umbilical-artery Doppler pathway rather than a separate unvalidated fibroid protocol. [13] Low amniotic fluid also requires its own assessment, including medicine exposure, membrane status and placental function.

Can fibroids affect the placenta?

They can influence placental implantation or make placental imaging more difficult, and fibroids are associated in population studies with placenta praevia and placental abruption. [1,2] The scan should document whether the placenta is separate from, beside, partly over or genuinely behind a fibroid, and whether it lies near a previous uterine scar. A placenta beside a fibroid may function normally. Bleeding, pain, fetal-growth concern or suspicious implantation findings require prompt assessment through the relevant placental pathway.

Do fibroids cause preterm labour?

Fibroids are associated with a higher rate of preterm birth in observational evidence, but most women with fibroids do not deliver preterm. [1,2] Fibroid pain and uterine irritability can also mimic contractions. Regular painful tightenings, pelvic pressure, fluid leakage, bleeding, backache or a change in discharge require maternity assessment. Progesterone, cerclage, tocolysis, corticosteroids and admission should be used only when the woman meets the separate clinical criteria for those treatments.

Can I have a vaginal birth with multiple or large fibroids?

Yes, vaginal birth may be appropriate when the fetus is cephalic, the placenta does not cover the cervix, the lower segment is not obstructed, the presenting part can engage and no uterine scar or other obstetric condition requires planned caesarean birth. Fibroids are associated with a higher caesarean rate at a population level, but they are not an automatic surgical indication. [1,2] Late-pregnancy anatomy and the specific reason for any recommended caesarean birth should be documented.

Will I need induction or early birth?

Not solely because fibroids are present. Induction or earlier birth may be recommended for an established reason such as hypertension, diabetes, fetal-growth restriction, abnormal Doppler, placenta praevia, recurrent significant bleeding, maternal deterioration or another recognised obstetric indication. Fibroid-related factors may influence whether induction is technically appropriate, especially when a cervical or lower-segment fibroid affects the birth canal. The condition driving risk should determine timing.

When is caesarean birth recommended?

Caesarean birth may be recommended for placenta praevia, suspected placenta accreta spectrum, persistent transverse lie, selected breech presentations, a fibroid obstructing the cervix or pelvic inlet, failure of engagement or descent, fetal compromise, failed induction, or a previous uterine operation for which labour is not advised. The indication should be stated clearly. The phrase multiple large fibroids is not, by itself, a complete reason for surgery.

Can my fibroids be removed during caesarean birth?

Caesarean myomectomy is not routine, and removal of every fibroid should never be promised in advance. The evidence about its benefits and harms remains very uncertain. [5] An experienced surgeon may consider selected removal when a pedunculated fibroid is readily accessible or when a fibroid prevents uterine entry, fetal delivery or safe closure. The decision depends on placental location, blood-loss risk, haemoglobin, blood availability, fibroid anatomy, surgical expertise and the findings at the operation.

What changes if I previously had a myomectomy?

The full operative note should be reviewed whenever possible. Important details include surgical route, number and location of uterine incisions, depth of dissection, endometrial-cavity entry, closure, complications and the surgeon’s future-birth advice. Hysteroscopic, laparoscopic, robotic and open procedures do not create identical scars. Uterine rupture is uncommon but serious, and the available evidence cannot calculate an exact personal risk from one feature alone. [15] Placental location and remaining fibroids must also be mapped.

Can an ultrasound or MRI prove that my myomectomy scar is strong?

No validated ultrasound or MRI thickness threshold can guarantee that a myomectomy scar will remain intact during pregnancy or labour. Imaging may help define placental relationship, a suspected defect, lower-segment anatomy or complex residual fibroids, but it cannot certify scar strength. A reassuring image does not remove the need to assess severe unexplained pain, bleeding, maternal instability or fetal-heart-rate concern. Birth planning should use the operative record, current anatomy, symptoms and emergency resources together. [15]

Which symptoms need urgent assessment?

Seek urgent maternity or emergency assessment for heavy bleeding, sudden or severe worsening pain, fainting, fever, persistent vomiting, fluid leakage, regular contractions, reduced fetal movements, inability to pass urine, severe flank pain, chest pain, significant breathlessness, maternal collapse or feeling seriously unwell. After previous myomectomy, severe unexplained pain deserves a low threshold for assessment. Do not wait for the next clinic appointment or rely on a home fetal Doppler.

Is postpartum haemorrhage inevitable with large fibroids?

No. Fibroids, particularly larger fibroids, are associated with increased postpartum-haemorrhage risk at a population level, but most women will not experience severe haemorrhage. [1,2] Preparation may include antenatal anaemia correction, placental and surgical mapping, appropriate uterotonic prevention, measured blood-loss assessment and rapid use of the local haemorrhage protocol if bleeding occurs. [16] Preparation is not a prediction. The team must still assess tone, retained tissue, trauma and coagulation rather than blaming every bleed on fibroids.

Will fibroids shrink after pregnancy?

Many fibroids become smaller as pregnancy hormones fall and the uterus involutes, but the degree and timing vary. [1] Some remain large or symptomatic, and measurements in the early postpartum period may be difficult to interpret. Immediate surgery is not automatically required because a fibroid was large during pregnancy. Reassessment after recovery is often more useful unless persistent pain, heavy bleeding, urinary obstruction, an uncertain mass or another urgent problem requires earlier investigation.

When should treatment for fibroids be reconsidered after birth?

Postpartum review is appropriate when there is persistent pressure, pain, heavy menstrual bleeding, anaemia, urinary or bowel symptoms, uncertainty about the diagnosis or a desire to plan another pregnancy. Options outside pregnancy may include observation, medical treatment, hysteroscopic, laparoscopic, robotic or open myomectomy, uterine-artery embolisation, radiofrequency treatment or hysterectomy in selected circumstances. [1] The choice should reflect symptoms, fibroid map, cavity distortion, fertility plans, previous surgery, breastfeeding, recovery and access to expertise.

What should I bring to a specialist fibroid-pregnancy consultation?

Bring every ultrasound report and image link available, the myomectomy or caesarean operative note, pathology reports, discharge summaries, blood-group and antibody records, recent blood counts and ferritin, a medicine and supplement list, details of pain or bleeding episodes, previous pregnancy records and any advice previously given about mode of birth. A useful consultation should produce a written map, surveillance plan, nutrition and anaemia plan, emergency instructions, birth strategy and postpartum follow-up—not only another fibroid measurement.

Multiple and Large Uterine Fibroids in Pregnancy

When Fibroid Number, Size, Location and Placental Relationship Must Be Managed Together

Uterine fibroids are benign growths arising from the muscle of the uterus.

They are also called:

Leiomyomas.
Myomas.
Fibromyomas.

A woman may have:

One fibroid.
Several fibroids.
Many fibroids of different sizes.
A uterus whose shape is substantially altered by fibroids.
A large fibroid with several smaller fibroids.
Fibroids in more than one uterine region.

Most pregnancies with fibroids are not defined by catastrophe.

Many women have reassuring pregnancies.

Risk assessment becomes more important when fibroids are:

Large.
Numerous.
Located in the lower uterine segment.
Close to the cervix.
Distorting the uterine cavity.
Close to or behind the placenta.
Associated with pain.
Associated with previous heavy bleeding or anaemia.
Present after previous myomectomy.
Affecting fetal presentation.
Affecting the possible uterine incision at caesarean birth.

The safest plan cannot be built from the phrase:

Multiple fibroids present.

It should answer:

How many fibroids are visible?
Which are clinically important?
What is the largest measured diameter?
Where is each major fibroid?
Does any fibroid distort the uterine cavity?
Is the placenta over, beside or separate from a fibroid?
Is a fibroid close to the cervix or lower uterine segment?
Is the fetus able to assume a longitudinal presentation?
Is maternal pain truly caused by degeneration?
Has previous surgery altered the uterine wall?
Is birth likely to require additional haemorrhage preparation?

My approach begins with three principles:

Map the anatomy before predicting risk.
Treat symptoms and complications—not the ultrasound label alone.
Prepare for birth according to the placenta, fetal presentation, uterine scar, fibroid position and maternal condition.

No doctor can guarantee the outcome of a pregnancy.

Expert care can do something more useful:

Reconstruct the fibroid and pregnancy history.
Review pre-pregnancy imaging.
Map the dominant and strategically located fibroids.
Assess the placenta and cervix.
Distinguish fibroid pain from obstetric, urinary, gastrointestinal and surgical emergencies.
Review haemoglobin and iron reserve.
Monitor fetal growth when indicated.
Reassess fetal presentation.
Review previous myomectomy details.
Plan the safest birth route and incision when surgery may be required.
Prepare for postpartum haemorrhage without assuming that it will occur.
Plan postpartum reassessment and future treatment.

Schedule a Fibroid Pregnancy Consultation Review Your Ultrasound, Fibroid Map and Birth Plan

Map Every Fibroid

First Map Every Fibroid

The word fibroid describes a type of benign uterine tumour.

It does not describe:

Size.
Number.
Location.
Relationship to the uterine cavity.
Relationship to the placenta.
Relationship to the cervix.
Effect on fetal presentation.
Effect on a previous uterine scar.
Likely relevance to birth.

A useful pregnancy assessment converts a general diagnosis into an anatomical map.

Fibroids Are Usually Benign

Fibroids arise from smooth muscle and connective tissue within the uterus.

They may be:

Small and incidental.
Large enough to alter uterine shape.
Single.
Multiple.
Deep within the uterine wall.
Projecting toward the uterine cavity.
Projecting outward from the uterus.
Attached by a stalk.
Located near the cervix.
Located in the lower uterine segment.

Most are benign.

A rapidly changing mass should still be assessed properly rather than assumed to be either harmless or malignant from growth alone.

Pregnancy changes:

Uterine size.
Blood flow.
Hormonal environment.
Imaging appearance.
The position of pelvic organs.

These changes can complicate comparison with older scans.

Use More Than One Measurement

For each important fibroid, the report should ideally record:

Three dimensions.
Maximum diameter.
Location.
Relationship to the uterine cavity.
Relationship to the outer uterine surface.
Relationship to the cervix.
Relationship to the placenta.
Whether it is pedunculated.
Whether degeneration is suspected.
Whether it interferes with ultrasound views.

A single phrase such as large anterior fibroid is incomplete.

A fibroid measuring:

8 centimetres at the fundus.
8 centimetres behind the placenta.
8 centimetres in the lower uterine segment.
8 centimetres projecting into the cavity.

may have very different clinical implications.

Number Every Clinically Important Fibroid

When many fibroids are present, numbering helps the team compare scans.

For example:

Fibroid 1: anterior lower uterine segment.
Fibroid 2: posterior fundal intramural.
Fibroid 3: right lateral subserosal.
Fibroid 4: cervical or paracervical.
Additional smaller intramural fibroids.

The exact report should use measurements and anatomical terms.

Numbering is useful because:

Fibroids can appear different as the uterus enlarges.
One dominant fibroid may become difficult to distinguish from neighbouring lesions.
The placenta may move relative to the cervix but not literally migrate away from a fibroid.
Different sonographers may otherwise describe the same lesion differently.
Birth planning may depend on one strategically located fibroid rather than the total count.

Describe the Uterine Location

Fibroids may be described as:

Fundal.
Anterior.
Posterior.
Right lateral.
Left lateral.
Cornual.
Lower uterine segment.
Cervical.
Paracervical.
Broad-ligament or extrauterine-appearing when anatomy is complex.

This location matters because a fibroid may affect:

Placental implantation.
Fetal lie.
Engagement of the presenting part.
Cervical access.
Vaginal birth.
Uterine incision.
Surgical exposure.
Bladder or ureteric anatomy.

Describe the Relationship to the Uterine Wall

Fibroids are often described as:

Submucosal.
Intramural.
Subserosal.
Pedunculated subserosal.
Transmural.
Cervical.

Submucosal fibroids project toward or into the uterine cavity.

Intramural fibroids lie mainly within the uterine muscle.

Subserosal fibroids project toward the outer uterine surface.

Pedunculated fibroids are attached by a stalk.

A single fibroid may cross more than one layer.

The most important question is not the label alone.

It is what the fibroid is doing to:

The cavity.
Placenta.
Cervix.
Fetal position.
Uterine wall.
Possible birth route.

Cavity Distortion Matters

A fibroid may:

Project into the cavity.
Flatten or elongate the gestational sac early in pregnancy.
Alter the shape of the uterine cavity.
Occupy space without directly entering the cavity.
Have no meaningful cavity effect.

Cavity distortion may be more relevant to:

Implantation.
Early pregnancy.
Miscarriage evaluation.
Fetal lie.

The degree of distortion should not be assumed from overall uterine size.

Map the Placenta

The report should describe:

Placental location.
Whether the placenta overlies a fibroid.
Whether it is adjacent to a fibroid.
Whether a retroplacental fibroid is present.
Whether a fibroid appears to distort the placental bed.
Whether placenta praevia or low placentation is present.
Whether a previous caesarean scar is relevant.
Whether placental assessment is limited by fibroids.

A placenta close to a fibroid is not automatically dysfunctional.

It may justify closer attention when accompanied by:

Bleeding.
Growth concern.
Abnormal Doppler.
Placental separation.
Pain.
Hypertension.
Another obstetric finding.

Map the Cervix and Lower Uterine Segment

A lower-segment or cervical fibroid may affect:

Cervical measurement.
Engagement of the fetal head.
Labour progress.
Vaginal examination.
Bladder displacement.
Ureteric anatomy.
Caesarean incision planning.
Delivery of the baby at surgery.
Closure of the uterus.

The report should state:

Distance from the cervix when feasible.
Whether the fibroid lies anterior or posterior.
Whether it occupies the likely incision site.
Whether it appears to obstruct the pelvic inlet or birth canal.
Whether the bladder is displaced.

The word low fibroid should be translated into usable anatomy.

Map the Fetus

Fibroids may influence:

Longitudinal lie.
Transverse lie.
Oblique lie.
Breech presentation.
Engagement.
Flexion of the fetal head.
Available uterine space.

Presentation may change as pregnancy advances.

A breech or transverse fetus in mid-pregnancy does not establish the final mode of birth.

Later reassessment matters.

Map Previous Uterine Surgery

If the woman has had a myomectomy, the pregnancy map should include:

Surgical approach.
Number of fibroids removed.
Size and location.
Depth of uterine incisions.
Whether the endometrial cavity was entered.
Number of uterine incisions.
Method of closure.
Electrosurgery.
Haemostasis.
Postoperative complication.
Surgeon’s future-birth advice.
Operative note.

The scar may be more important to birth planning than the remaining fibroids.

The phrase previous fibroid surgery is not enough.

Review Pre-Pregnancy Imaging

Useful records may include:

Pelvic ultrasound.
Saline sonography.
Hysteroscopy.
Magnetic resonance imaging.
Operative mapping.
Pathology.
Previous pregnancy ultrasound.

Comparison can show:

Which fibroids are longstanding.
Which are new or newly visible.
Whether cavity distortion existed.
Whether a lesion changed substantially.
Whether the apparent change reflects different technique or measurement.
Whether previous surgery removed the dominant lesion.
Whether adenomyosis or another condition coexists.

Ultrasound Is the First-Line Pregnancy Tool

Ultrasound can assess:

Number.
Size.
Location.
Placenta.
Cervix.
Fetal anatomy.
Fetal growth.
Fetal presentation.
Amniotic fluid.
Doppler when indicated.

Transabdominal ultrasound often gives the best overall pregnancy view.

Transvaginal ultrasound may add information about:

Cervix.
Lower uterine segment.
Placental edge.
Early pregnancy.
Selected pelvic anatomy.

ISUOG describes ultrasound as the primary diagnostic method for fibroids and notes that large or multiple fibroids may require broader anatomical assessment. ^[4]

Magnetic Resonance Imaging Has a Selected Role

Magnetic resonance imaging may be considered when:

Ultrasound cannot define anatomy.
A pelvic mass is indeterminate.
Surgical planning requires additional detail.
A large uterus contains many overlapping fibroids.
Placental or lower-segment anatomy is difficult to understand.
The result will change management.

During pregnancy, imaging decisions should follow pregnancy-safety guidance.

Gadolinium contrast is generally avoided unless there is a strong clinical reason.

MRI should answer a defined question.

It is not routine surveillance for every fibroid pregnancy.

Distinguish Fibroids From Other Findings

Possible alternatives or coexisting findings include:

Adenomyosis.
Focal myometrial contraction.
Uterine anomaly.
Ovarian mass.
Broad-ligament mass.
Haematoma.
Placental abnormality.
Caesarean-scar pathology.
Rare uterine malignancy.
Another pelvic lesion.

A focal uterine contraction may temporarily mimic a myometrial mass.

Repeat imaging or specialist review may clarify uncertain anatomy.

Use Consistent Terminology

The page may use:

Fibroid.
Leiomyoma.
Myoma.

The clinical report should avoid vague phrases such as:

Huge uterus.
Multiple lumps.
Bad fibroids.
Fibroid baby.
Blocked uterus.

Precise language reduces fear and improves communication between:

Obstetrician.
Radiologist.
Sonographer.
Anaesthetist.
Surgeon.
Neonatal team.
Patient.

The Fibroid Map Should Change Care

Before adding repeated measurements, ask:

Which fibroid is being followed?
What question will the next scan answer?
Will the result change pain assessment, fetal surveillance or birth planning?
Is the placenta involved?
Is the cervix or lower segment involved?
Is fetal presentation affected?
Is a previous scar present?
Does the woman have symptoms?

A complete map is not the longest list.

It is the map that identifies clinically relevant anatomy.

In a pregnancy with multiple fibroids, risk is not counted one tumour at a time. It is understood by mapping the dominant fibroids, the cavity, placenta, cervix, lower uterine segment, fetal position and any previous uterine scar.

Size Alone Is Not Enough

Why Size Alone Is Not Enough

Large fibroids deserve attention.

Size alone does not determine:

Pregnancy outcome.
Pain severity.
Need for surgery.
Need for caesarean birth.
Need for early birth.
Risk of haemorrhage.
Fetal growth.
Placental function.

A smaller fibroid in a strategically important position may matter more than a larger fibroid that projects away from the cavity and birth canal.

“Large” Is a Study Definition—not a Universal Decision Rule

Research commonly defines a large fibroid as measuring at least 5 centimetres.

This helps compare groups in studies.

It does not mean:

Every fibroid below 5 centimetres is irrelevant.
Every fibroid above 5 centimetres causes complications.
A 5-centimetre fibroid requires caesarean birth.
A 5-centimetre fibroid requires serial scans.
A 5-centimetre fibroid requires myomectomy.

The 2024 meta-analysis used 5 centimetres to examine outcomes and found that larger fibroids were associated with some outcomes, including breech presentation, placenta praevia and postpartum haemorrhage, but this remains population-level evidence rather than an individual treatment threshold. ^[2]

Number Alone Is Also Incomplete

A woman may have:

Ten small subserosal fibroids with little cavity effect.
Two large lower-segment fibroids.
Three intramural fibroids beside the placenta.
One cavity-distorting fibroid.
Numerous fibroids after a previous deep myomectomy.

These are different pregnancies.

The same 2024 meta-analysis did not find that multiple fibroids independently increased several assessed outcomes after subgroup analysis, while size affected selected risks. ^[2]

This does not mean that number never matters.

Multiple fibroids may:

Make mapping difficult.
Distort uterine shape.
Limit ultrasound windows.
Affect fetal lie.
Complicate surgery.
Increase total fibroid burden.
Coexist with anaemia or previous surgery.

The number should be interpreted with anatomy.

Location May Be More Important Than Diameter

A fibroid may be clinically important because it is:

Submucosal.
Cavity distorting.
Retroplacental.
Lower segment.
Cervical.
Beside a previous uterine scar.
In the likely caesarean incision path.
Pedunculated and at risk of torsion.
Compressing bladder or ureter.

A very large fundal subserosal fibroid may produce pressure and pain without obstructing the cervix.

A smaller lower-segment fibroid may affect engagement or surgical access.

Volume and Diameter Are Not the Same

Fibroids are three-dimensional.

A small change in diameter may represent a larger proportional change in volume.

Measurement differences may also arise from:

Scan plane.
Operator.
Fibroid shape.
Uterine growth.
Degeneration.
Difficulty separating adjacent fibroids.
Different imaging equipment.

Do not interpret every small measurement difference as biological growth.

Fibroid Growth Is Variable

Fibroids do not all grow continuously during pregnancy.

Studies suggest that:

Some enlarge, particularly earlier in pregnancy.
Some remain stable.
Some decrease in size.
Some become difficult to measure as the uterus changes.
Degeneration may alter appearance.
Postpartum shrinkage is common.

The newest comprehensive review emphasises that pregnancy outcomes are generally uncomplicated and that high-quality evidence remains limited. ^[1]

A single growth measurement should not determine the entire pregnancy plan.

Rapid Growth Does Not Automatically Mean Cancer

Fibroid growth in pregnancy may reflect:

Hormonal and vascular change.
Measurement variation.
Degeneration.
Oedema.
Haemorrhagic change.
A different scan plane.

Uterine sarcoma is rare.

Concern increases when imaging or symptoms are atypical, but rapid growth alone cannot reliably diagnose malignancy.

The response should be specialist assessment—not panic or false reassurance.

Symptoms Do Not Correlate Perfectly With Size

A large fibroid may be asymptomatic.

A smaller fibroid may cause:

Severe degeneration pain.
Torsion when pedunculated.
Pressure near the bladder.
Cavity distortion.
Placental or lower-segment concern.

Pain severity should be assessed clinically.

It should not be dismissed because the fibroid is “only” a certain size.

Total Uterine Burden May Matter

The pregnancy may be affected by:

One dominant fibroid.
Several medium fibroids.
Numerous small fibroids.
A combination of intramural and subserosal lesions.
A uterus enlarged beyond what one diameter suggests.

Assessment may include:

Overall uterine contour.
Available space for the fetus.
Placental location.
Cervical access.
Surgical access.
Maternal pressure symptoms.

There is no validated single total-fibroid-volume score that predicts every pregnancy outcome.

The Placental Relationship May Matter

Possible relationships include:

Placenta separate from fibroids.
Placenta beside a fibroid.
Placenta partly overlying a fibroid.
Retroplacental fibroid.
Placenta implanted near a cavity-distorting fibroid.
Placenta low in a fibroid-distorted lower segment.

The relationship may influence attention to:

Bleeding.
Placental separation.
Fetal growth.
Birth planning.
Surgical entry.

It does not provide a guaranteed outcome.

The Lower Uterine Segment Changes With Gestation

A fibroid described as low early in pregnancy may appear different as the uterus expands.

Later assessment should establish:

Whether it remains below the presenting part.
Whether the cervix is accessible.
Whether the fetal head can engage.
Whether the fibroid lies in the likely uterine incision.
Whether the bladder is displaced.
Whether vaginal birth remains anatomically possible.

Birth planning should use late-pregnancy anatomy—not only the first scan.

Fetal Presentation Can Change

Multiple or large fibroids may be associated with:

Breech presentation.
Transverse lie.
Oblique lie.
Unstable lie.

The risk depends on:

Fibroid location.
Available uterine space.
Placenta.
Parity.
Amniotic fluid.
Fetal factors.
Gestational age.

A non-cephalic presentation before term is not a final diagnosis.

A Fibroid Near the Caesarean Incision Requires Planning

An anterior lower-segment fibroid may affect:

Skin incision choice.
Entry into the abdomen.
Bladder dissection.
Uterine incision.
Delivery of the fetus.
Haemostasis.
Closure.
Whether a classical or alternative uterine incision is considered.

This is not decided from size alone.

Specialist ultrasound, operative records and surgical expertise may be required.

Multiple Fibroids Can Complicate Ultrasound

Fibroids may:

Distort uterine landmarks.
Create acoustic shadowing.
Limit views of fetal anatomy.
Make cervical assessment difficult.
Make placental edges difficult to define.
Reduce confidence in serial measurements.

The solution may include:

Specialist sonography.
Different probe approaches.
Repeat imaging.
MRI in selected cases.
Clear documentation of limitations.

A limited scan should be described as limited.

It should not be reported as normal without qualification.

Previous Myomectomy Changes the Meaning of Size

A woman may have small residual fibroids but a deep uterine scar.

Another may have large fibroids without previous surgery.

The first pregnancy may require scar-specific birth planning.

The second may require anatomy-specific birth planning.

The largest current fibroid does not capture scar risk.

The Woman’s Symptoms and Health Matter

Risk assessment should include:

Pain.
Bleeding.
Pressure.
Urinary symptoms.
Bowel symptoms.
Haemoglobin.
Iron deficiency.
Previous transfusion.
Previous fertility treatment.
Previous pregnancy outcome.
Hypertension.
Diabetes.
Body mass index.
Other uterine conditions.

A scan should not replace the clinical history.

A Practical Risk Matrix

I consider four dimensions:

1. Fibroid anatomy

Number.
Size.
Location.
Cavity distortion.
Pedunculation.
Lower-segment involvement.

2. Placental and fetal relationship

Placental site.
Cervix.
Presentation.
Growth.
Amniotic fluid.
Doppler when indicated.

3. Maternal condition

Pain.
Bleeding.
Anaemia.
Pressure.
Urinary obstruction.
Other medical disease.

4. Uterine surgical history

Myomectomy.
Caesarean birth.
Cavity entry.
Scar location.
Operative recommendation.

The pregnancy plan should state which dimensions are reassuring and which require follow-up.

A fibroid becomes clinically important through its anatomy, symptoms, placental relationship, effect on fetal position or interaction with a uterine scar—not through diameter alone.

How Fibroids Can Affect Pregnancy

Most pregnancies with fibroids are uncomplicated.

Fibroids are associated with increased rates of selected complications at a population level.

The evidence is limited by:

Retrospective studies.
Different definitions of fibroid size.
Incomplete mapping of location.
Variation in maternal age.
Assisted reproduction.
Ethnicity and healthcare inequity.
Different surveillance practices.
Confounding by previous surgery.
Variation in outcome definitions.

The presence of an association does not prove that a fibroid caused an individual outcome.

Early Pregnancy May Be Uncomplicated

Many women with multiple or large fibroids have:

A normally implanted pregnancy.
Reassuring fetal development.
No significant pain.
No bleeding.
No early intervention.

Fibroids should not be used to predict miscarriage before there is clinical evidence.

Miscarriage Risk Is Not Determined by Count Alone

Possible relevant factors include:

Submucosal location.
Cavity distortion.
Fibroid size.
Number.
Placental implantation.
Maternal age.
Fetal chromosome status.
Assisted conception.
Adenomyosis.
Another uterine or maternal condition.

A miscarriage after a fibroid diagnosis does not prove causation.

Recurrent pregnancy loss requires a complete assessment.

Bleeding Requires Obstetric Assessment

Bleeding in pregnancy may reflect:

Threatened miscarriage.
Pregnancy loss.
Subchorionic bleeding.
Placenta praevia.
Placental abruption.
Cervical or vaginal cause.
Labour.
Another condition.

Fibroids may coexist with bleeding.

They should not be used to explain bleeding without assessing the pregnancy.

Urgent assessment is required with:

Heavy bleeding.
Dizziness.
Fainting.
Severe pain.
Contractions.
Reduced fetal movements.
Feeling seriously unwell.

Pain Is Common—but Not Automatically Degeneration

Possible causes of pain include:

Red degeneration.
Mechanical pressure.
Stretching of the fibroid capsule.
Torsion of a pedunculated fibroid.
Urinary infection.
Kidney stone.
Appendicitis.
Gallbladder disease.
Ovarian torsion.
Placental abruption.
Preterm labour.
Uterine rupture after previous surgery.
Bowel disease.
Another condition.

Red degeneration is among the most frequently described fibroid complications in pregnancy. ^[1]

It remains a diagnosis made after clinical assessment.

Red Degeneration

Red degeneration occurs when a fibroid undergoes haemorrhagic and ischaemic change.

Possible features include:

Localised abdominal pain.
Uterine tenderness.
Low-grade fever.
Nausea.
Vomiting.
Raised inflammatory markers.
Ultrasound change.
No specific abnormality on imaging.

Symptoms can mimic more serious conditions.

The woman should not self-diagnose degeneration from known fibroids and pain.

Torsion of a Pedunculated Fibroid

A pedunculated subserosal fibroid may rarely twist.

Possible features include:

Sudden severe focal pain.
Nausea.
Vomiting.
Peritoneal irritation.
Persistent symptoms.

Torsion may require urgent surgical assessment.

It cannot be distinguished reliably from degeneration or other emergencies through symptoms alone.

Pressure Symptoms

Large or multiple fibroids may cause:

Urinary frequency.
Difficulty emptying the bladder.
Urinary retention.
Hydronephrosis.
Constipation.
Rectal pressure.
Pelvic heaviness.
Breathlessness from abdominal distension in extreme cases.
Difficulty lying comfortably.

The plan should identify whether symptoms are mechanical or caused by another pregnancy condition.

Urinary Obstruction Requires Prompt Review

Seek assessment for:

Inability to pass urine.
Severe flank pain.
Fever.
Painful urination.
Blood in urine.
Reduced urine output.
Vomiting.
Signs of kidney impairment.

A fibroid may compress the bladder outlet or ureter.

Infection and stones must also be considered.

Fibroids May Affect Placental Implantation

Population studies report associations with:

Placenta praevia.
Placental abruption.
Other placental complications.

The 2024 meta-analysis found increased adjusted risks for placenta praevia and placental abruption among pregnancies with fibroids, with larger fibroids associated with placenta praevia in subgroup analysis. ^[2]

These are population associations.

A placenta beside a fibroid is not automatically abnormal.

Placental Abruption Is an Emergency

Possible features include:

Vaginal bleeding.
Abdominal or back pain.
Uterine tenderness.
Frequent contractions.
Reduced fetal movements.
Maternal collapse.
Fetal-heart-rate abnormality.

Bleeding may be concealed.

A woman with pain and known fibroids should not be told remotely that the pain is degeneration when abruption or another emergency is possible.

Preterm Contractions and Birth

Fibroids have been associated with:

Preterm contractions.
Preterm labour.
Preterm birth.
Preterm prelabour rupture of membranes in some studies.

The newest review reports an increased population risk of preterm birth but emphasises limited high-quality evidence. ^[1]

Symptoms requiring assessment include:

Regular painful contractions.
Pelvic pressure.
Backache.
Fluid leakage.
Bleeding.
Change in discharge.
Reduced fetal movements.

Bed rest should not be prescribed routinely because fibroids are present.

Fetal Presentation

Fibroids may be associated with:

Breech presentation.
Transverse lie.
Oblique lie.
Unstable lie.
Failure of the presenting part to engage.

The 2024 meta-analysis found larger fibroids associated with breech presentation. ^[2]

Presentation should be reassessed later in pregnancy.

The mode of birth should not be decided from an early non-cephalic scan.

Fetal Growth

Evidence about fetal growth restriction is inconsistent.

Possible contributors include:

Placental location.
Maternal anaemia.
Hypertension.
Smoking.
Poor nutrition.
Multiple pregnancy.
Fetal condition.
Placental dysfunction.
Another maternal disease.

Fibroids may make fundal-height measurement and ultrasound technically difficult.

A fetus should not be labelled growth restricted solely because fibroids are present.

Fundal Height May Be Unreliable

A fibroid uterus may measure larger than expected.

Fundal height may reflect:

Fetal size.
Fibroid size.
Multiple pregnancy.
Amniotic fluid.
Maternal anatomy.
Gestational age.

When clinical measurement is unreliable, ultrasound may be used according to the complete risk profile.

The need and frequency should be individualised.

Caesarean Birth Is More Common—but Not Inevitable

Population data show a higher caesarean-birth rate among women with fibroids. ^[1,2]

Possible reasons include:

Malpresentation.
Lower-segment obstruction.
Placenta praevia.
Labour dystocia.
Fetal compromise.
Previous myomectomy.
Previous caesarean birth.
Clinician concern.
Another obstetric indication.

Fibroids alone do not make vaginal birth impossible.

Labour Dystocia

Fibroids may affect:

Uterine contractility.
Fetal position.
Engagement.
Cervical access.
Descent.
Rotation.

Labour progress should be assessed clinically.

A prolonged labour may have multiple causes.

The presence of fibroids does not automatically diagnose obstruction.

Postpartum Haemorrhage

Fibroids have been associated with postpartum haemorrhage.

Possible mechanisms include:

Reduced uterine contraction.
Distorted uterine anatomy.
Prolonged labour.
Operative birth.
Placenta praevia.
Retained placenta.
Large uterine volume.
Surgical complexity.

The 2024 meta-analysis found larger fibroids associated with postpartum haemorrhage. ^[2]

Preparation may include:

Current haemoglobin.
Blood group.
Intravenous access.
Uterotonic plan.
Haemorrhage resources.
Experienced team.

Preparation does not mean haemorrhage is certain.

Retained Placenta

Fibroids may distort the uterine cavity and may be associated with:

Retained placenta.
Difficult placental delivery.
Manual removal.
Haemorrhage.

The actual risk depends on:

Placental location.
Fibroid location.
Uterine tone.
Previous surgery.
Labour and birth factors.

Routine intervention is not required before the problem occurs.

Surgical Complexity

At caesarean birth, fibroids may affect:

Abdominal entry.
Bladder position.
Uterine incision.
Delivery of the fetus.
Uterine closure.
Blood loss.
Ability of the uterus to contract.
Whether a fibroid blocks access.
Need for senior surgical support.

A preoperative fibroid map can be more useful than a simple size estimate.

Caesarean Myomectomy Is Not Routine

Removing a fibroid during caesarean birth may increase bleeding and technical risk.

Selected surgeons may remove:

A pedunculated fibroid.
A fibroid that prevents fetal delivery.
A fibroid that prevents closure.
A strategically accessible lesion.

The 2024 Cochrane review found the evidence too uncertain to draw meaningful conclusions about benefits and harms of caesarean myomectomy. ^[5]

It should not be promised or planned routinely from a webpage.

Myomectomy During Pregnancy Is Rare

Surgery during pregnancy may be considered in exceptional situations such as:

Torsion.
Persistent severe symptoms despite appropriate treatment.
Obstruction.
Rapidly worsening compressive complications.
Diagnostic uncertainty.
Another surgical emergency.

The decision requires:

Specialist obstetric and surgical review.
Gestational-age assessment.
Imaging.
Blood preparation.
Anaesthetic input.
Discussion of pregnancy loss, bleeding and preterm-birth risk.

Conservative management is usual when clinically safe.

Uterine Rupture After Myomectomy Is Rare but Serious

A previous deep myomectomy may leave a uterine scar.

Risk assessment should consider:

Surgical approach.
Cavity entry.
Number and depth of incisions.
Closure.
Interval to conception.
Previous operative advice.
Current symptoms.

Severe sudden abdominal pain, maternal instability or fetal-heart-rate abnormality requires emergency assessment.

The current size of residual fibroids does not determine scar integrity.

Fibroids May Change After Birth

After birth, fibroids may:

Shrink.
Remain similar.
Become easier to map.
Degenerate.
Continue to cause pressure or bleeding.
Require later gynaecological treatment.
Be reassessed before another pregnancy.

Immediate postpartum imaging is not required for every woman.

Timing should reflect symptoms and future plans.

Symptoms That Require Prompt Assessment

Seek urgent medical or maternity assessment for:

Heavy vaginal bleeding.
Severe or persistent abdominal pain.
Sudden focal pain with vomiting.
Fainting.
Fever.
Fluid leakage.
Regular contractions.
Reduced fetal movements.
Chest pain.
Significant breathlessness.
Inability to pass urine.
Severe flank pain.
Severe headache or visual disturbance.
Upper-abdominal pain.
Heavy postpartum bleeding.
Feeling seriously unwell.

Known fibroids should not delay assessment of an obstetric or surgical emergency.

Fibroids may influence pain, placental location, fetal presentation, preterm birth, caesarean birth and postpartum haemorrhage. The safest care identifies which risk is actually present instead of assuming that every multiple-fibroid pregnancy will follow the same course.

The next part will reconstruct the complete fibroid, fertility, surgical and pregnancy history; create the investigation map; and distinguish fibroid degeneration from obstetric, urinary, gastrointestinal and surgical emergencies.

Reconstructing the Story

A safe pregnancy plan begins by reconstructing three timelines:

The fibroid timeline.
The uterine-surgery and fertility timeline.
The current-pregnancy timeline.

The purpose is to understand:

When fibroids were first identified.
Which fibroids existed before pregnancy.
Which symptoms preceded pregnancy.
Whether the uterine cavity was distorted.
Whether fertility treatment or surgery occurred.
Whether the placenta or cervix is now involved.
Whether pain represents a known fibroid complication or another emergency.
Whether previous birth or surgery changes the safest birth plan.

The pregnancy should not be managed from the latest ultrasound sentence alone.

Reconstruct the Original Diagnosis

I ask:

When were fibroids first identified?
Why was imaging performed?
Were they found incidentally?
Was there heavy menstrual bleeding?
Was there pelvic pressure?
Was there pain?
Was there infertility?
Was there recurrent pregnancy loss?
Was a pelvic mass felt on examination?
Was the first diagnosis made by ultrasound, magnetic resonance imaging, hysteroscopy or surgery?
Were any lesions uncertain?
Was adenomyosis or another pelvic condition also reported?

The first scan may show whether:

The fibroids predated pregnancy.
A lesion was already large.
Cavity distortion existed.
A lower-segment lesion was present.
An ovarian or broad-ligament mass was considered.
The current anatomy represents change or simply better imaging.

Retrieve Every Useful Imaging Report

Please bring:

Pre-pregnancy pelvic ultrasound.
Fertility ultrasound.
Saline sonography.
Hysteroscopy report.
Magnetic resonance imaging.
Early-pregnancy scans.
Detailed anatomy scan.
Growth scans.
Placental reports.
Cervical measurements.
Any image review by maternal-fetal medicine.
Previous operative imaging.

The actual images may be more informative than the written report.

Different reports may use different names for the same fibroid.

Build a Longitudinal Fibroid Map

For each major fibroid, record:

Number or label.
Date.
Three dimensions.
Maximum diameter.
Location.
Relationship to the uterine cavity.
Relationship to the serosal surface.
Relationship to the placenta.
Relationship to the cervix.
Relationship to the lower uterine segment.
Whether pedunculated.
Whether degeneration was suspected.
Whether it limited fetal imaging.
Whether it was removed surgically.

The map should distinguish:

A fibroid that grew.
A fibroid measured in a different plane.
Two adjacent fibroids reported as one.
One fibroid later divided into two measured lesions.
A lesion obscured by the enlarged uterus.
A lesion that became less conspicuous postpartum or after pregnancy progression.

Establish the Dominant Fibroids

When numerous fibroids are present, not every lesion requires equal attention.

I identify:

The largest fibroid.
The fibroid closest to the cavity.
The fibroid closest to the placenta.
The fibroid closest to the cervix.
The fibroid occupying the lower uterine segment.
The fibroid most likely to affect fetal lie.
The fibroid most likely to affect a caesarean incision.
Any pedunculated lesion.
Any lesion associated with focal pain.
Any lesion with atypical imaging.

This approach prevents a clinically important lower-segment lesion from being lost within a long list of measurements.

Reconstruct Fibroid Growth Carefully

For each comparison, ask:

Was the same imaging method used?
Was the same fibroid identified?
Were the same three dimensions measured?
Was the scan performed by the same unit?
Was the uterus in a different pregnancy stage?
Was degeneration present?
Were the margins difficult to define?
Was the lesion compressed or stretched by uterine growth?

A change of a few millimetres may reflect measurement variation.

A substantial change may still require interpretation in context.

Pregnancy-related growth does not automatically indicate malignancy.

Review Menstrual Symptoms Before Pregnancy

I ask about:

Cycle length.
Duration of bleeding.
Flooding.
Clots.
Night-time changes.
Pain.
Intermenstrual bleeding.
Bleeding after intercourse.
Previous emergency care.
Iron treatment.
Transfusion.
Work or activity limitation.

Heavy menstrual bleeding may explain:

Low haemoglobin before conception.
Low ferritin despite normal haemoglobin.
Fatigue.
Poor pregnancy iron reserve.
Previous intravenous iron.
Previous transfusion.

The current pregnancy plan should know whether anaemia began before pregnancy.

Reconstruct Anaemia and Blood-Loss History

I review:

Lowest documented haemoglobin.
Ferritin.
Mean-cell volume.
Iron studies.
Folate and vitamin B12 when relevant.
Oral iron.
Intravenous iron.
Transfusion.
Menstrual blood loss.
Previous miscarriage or birth blood loss.
Gastrointestinal blood loss.
Haemoglobinopathy testing.
Response to treatment.
Current symptoms.

Fibroids may explain heavy menstrual bleeding before pregnancy.

They do not explain every anaemia.

Review Pressure Symptoms

Before and during pregnancy, ask about:

Urinary frequency.
Urinary urgency.
Difficulty starting urination.
Incomplete bladder emptying.
Urinary retention.
Recurrent urinary infection.
Flank pain.
Hydronephrosis.
Constipation.
Rectal pressure.
Pelvic heaviness.
Leg swelling.
Breathlessness related to abdominal size.
Difficulty lying flat.

The pattern may identify:

Bladder-outlet compression.
Ureteric compression.
Bowel compression.
Venous compression.
Another urinary or gastrointestinal condition.

Review Pain Before Pregnancy

Establish:

Location.
Frequency.
Relation to menstruation.
Severity.
Duration.
Radiation.
Associated urinary or bowel symptoms.
Previous emergency assessment.
Imaging during pain.
Response to medicines.
Whether pain persisted after fibroid treatment.

Pain may have reflected:

Dysmenorrhoea.
Fibroid degeneration.
Adenomyosis.
Endometriosis.
Ovarian disease.
Urinary disease.
Bowel disease.
Musculoskeletal pain.
Another cause.

A pre-existing pain diagnosis should not be carried into pregnancy without reassessment.

Reconstruct Fertility History

I review:

Duration of trying to conceive.
Age at fertility assessment.
Ovulation.
Ovarian reserve.
Tubal assessment.
Semen analysis.
Endometriosis.
Adenomyosis.
Uterine-cavity assessment.
Fibroid size and location at the time.
Assisted reproduction.
Embryo-transfer history.
Implantation failure.
Previous treatment recommendation.
Whether surgery was offered or declined.

Fibroids may be one factor in infertility.

They should not replace a complete fertility assessment.

Reconstruct Every Previous Pregnancy

For each pregnancy, record:

Conception method.
Early ultrasound.
Miscarriage.
Gestational age.
Fetal cardiac activity.
Bleeding.
Pain.
Fibroid measurements.
Placental location.
Fetal growth.
Fetal presentation.
Preterm contractions.
Preterm birth.
Hypertension.
Placental abruption.
Placenta praevia.
Labour progress.
Mode of birth.
Caesarean indication.
Uterine incision.
Blood loss.
Transfusion.
Retained placenta.
Manual removal.
Postpartum haemorrhage.
Neonatal outcome.
Placental pathology.

A previous successful vaginal birth may be reassuring.

It does not guarantee that the current anatomy is identical.

A previous caesarean birth may add a separate uterine scar and placental consideration.

Define Previous Pregnancy Losses

For each loss, clarify:

Biochemical pregnancy.
Intrauterine gestational sac.
Fetal pole.
Cardiac activity.
Gestational age.
Ectopic pregnancy.
Molar pregnancy.
Genetic testing.
Uterine-cavity findings.
Fibroid relationship.
Other recurrent-loss investigations.

Do not assume that fibroids caused a loss because they were present.

Maternal age and fetal chromosomal factors remain important.

Review Every Fibroid Procedure

Possible procedures include:

Hysteroscopic myomectomy.
Laparoscopic myomectomy.
Robotic myomectomy.
Open abdominal myomectomy.
Vaginal myomectomy.
Uterine-artery embolisation.
Radiofrequency ablation.
Focused ultrasound.
Endometrial ablation.
Another procedure.

Each procedure has different implications.

The exact treatment should be identified.

Retrieve the Myomectomy Operative Note

The operative note may describe:

Surgical approach.
Number of fibroids removed.
Fibroid size.
Fibroid location.
Number of uterine incisions.
Depth of dissection.
Whether the endometrial cavity was entered.
Whether a full-thickness incision occurred.
Electrosurgery.
Method and number of closure layers.
Haemostatic agents.
Adhesions.
Blood loss.
Transfusion.
Postoperative complications.
Surgeon’s future-pregnancy advice.

A patient may have been told:

Caesarean birth is recommended.
Labour may be considered.
Birth should occur before labour.
No special restriction is needed.

The reasoning should be checked against the operative details.

Hysteroscopic Surgery Is Different

Hysteroscopic myomectomy usually removes a fibroid through the cervix from inside the uterine cavity.

It does not usually create the same outer uterine-wall scar as laparoscopic or open myomectomy.

Review:

Fibroid type.
Depth.
Perforation.
Extent of myometrial resection.
Adhesions.
Repeat surgery.
Cavity appearance afterward.

Hysteroscopic surgery should not be labelled automatically as a scar requiring caesarean birth.

Laparoscopic, Robotic and Open Myomectomy Require Detail

The external approach alone does not establish scar strength.

Important details include:

Depth of uterine entry.
Number of incisions.
Cavity entry.
Closure.
Fibroid location.
Postoperative healing.
Surgeon’s advice.

A laparoscopic operation may involve deep full-thickness uterine incisions.

An open operation may involve a superficial lesion.

The label alone is incomplete.

Review Uterine-Artery Embolisation or Ablative Treatment

A pregnancy after:

Uterine-artery embolisation.
Radiofrequency ablation.
Focused ultrasound.
Another fibroid-ablation procedure.

requires specialist review because:

The uterine wall and blood supply may have been altered.
Evidence about pregnancy outcomes may be limited.
Placental and fetal-growth considerations may differ.
Operative and imaging records are important.

The treatment should not be recorded simply as fibroid surgery.

Review Caesarean and Other Uterine Surgery

I ask about:

Previous caesarean birth.
Number of caesareans.
Uterine incision type.
Extension.
Postpartum infection.
Haemorrhage.
Curettage.
Uterine perforation.
Septum surgery.
Adenomyosis surgery.
Cornual or ectopic surgery.
Another uterine procedure.

The current uterus may contain:

Fibroids.
A myomectomy scar.
A caesarean scar.
More than one surgical scar.

Birth planning must integrate all of them.

Reconstruct the Current Pregnancy From the Beginning

I review:

Last menstrual period.
Cycle regularity.
Ovulation or embryo-transfer date.
Earliest ultrasound.
Estimated due date.
Number of fetuses.
Chorionicity in multiple pregnancy.
First-trimester bleeding.
First-trimester pain.
Fibroid map.
Placental site.
Cervical findings.
Fetal anatomy.
Fetal growth.
Presentation.
Every hospital visit.
Every pain episode.
Every medicine given.
Current symptoms.

The timeline should identify whether pain began:

Before pregnancy.
During rapid uterine enlargement.
After bleeding.
With contractions.
With urinary symptoms.
With fever.
After a procedure.
At the site of a known fibroid.

Review Every Pain Episode in Pregnancy

For each episode, document:

Gestational age.
Exact location.
Sudden or gradual onset.
Constant or intermittent pattern.
Contractions.
Uterine tenderness.
Guarding.
Fever.
Vomiting.
Bowel symptoms.
Urinary symptoms.
Vaginal bleeding.
Fluid leakage.
Fetal movements.
Blood pressure.
Laboratory results.
Ultrasound.
Cervical assessment.
Diagnosis.
Treatment.
Response.
Recurrence.

A pain episode labelled fibroid degeneration should have enough information to show why more urgent causes were considered unlikely.

Review Every Bleeding Episode

Document:

Gestational age.
Amount.
Colour.
Pain.
Contractions.
Placental site.
Cervical findings.
Fetal status.
Ultrasound.
Haemoglobin.
Blood group and anti-D considerations where relevant.
Diagnosis.
Recurrence.

Fibroids may coexist with:

Threatened miscarriage.
Placenta praevia.
Placental abruption.
Cervical bleeding.
Labour.
Another cause.

The clinical diagnosis should be explicit.

Review Preterm Symptoms

I ask about:

Tightenings.
Regular contractions.
Pelvic pressure.
Back pain.
Fluid leakage.
Bleeding.
Cervical change.
Fetal fibronectin or other local testing when used.
Admission.
Tocolysis.
Corticosteroids.
Magnesium sulphate.
Transfer.
Outcome.

Fibroids may be associated with preterm birth at a population level.

The individual plan depends on actual symptoms, cervix and obstetric history.

Review the Placenta Over Time

Record:

Early placental site.
Anatomy-scan placental site.
Relationship to dominant fibroids.
Relationship to the cervix.
Relationship to a caesarean scar.
Bleeding.
Placental lakes or other findings when clinically relevant.
Accreta-spectrum assessment when indicated.
Abruption concern.
Growth and Doppler.

A placenta may appear to change relative to the cervix as the uterus grows.

Its relationship to a fixed fibroid should be described carefully.

Review the Cervix

Information may include:

Cervical length.
Method of measurement.
Lower-segment distortion.
Cervical fibroid.
Previous cervical surgery.
Previous preterm birth.
Symptoms.
Dilatation.
Cerclage when present.

Fibroids alone do not create a universal indication for serial cervical-length surveillance.

Review Fetal Presentation Over Time

Document:

Longitudinal lie.
Breech.
Transverse.
Oblique.
Unstable lie.
Presenting part relative to lower-segment fibroids.
Engagement.
Placental site.
Amniotic fluid.
Gestational age.

Presentation should be reassessed near birth.

A mid-pregnancy breech fetus does not determine mode of birth.

Review Fetal Growth

I ask for:

Estimated fetal weight.
Abdominal circumference.
Growth centile.
Growth velocity.
Amniotic fluid.
Umbilical-artery Doppler when performed.
Technical limitations.
Maternal blood pressure.
Anaemia.
Placental relationship.
Previous growth-restricted pregnancy.

Fibroids may make measurement difficult.

The report should state when views or measurements are limited.

Review Maternal Examination Findings

Clinical findings may include:

Uterine size.
Tenderness.
Palpable fibroid.
Fetal lie.
Presenting part.
Cervical accessibility.
Bladder distension.
Abdominal guarding.
Surgical scars.
Blood pressure.
Fever.
Maternal pulse.

Physical examination should be interpreted with imaging.

A large irregular uterus may make fundal-height measurement unreliable.

Review Medicines Used for Pain

Document:

Paracetamol or acetaminophen.
Non-steroidal anti-inflammatory medicine.
Opioid.
Antispasmodic.
Antibiotic.
Antiemetic.
Tocolytic.
Steroid.
Herbal or traditional medicine.
Dose.
Gestational age.
Duration.
Response.
Adverse effects.

A medicine considered acceptable at one gestational stage may be unsuitable later.

The diagnosis and prescribing clinician should be clear.

Review Supplements and Alternative Treatments

I ask about:

Iron.
Folic acid.
Vitamin D.
Calcium.
Magnesium.
Herbal fibroid remedies.
Castor-oil packs.
Detox products.
Enzymes.
Green-tea extract.
High-dose vitamins.
Traditional medicines.
Hormone-balancing products.

No supplement has been shown to shrink fibroids safely during pregnancy.

Products may cause:

Liver injury.
Bleeding.
Medicine interactions.
Uterine effects.
Contamination.
Delayed emergency care.

Review Allergies and Anaesthetic History

Document:

Medicine allergy.
Latex allergy.
Previous transfusion reaction.
Anaesthetic difficulty.
Difficult airway.
Postoperative nausea.
Malignant hyperthermia history.
Neuraxial difficulty.
Chronic pain medicine.
Anticoagulation.

Large fibroids may increase the possibility of planned operative birth.

Anaesthetic preparation should reflect the full history.

Review Thrombosis Risk Separately

Assess:

Previous venous thromboembolism.
Thrombophilia when validly diagnosed.
Immobility.
Hospital admission.
Surgery.
Obesity.
Multiple pregnancy.
Preeclampsia.
Postpartum haemorrhage.
Other risk factors.

Fibroids alone do not create a universal indication for anticoagulation.

Pain should not lead to prolonged bed rest without reviewing thrombosis risk.

Review Social and Practical Factors

Ask about:

Distance from maternity care.
Access to emergency transport.
Blood-bank availability.
Safe analgesia.
Support at home.
Work demands.
Ability to rest during an acute episode.
Childcare.
Food access.
Financial pressure.
Previous traumatic birth.
Fear of haemorrhage or surgery.

A plan is incomplete if it cannot be followed in the woman’s setting.

Review the Woman’s Priorities

I ask what matters most to her:

Avoiding unnecessary intervention.
Understanding whether vaginal birth is possible.
Reducing pain.
Avoiding transfusion.
Preserving future fertility.
Knowing whether fibroids can be removed during caesarean birth.
Planning family size.
Recovering quickly.
Avoiding another traumatic birth.
Receiving a clear emergency plan.

Shared decision-making requires accurate anatomy and honest uncertainty.

What I Ask Patients to Bring

Please bring every available:

Pre-pregnancy ultrasound.
Magnetic resonance imaging.
Fertility imaging.
Hysteroscopy report.
Myomectomy operative note.
Pathology report.
Caesarean operative note.
Anaesthetic record.
Previous birth summary.
Placental pathology.
Previous transfusion record.
Full blood count.
Ferritin and iron studies.
Earliest dating scan.
Anatomy scan.
Growth scans.
Cervical reports.
Every emergency-assessment summary.
Current medicine and supplement list.
Blood group and antibody results when available.

Missing records should not prevent consultation.

The anatomy and history can still be reconstructed from what is available.

The fibroid story is not one ultrasound measurement. It is a timeline of anatomy, symptoms, bleeding, fertility, surgery, placental relationship, fetal position and previous birth—read together to identify what changes this pregnancy.

The next part will map the investigations needed to define maternal, fetal, placental, cervical, urinary and surgical risk.

The Investigation Map

Investigations should answer defined questions:

How many clinically important fibroids are present?
Where are they?
Which one explains the current symptom?
Is the placenta affected?
Is the cervix or lower uterine segment affected?
Is fetal growth or presentation affected?
Is anaemia present?
Is urinary obstruction present?
Is previous surgery relevant?
Is another emergency being missed?
Will the result change surveillance, treatment or birth planning?

Not every woman needs every test.

A useful investigation map is selective and question led.

1. Review the Original Images

The most useful first step may be expert review of:

Pre-pregnancy ultrasound.
Magnetic resonance imaging.
Early-pregnancy imaging.
Current ultrasound.
Operative records.

This can clarify:

Whether a lesion is truly new.
Whether the same fibroid was measured.
Whether two lesions overlap.
Whether the cavity is distorted.
Whether the placenta overlies a fibroid.
Whether the lower segment is occupied.
Whether an ovarian or broad-ligament mass is possible.

Repeating a scan without reviewing prior anatomy may reproduce uncertainty.

2. Transabdominal Ultrasound

Transabdominal ultrasound may assess:

Overall uterine contour.
Dominant fibroids.
Placenta.
Fetus.
Amniotic fluid.
Fetal presentation.
Fetal growth.
Upper urinary tract in selected cases.
Relationship between the presenting part and lower-segment fibroids.

Its strengths include:

Broad field of view.
Later-pregnancy fetal assessment.
Relationship between uterus and abdomen.

Limitations may include:

Maternal body habitus.
Very large or numerous fibroids.
Acoustic shadowing.
Fetal position.
Difficulty defining the cervix.
Difficulty separating adjacent fibroids.

3. Transvaginal Ultrasound

Transvaginal ultrasound may add detail about:

Early pregnancy.
Cervix.
Lower uterine segment.
Placental edge.
Cervical or paracervical fibroid.
Relationship to the uterine cavity.
Selected adnexal findings.

It is not required merely because fibroids are present.

The clinical question should justify the examination.

4. Three-Dimensional Ultrasound

Three-dimensional ultrasound may help in selected situations involving:

Uterine-cavity distortion.
Submucosal fibroids.
Uterine anomaly.
Pre-pregnancy planning.
Postpartum surgical planning.

It is not required routinely during pregnancy.

A standard high-quality two-dimensional examination often answers the pregnancy question.

5. Fibroid Measurements

For each clinically relevant fibroid, record:

Length.
Width.
Depth.
Maximum diameter.
Location.
Wall relationship.
Placental relationship.
Cervical relationship.
Whether pedunculated.
Imaging limitations.

Measurements should be compared only when the same lesion and plane can be identified.

Volume calculations may be useful in research or selected planning.

They are not a validated universal pregnancy-risk score.

6. FIGO Fibroid Classification

The FIGO system describes fibroids according to their relationship with:

Endometrium.
Myometrium.
Serosal surface.

It may be useful when reconstructing:

Pre-pregnancy cavity distortion.
Fertility impact.
Surgical history.
Postpartum treatment planning.

During later pregnancy, anatomy may be stretched and difficult to classify precisely.

The classification should not replace direct description of:

Placenta.
Cervix.
Lower segment.
Fetal presentation.
Uterine scar.

7. Placental Assessment

Ultrasound should document:

Anterior, posterior, fundal or lateral site.
Distance from the cervix when relevant.
Relationship to dominant fibroids.
Whether a retroplacental fibroid is present.
Whether placenta praevia exists.
Whether a previous caesarean scar is involved.
Whether accreta-spectrum assessment is indicated.
Whether views are limited.

A fibroid behind the placenta may justify attention.

It does not diagnose placental dysfunction.

8. Cervical Assessment

Cervical assessment may be performed because of:

Previous spontaneous preterm birth.
Previous second-trimester loss.
Symptoms.
A cervical fibroid.
Lower-segment distortion.
Planned cerclage.
Another recognised indication.

Transvaginal measurement is generally the most reliable ultrasound method for cervical length.

Fibroids alone do not mandate serial cervical scans for every woman.

9. Fetal Anatomy Assessment

Large or multiple fibroids may limit views.

The report should state:

Which structures were seen.
Which were not seen.
Why views were limited.
Whether repeat imaging is needed.
Whether specialist fetal imaging is required.

A technically limited scan is not the same as a normal complete scan.

10. Fetal Growth Assessment

Growth ultrasound may include:

Biparietal diameter.
Head circumference.
Abdominal circumference.
Femur length.
Estimated fetal weight.
Growth centile.
Growth velocity.
Amniotic fluid.
Placental assessment.
Doppler when indicated.

Fibroids may distort fundal height and limit ultrasound planes.

Serial growth should be based on actual risk and technical need—not performed automatically in every stable pregnancy.

11. Fetal Presentation

Ultrasound can define:

Cephalic.
Breech.
Transverse.
Oblique.
Unstable lie.
Presenting part relative to a lower-segment fibroid.
Whether engagement appears possible.
Placental and cord considerations.

Presentation should be reassessed near birth.

12. Umbilical-Artery Doppler

Umbilical-artery Doppler is used when:

Fetal growth restriction is diagnosed.
Placental dysfunction is suspected.
Another obstetric indication exists.

It is not a fibroid-severity test.

A normal Doppler does not prove that a fibroid is harmless.

An abnormal Doppler requires a fetal-growth-restriction and placental pathway.

13. Other Doppler Studies

Depending on findings and local practice, assessment may include:

Middle-cerebral-artery Doppler.
Uterine-artery Doppler.
Ductus-venosus Doppler.
Cerebroplacental ratio.

Their use depends on:

Gestation.
Fetal size.
Placental disease.
Maternal condition.
Local protocol.

They should not be ordered merely to count fibroid risk.

14. Magnetic Resonance Imaging

MRI may be useful when ultrasound cannot define:

Lower-segment anatomy.
Cervical fibroid.
Broad-ligament extension.
Bladder or ureteric displacement.
A complex pelvic mass.
Relationship to a previous scar.
Surgical access.
Atypical degeneration.
Another diagnosis.

MRI does not use ionising radiation.

Pregnancy use should follow specialist radiology guidance.

Gadolinium contrast is generally avoided unless its expected benefit clearly justifies its use.

15. MRI for Pain

MRI may help differentiate selected causes of severe abdominal or pelvic pain when:

Ultrasound is inconclusive.
Appendicitis is considered.
Ovarian torsion is possible.
Fibroid degeneration is uncertain.
A complex mass requires characterisation.
Surgery is being considered.

Imaging should not delay emergency treatment when maternal or fetal instability is present.

16. Full Blood Count

A full blood count assesses:

Haemoglobin.
Mean-cell volume.
White-cell count.
Platelets.

It may identify:

Pre-existing iron-deficiency anaemia.
Blood loss.
Infection or inflammation.
Pregnancy-related haemodilution.
Thrombocytopenia relevant to anaesthesia or haemorrhage planning.
Another haematological condition.

Interpretation should include symptoms and previous results.

17. Ferritin and Iron Studies

Ferritin may show depleted iron stores even when haemoglobin is normal.

Assessment may include:

Ferritin.
Transferrin saturation.
Other iron indices.
C-reactive protein when inflammation affects interpretation.

Previous heavy menstrual bleeding may reduce pregnancy iron reserve.

Treatment should be based on the actual deficiency and response.

18. Blood Group and Antibody Screen

Pregnancy care should document:

ABO group.
Rhesus status.
Red-cell antibodies.
Previous transfusion.
Previous transfusion reaction.
Availability of compatible blood when relevant.

This becomes particularly important with:

Severe anaemia.
Placenta praevia.
Previous haemorrhage.
Anticipated complex caesarean birth.
Multiple antibodies.
Rare blood group.
Planned surgery.

Blood preparation should reflect realistic risk.

19. Coagulation Testing

Coagulation studies are not required routinely because fibroids are present.

They may be indicated with:

Significant bleeding.
Placental abruption.
Liver disease.
Anticoagulation.
Severe preeclampsia.
Suspected coagulopathy.
Massive transfusion.
Another clinical reason.

A normal coagulation test does not remove haemorrhage risk.

20. C-Reactive Protein and Inflammatory Markers

Inflammatory markers may rise with:

Fibroid degeneration.
Infection.
Appendicitis.
Urinary disease.
Inflammatory bowel disease.
Another condition.

They are not specific.

A raised result should be interpreted with:

Fever.
Examination.
White-cell count.
Urine.
Imaging.
Fetal assessment.
Clinical course.

Pregnancy itself changes some laboratory ranges.

21. Urinalysis and Urine Culture

Urinary assessment may be useful with:

Pain.
Fever.
Frequency.
Dysuria.
Haematuria.
Flank pain.
Retention.
Preterm contractions.
Previous urinary infection.

A urinary infection can mimic or trigger abdominal pain and contractions.

It should not be missed because fibroids are visible.

22. Kidney Function

Assessment may include:

Creatinine.
Electrolytes.
Urine output.
Urinalysis.
Renal ultrasound.

It may be indicated with:

Hydronephrosis.
Ureteric compression.
Urinary retention.
Severe vomiting.
Hypertension.
Kidney disease.
Another clinical concern.

A large pelvic fibroid can occasionally produce obstructive urinary complications.

23. Renal Ultrasound

Renal or urinary-tract ultrasound may assess:

Hydronephrosis.
Bladder distension.
Post-void residual.
Stones.
Another urinary cause.

It may be particularly useful when:

Flank pain is present.
Urine output falls.
Retention occurs.
Kidney function changes.
A large lower or lateral fibroid may compress urinary structures.

24. Liver and Metabolic Testing

Testing may include:

AST.
ALT.
Bilirubin.
Kidney function.
Electrolytes.
Glucose.
Lipase or amylase when indicated.
Other targeted tests.

These investigations may distinguish:

Gallbladder disease.
Pancreatic disease.
Preeclampsia-related organ involvement.
Hyperemesis.
Another abdominal emergency.

Fibroids do not explain every abnormal laboratory result.

25. Cervical and Vaginal Assessment

With bleeding, pressure, contractions or fluid leakage, examination may assess:

Cervical dilatation.
Cervical source of bleeding.
Ruptured membranes.
Labour.
Infection.
Presenting part.

Digital examination may be avoided until placenta praevia is excluded when clinically relevant.

A cervical fibroid may make examination difficult.

26. Fetal Fibronectin or Other Preterm-Birth Tests

Local pathways may use:

Fetal fibronectin.
Cervical length.
Other biochemical tests.

Their use depends on:

Gestation.
Symptoms.
Membrane status.
Bleeding.
Cervical findings.
Local protocol.

Fibroids do not determine the test result by themselves.

27. Cardiotocography

Cardiotocography may be indicated with:

Pain.
Bleeding.
Reduced fetal movements.
Contractions.
Hypertension.
Fetal growth restriction.
Another concern.

Its use depends on gestational age and clinical context.

A reassuring tracing does not diagnose red degeneration.

An abnormal tracing requires obstetric assessment regardless of the fibroid history.

28. Placental-Abruption Assessment

There is no single test that excludes placental abruption.

Assessment may include:

Clinical history.
Maternal vital signs.
Uterine tenderness.
Bleeding.
Fetal monitoring.
Ultrasound.
Blood count.
Coagulation.
Fibrinogen where clinically indicated.
Ongoing reassessment.

Ultrasound can be normal despite abruption.

Clinical deterioration requires urgent management.

29. Appendicitis Assessment

Evaluation may include:

History.
Examination.
Blood tests.
Ultrasound.
MRI.
Surgical review.

The appendix may be displaced by the enlarged uterus.

Pain over a known right-sided fibroid does not exclude appendicitis.

30. Ovarian and Adnexal Assessment

Ultrasound may evaluate:

Ovarian cyst.
Ovarian torsion.
Adnexal mass.
Free fluid.
Blood flow when useful.

A pedunculated fibroid and ovarian mass can sometimes appear similar.

MRI or specialist imaging may clarify uncertain anatomy.

31. Bowel Assessment

Depending on symptoms, assessment may consider:

Constipation.
Obstruction.
Appendicitis.
Inflammatory bowel disease.
Diverticular disease.
Gastroenteritis.
Another cause.

Warning features include:

Persistent vomiting.
Severe distension.
Inability to pass stool or gas.
Peritoneal signs.
Blood in stool.
Fever.

A large fibroid may compress bowel.

It should not be assumed without excluding more urgent disease.

32. Uterine-Rupture Assessment After Myomectomy

There is no routine ultrasound test that proves a myomectomy scar will or will not rupture.

Assessment of severe symptoms may include:

Maternal vital signs.
Abdominal examination.
Fetal-heart-rate assessment.
Ultrasound.
Haemoglobin.
Emergency surgical review.

The operative note and clinical picture are more important than an unvalidated scar-thickness threshold.

33. Placenta Accreta Spectrum Assessment

Assessment may be appropriate when risk factors include:

Placenta praevia.
Previous caesarean birth.
Previous full-thickness uterine surgery.
Myomectomy.
Other uterine surgery.
Suspicious ultrasound findings.

Fibroids can distort anatomy and make imaging difficult.

Specialist ultrasound and MRI may be used according to the accreta pathway.

A prior myomectomy does not automatically diagnose placenta accreta spectrum.

34. Anaesthetic Assessment

Antenatal anaesthetic review may be useful with:

Anticipated complex caesarean birth.
Severe anaemia.
Previous major haemorrhage.
Difficult airway.
Spinal disease.
Anticoagulation.
Significant comorbidity.
Planned vertical or unusual abdominal incision.
Possible intensive-care need.

The review should identify:

Monitoring.
Vascular access.
Blood availability.
Neuraxial or general-anaesthesia considerations.
Postoperative pain plan.

35. Surgical Planning Imaging

Near birth, imaging may need to answer:

Where is the placenta?
Where is the presenting part?
Is a lower-segment fibroid obstructing access?
Where is the bladder?
Where might the uterine incision be placed?
Is the cervix accessible?
Is fetal delivery through a standard incision feasible?
Is senior gynaecological or urological support required?

This is different from routine fibroid measurement.

36. Blood-Bank Planning

Planning may include:

Current haemoglobin.
Blood group.
Antibody screen.
Crossmatch.
Availability of compatible units.
Cell-salvage policy.
Massive-haemorrhage protocol.
Previous reaction.
Rare blood needs.

Not every fibroid pregnancy requires crossmatched blood.

Complex anatomy, anaemia and placental disease may justify more preparation.

37. Pathology

Pathology may be available from:

Previous myomectomy.
A pedunculated fibroid removed during pregnancy.
Selected caesarean myomectomy.
Postpartum surgery.

The report may confirm:

Leiomyoma.
Degeneration.
Cellular or atypical features.
Another diagnosis.

Routine biopsy of a stable fibroid during pregnancy is not required.

38. Postpartum Imaging

Postpartum ultrasound or MRI may be considered when:

Symptoms persist.
Bleeding remains heavy.
A mass remains uncertain.
Future treatment is being planned.
Hydronephrosis or compression occurred.
Birth surgery was complex.
The woman is planning another pregnancy.

Timing should allow for uterine involution when clinically appropriate.

Immediate routine imaging is not necessary for every woman.

39. Tests That Should Not Be Used as Fibroid-Risk Screens

I do not use:

Tumour markers.
Routine CA-125.
Commercial hormone panels.
Salivary hormone tests.
Hair mineral tests.
Food-sensitivity tests.
Unvalidated inflammation panels.
Genetic wellness reports.
Repeated progesterone levels.
Unvalidated scar-thickness cut-offs.

These tests do not provide a validated pregnancy-risk score for fibroids.

40. Every Investigation Needs an Owner

Before ordering a test, establish:

What question is being answered?
Is the test valid during pregnancy?
Will the result change care?
Who will review it?
When will it be reviewed?
What happens if it is abnormal?
Does the woman know the plan?

The investigation map should define anatomy, maternal reserve, fetal wellbeing and the cause of symptoms. It is complete only when each test answers a clinical question and each abnormal result has a named follow-up plan.

The next part will distinguish red degeneration and fibroid pressure from placental abruption, preterm labour, urinary obstruction, appendicitis, ovarian torsion, bowel disease and uterine-scar emergencies.

Fibroid Pain or Emergency?

Fibroid Pain or Another Emergency?

Pain is one of the most common fibroid-related problems in pregnancy.

Known fibroids can create a dangerous shortcut:

Pain equals degeneration.

That conclusion should never be automatic.

A pregnant woman with fibroids can still develop:

Miscarriage.
Ectopic pregnancy in an early uncertain pregnancy.
Placental abruption.
Preterm labour.
Ruptured membranes.
Urinary infection.
Kidney stone.
Urinary obstruction.
Appendicitis.
Gallbladder disease.
Pancreatitis.
Ovarian torsion.
Bowel obstruction.
Gastroenteritis.
Preeclampsia-related pain.
Uterine rupture after previous surgery.
Another medical or surgical emergency.

The safest approach is to stabilise first, localise the problem and exclude time-critical diagnoses.

First Assess Maternal Stability

Urgent assessment begins with:

Airway.
Breathing.
Circulation.
Blood pressure.
Pulse.
Temperature.
Oxygen saturation.
Level of consciousness.
Pain severity.
Bleeding.
Hydration.
Urine output.

Maternal instability requires emergency management.

Imaging should not delay resuscitation.

Then Assess the Pregnancy

Depending on gestation and presentation, assess:

Fetal viability.
Fetal heart rate.
Fetal movements.
Cardiotocography.
Contractions.
Cervix.
Membranes.
Placenta.
Bleeding.
Fetal presentation.
Fetal growth when relevant.

A reassuring fetus does not prove that the maternal diagnosis is benign.

Maternal and fetal assessment should proceed together.

Red Degeneration

Red degeneration is haemorrhagic and ischaemic change within a fibroid.

It may present with:

Localised pain.
Focal uterine tenderness.
Guarding over the fibroid.
Nausea.
Vomiting.
Low-grade fever.
Raised white-cell count.
Raised inflammatory markers.
Ultrasound change.
No specific imaging change.

It is often managed conservatively when the mother and fetus are stable and urgent alternatives have been excluded. ^[1]

The detailed treatment plan will be discussed in Part 3.

Red Degeneration Is a Clinical Diagnosis

No single feature proves the diagnosis.

Supportive findings may include:

Pain localised to a known fibroid.
Focal tenderness.
Stable maternal observations.
Reassuring fetal assessment.
No significant bleeding.
No cervical change.
No urinary or gastrointestinal explanation.
Imaging compatible with degeneration.
Improvement with conservative treatment.

Reassessment is required when the course does not fit.

Pain May Occur Without Visible Imaging Change

Ultrasound may show:

Heterogeneous echogenicity.
Cystic change.
Altered internal appearance.
Peripheral or reduced flow.
No specific abnormality.

MRI may show additional features in selected cases.

A normal-appearing fibroid does not completely exclude degeneration.

The clinical picture remains important.

Torsion of a Pedunculated Fibroid

A pedunculated subserosal fibroid may rarely twist.

Possible features include:

Sudden severe focal pain.
Persistent pain.
Nausea.
Vomiting.
Peritoneal irritation.
A pedunculated mass.
Reduced or altered flow.
Diagnostic uncertainty.

Torsion can threaten tissue viability and may require surgery.

It should not be labelled degeneration without specialist review when symptoms are severe or persistent.

Placental Abruption

Placental abruption may present with:

Vaginal bleeding.
Abdominal pain.
Back pain.
Uterine tenderness.
Frequent contractions.
A tense uterus.
Reduced fetal movements.
Abnormal fetal heart rate.
Maternal shock.
Coagulopathy.

Bleeding may be concealed.

Ultrasound may be normal.

Abruption is a clinical emergency and must remain in the differential when pain occurs near the placenta or with bleeding and contractions.

Placenta Praevia With Bleeding

Placenta praevia may cause painless or painful bleeding.

Assessment should establish:

Placental location.
Amount of bleeding.
Maternal stability.
Fetal status.
Contractions.
Previous caesarean or uterine surgery.
Accreta-spectrum risk.

Digital vaginal examination should be avoided until praevia is excluded when clinically relevant.

Fibroids may coexist with placenta praevia.

Preterm Labour

Possible features include:

Regular contractions.
Pelvic pressure.
Backache.
Change in discharge.
Cervical change.
Fluid leakage.
Bleeding.

Assessment may include:

Contraction pattern.
Cervical examination.
Transvaginal cervical length.
Membrane assessment.
Fetal fibronectin or another local test.
Urine testing.
Fetal monitoring.

Fibroid pain may trigger uterine irritability.

True preterm labour requires its own pathway.

Ruptured Membranes

Possible features include:

Gush of fluid.
Continuous leakage.
Dampness.
Change in discharge.
Contractions.
Fever.
Reduced fetal movements.

Assessment should confirm:

Membrane status.
Gestation.
Infection.
Fetal status.
Presentation.
Cord risk.

Fluid leakage should not be attributed to urinary pressure from fibroids without assessment.

Miscarriage

Early-pregnancy pain may reflect:

Threatened miscarriage.
Pregnancy loss.
Subchorionic bleeding.
Ectopic pregnancy.
Ovarian pathology.
Fibroid degeneration.
Another cause.

Assessment may include:

Ultrasound.
Bleeding history.
Maternal stability.
Haemoglobin.
Pregnancy hormone trend when appropriate.
Blood group.
Pain examination.

The presence of an intrauterine fibroid does not exclude an ectopic pregnancy when pregnancy location is uncertain.

Uterine Rupture After Myomectomy

Uterine rupture is rare but serious.

Possible features include:

Sudden severe pain.
Persistent pain.
Fetal-heart-rate abnormality.
Vaginal bleeding.
Maternal tachycardia.
Hypotension.
Loss of fetal station.
Abdominal tenderness.
Haemoperitoneum.
Cessation of contractions.
No classic pattern.

A woman with previous deep uterine surgery and severe unexplained pain requires urgent obstetric assessment.

A normal scan does not always exclude rupture.

Scar Dehiscence

Scar thinning or dehiscence may be asymptomatic or discovered during imaging or surgery.

There is no universal validated ultrasound threshold that predicts rupture after myomectomy.

Management should consider:

Operative details.
Symptoms.
Gestation.
Fetal assessment.
Imaging.
Specialist opinion.

The current residual fibroid size does not measure scar strength.

Appendicitis

Pregnancy can alter the location of appendiceal pain.

Possible features include:

Right-sided pain.
Migration of pain.
Nausea.
Vomiting.
Fever.
Loss of appetite.
Guarding.
Raised inflammatory markers.

Assessment may include:

Surgical review.
Ultrasound.
MRI.
Repeat examination.

A known right-sided fibroid should not delay appendicitis assessment.

Gallbladder Disease

Possible features include:

Right upper-abdominal pain.
Pain after food.
Back or shoulder radiation.
Nausea.
Vomiting.
Fever.
Jaundice.

Assessment may include:

Liver tests.
Lipase.
Ultrasound.
Surgical or medical review.

Fundal fibroid pain and gallbladder pain may overlap anatomically.

Pancreatitis

Possible features include:

Severe upper-abdominal pain.
Back radiation.
Vomiting.
Systemic illness.
Raised lipase or amylase.
Gallstones.
Metabolic risk.

Pancreatitis requires medical assessment.

It should not be treated as degeneration with analgesia alone.

Ovarian Torsion

Possible features include:

Sudden unilateral pain.
Nausea.
Vomiting.
Intermittent severe episodes.
Adnexal mass.
Peritoneal irritation.

Ultrasound may assess the adnexa and blood flow.

Normal flow does not always exclude torsion.

A pedunculated fibroid and adnexal mass may be difficult to distinguish.

Kidney Stone

Possible features include:

Flank pain.
Groin radiation.
Haematuria.
Nausea.
Vomiting.
Urinary urgency.
Restlessness.

Assessment may include:

Urinalysis.
Urine culture.
Kidney function.
Ultrasound.
MRI in selected cases.

A lateral fibroid can cause pressure.

It does not exclude a stone.

Urinary Infection

Possible features include:

Dysuria.
Frequency.
Urgency.
Suprapubic pain.
Fever.
Flank pain.
Contractions.
Nausea or vomiting.

Urinalysis and culture may be required.

Pyelonephritis can cause maternal sepsis and preterm labour.

It should not be mistaken for fibroid pain.

Urinary Retention

A lower uterine or cervical fibroid may contribute to:

Difficulty initiating urine.
Incomplete emptying.
Painful bladder distension.
Overflow leakage.
Recurrent infection.
Hydronephrosis.

Acute retention requires prompt bladder assessment and decompression.

The underlying anatomy should be reviewed.

Ureteric Obstruction and Hydronephrosis

Possible features include:

Flank pain.
Reduced kidney function.
Infection.
Reduced urine output.
Unilateral hydronephrosis.
Severe persistent symptoms.

Pregnancy itself can cause physiological hydronephrosis.

Fibroid compression may add mechanical obstruction.

Specialist urology or nephrology input may be required in severe cases.

Bowel Obstruction

Possible features include:

Colicky pain.
Distension.
Vomiting.
Inability to pass stool.
Inability to pass gas.
Previous abdominal surgery.
Hernia.
Severe constipation.

Large fibroids may contribute to compression.

Bowel obstruction is a surgical emergency and should not be treated as ordinary pregnancy constipation.

Severe Constipation

Constipation may cause:

Cramping.
Distension.
Rectal pressure.
Pain.
Reduced appetite.

Contributors include:

Iron.
Opioids.
Reduced activity.
Dehydration.
Pregnancy hormones.
Mechanical pressure.

The diagnosis should be reconsidered when pain is severe, persistent, focal or associated with vomiting or fever.

Gastroenteritis

Possible features include:

Vomiting.
Diarrhoea.
Cramping.
Fever.
Sick contacts.
Food exposure.
Dehydration.

Assessment should consider:

Maternal hydration.
Electrolytes.
Fetal wellbeing.
Infection severity.
Another abdominal diagnosis.

A coincidental infection can occur in a woman with fibroids.

Preeclampsia-Related Upper-Abdominal Pain

Warning features include:

Severe headache.
Visual disturbance.
Right upper-abdominal or epigastric pain.
Hypertension.
Nausea.
Vomiting.
Sudden deterioration.
Reduced fetal movements.

Assessment may include:

Blood pressure.
Urine protein.
Platelets.
Kidney function.
Liver tests.
Fetal assessment.

Upper abdominal pain should not be attributed to a fundal fibroid without checking for hypertensive disease.

Labour at Term

Pain may represent labour when there are:

Regular contractions.
Increasing frequency.
Increasing intensity.
Cervical change.
Ruptured membranes.
Bloody show.
Pelvic pressure.

Fibroids may alter contraction pattern or fetal position.

Labour should be assessed through the usual intrapartum pathway.

Musculoskeletal Pain

Possible causes include:

Round-ligament pain.
Abdominal-wall strain.
Pelvic-girdle pain.
Rib pain.
Back pain.
Scar pain.

Musculoskeletal pain may be diagnosed after:

Maternal stability.
Obstetric assessment.
Absence of red flags.
Reassuring examination.
Appropriate response.

The diagnosis should not be used to dismiss persistent severe pain.

When Red Degeneration Is More Likely

The pattern may support degeneration when:

A known fibroid corresponds to the pain.
Tenderness is focal.
Maternal observations remain stable.
There is no significant bleeding.
Cervical assessment is reassuring.
Fetal assessment is reassuring.
Urinary and gastrointestinal assessment is reassuring.
Imaging supports the diagnosis or excludes alternatives.
Symptoms improve with conservative care.

No single item is sufficient.

When the Diagnosis Should Be Reconsidered

Reassessment is required with:

Haemodynamic change.
Rising fever.
Persistent vomiting.
Worsening pain.
Generalised guarding.
Heavy bleeding.
Reduced fetal movements.
Abnormal fetal heart rate.
Regular contractions.
Cervical change.
Fluid leakage.
Abnormal kidney or liver results.
Falling haemoglobin.
Failure to improve.
New localising symptoms.

The label degeneration should not prevent escalation.

When Hospital Assessment May Be Needed

Hospital assessment may be appropriate with:

Severe pain.
Diagnostic uncertainty.
Need for intravenous analgesia.
Vomiting.
Dehydration.
Fever.
Bleeding.
Contractions.
Reduced fetal movements.
Urinary retention.
Suspected obstruction.
Significant anaemia.
Previous deep myomectomy.
Maternal or fetal instability.

The decision depends on gestation, severity and local resources.

When Surgical Review Is Needed

Urgent surgical or specialist review may be required with:

Suspected torsion.
Appendicitis.
Bowel obstruction.
Ovarian torsion.
Uterine rupture.
Persistent severe pain despite treatment.
Compression of urinary or bowel structures.
Diagnostic uncertainty.
Maternal deterioration.
Another surgical emergency.

Myomectomy during pregnancy is uncommon.

The indication should be specific.

When Myomectomy May Be Considered During Pregnancy

The newest comprehensive review notes selected indications such as:

Persistent symptoms after conservative management.
Torsion of a pedunculated fibroid.
Severe compression of pelvic organs.
Rapid growth with concern for an alternative diagnosis. [1]

These are not automatic surgical rules.

The decision depends on:

Gestation.
Fibroid location.
Fibroid type.
Number.
Placenta.
Surgical access.
Blood-loss risk.
Maternal condition.
Fetal condition.
Available expertise.

Surgery Carries Pregnancy-Specific Risk

Possible risks include:

Severe haemorrhage.
Transfusion.
Pregnancy loss.
Preterm contractions.
Preterm birth.
Uterine scar.
Adhesions.
Need for hysterectomy in extreme circumstances.
Anaesthetic complications.
Fetal compromise.

Conservative management is preferred when clinically safe.

Emergency surgery should not be delayed when a time-critical diagnosis is present.

Pain Severity Is Not a Test of Fibroid Size

A small pedunculated lesion may cause torsion.

A larger intramural lesion may be painless.

Clinical decisions should not be based on:

Diameter alone.
Number alone.
The woman’s pain tolerance.
One normal ultrasound.
One dose of analgesia.
A previous degeneration diagnosis.

The current episode requires current assessment.

Do Not Prescribe Bed Rest Routinely

Routine bed rest has not been shown to treat fibroids or prevent pregnancy complications.

It may increase:

Thrombosis risk.
Muscle loss.
Constipation.
Anxiety.
Financial and social harm.

Short-term activity adjustment may be reasonable during acute pain.

Prolonged restriction requires a defined indication.

Do Not Use Pain Relief to Mask Deterioration

Analgesia is important.

It should be combined with:

Diagnosis.
Reassessment.
Maternal observations.
Fetal assessment.
Clear return precautions.

Temporary improvement does not prove that a serious condition is absent.

A Written Emergency Plan

The woman should know where to seek care for:

Heavy bleeding.
Severe pain.
Persistent vomiting.
Fever.
Fluid leakage.
Regular contractions.
Reduced fetal movements.
Fainting.
Inability to pass urine.
Severe headache or visual disturbance.
Chest pain.
Significant breathlessness.
Feeling seriously unwell.

The plan should include:

Maternity triage number.
Nearest suitable hospital.
Transport.
Relevant operative history.
Current gestation.
Blood group and antibody information when available.
Current medicines and allergies.

Dr Tania’s Acute-Pain Framework

I ask six questions:

1. Is the mother stable?

If not, resuscitation and emergency care come first.

2. Is the fetus stable?

Assess according to gestation and the clinical presentation.

3. Is there bleeding, labour or placental disease?

Exclude miscarriage, abruption, praevia bleeding, ruptured membranes and preterm labour.

4. Is there a urinary, gastrointestinal or surgical cause?

Review infection, obstruction, stones, appendix, gallbladder, ovary and bowel.

5. Is previous uterine surgery relevant?

Severe pain after myomectomy or other full-thickness surgery requires a lower threshold for urgent obstetric review.

6. Does the course fit degeneration?

The diagnosis should remain provisional until the woman improves as expected and no new warning sign develops.

Known fibroids can explain pain, but they cannot be allowed to hide placental abruption, preterm labour, urinary obstruction, appendicitis, ovarian torsion, bowel disease or uterine-scar emergencies. The diagnosis must fit the whole maternal and fetal picture.

The next part will explain Dr Tania’s nutrition-led approach, management of red-degeneration pain and prevention and treatment of anaemia without unsupported claims that food or supplements can shrink fibroids during pregnancy.

Nutrition-Led Approach

Dr Tania’s Nutrition-Led Approach

Nutrition cannot remove a fibroid during pregnancy.

No food, juice, tea, powder or supplement has been shown to:

Shrink a fibroid safely during pregnancy.
Prevent red degeneration.
Guarantee normal fetal growth.
Prevent preterm birth.
Prevent caesarean birth.
Prevent postpartum haemorrhage.
Replace ultrasound or maternity care.

Nutrition still matters profoundly.

A well-designed plan can support:

Maternal energy.
Protein intake.
Iron reserve.
Haemoglobin.
Folate.
Vitamin B12.
Calcium.
Vitamin D.
Hydration.
Bowel function.
Recovery from vomiting or pain.
Preparation for possible blood loss.
Fetal growth when intake has been poor.
Postpartum healing.

The purpose is not to treat the fibroid with food.

It is to protect the mother and pregnancy from avoidable nutritional depletion while medical and obstetric care address the anatomy and complications.

Begin With the Woman’s Actual Intake

I ask:

What does she eat on an ordinary day?
Is she vegetarian, vegan or non-vegetarian?
Are meals regular?
Is nausea limiting intake?
Does pain reduce appetite?
Is constipation severe?
Is there reflux?
Is there vomiting?
Is there food insecurity?
Is she avoiding foods because of internet advice?
Has she removed dairy, soy, gluten, sugar, fruit, grains or pulses without a medical reason?
Is she taking several supplements?
Does she have diabetes, hypertension, kidney disease, liver disease or another condition that changes nutrition?
What is her weight trend?
What did she eat before pregnancy?
Is there a history of anaemia?

The plan should fit:

Culture.
Budget.
Appetite.
Cooking facilities.
Work schedule.
Symptoms.
Medical conditions.
Laboratory results.
Pregnancy stage.

A generic fibroid diet is not a clinical plan.

Protect Adequate Energy Intake

Large or multiple fibroids may cause:

Early fullness.
Abdominal pressure.
Nausea.
Reflux.
Pain.
Reduced meal size.
Constipation.
Fear of eating.

Inadequate intake can contribute to:

Weight loss.
Fatigue.
Ketosis during illness.
Poor protein intake.
Micronutrient deficiency.
Reduced ability to recover from an acute pain episode.
Difficulty tolerating iron.
Reduced maternal reserve before birth.

When large meals are uncomfortable, the plan may use:

Smaller meals.
More frequent meals.
Nutrient-dense snacks.
Softer foods during pain or nausea.
Liquids between meals rather than large volumes with food.
A planned evening or bedtime snack.
Portable food for appointments and hospital visits.

The goal is not to force a standard meal pattern.

It is to maintain adequate intake safely.

Protein Supports Maternal and Fetal Needs

Protein sources may include:

Pulses.
Lentils.
Beans.
Chickpeas.
Soy foods.
Dairy.
Eggs.
Fish.
Poultry.
Lean meat.
Nuts.
Seeds.
Nut or seed pastes.
Fortified alternatives.

The plan should spread protein through the day.

This may be especially helpful when:

Appetite is reduced.
Meals are small.
The woman is vegetarian or vegan.
Vomiting has limited intake.
Surgery or caesarean birth may be anticipated.
Anaemia or poor weight gain is present.

Protein powders are not automatically required.

When used, review:

Ingredients.
Sweeteners.
Herbal additions.
Vitamin doses.
Contamination risk.
Diabetes.
Kidney disease.
Total dietary intake.

A product labelled pregnancy protein is not automatically necessary or superior to food.

Build Iron Reserve Early

Fibroids may have caused heavy menstrual bleeding before conception.

A woman may enter pregnancy with:

Low ferritin.
Iron-deficiency anaemia.
Normal haemoglobin but depleted iron stores.
Previous oral-iron intolerance.
Previous intravenous iron.
Previous transfusion.

Pregnancy then increases iron demand.

Possible blood loss at miscarriage, birth or surgery makes early assessment more important.

The plan should distinguish:

Prevention.
Low iron stores.
Established iron-deficiency anaemia.
Anaemia from another cause.
Urgent need for correction.

WHO continues to recommend routine antenatal iron and folic-acid supplementation within public-health guidance, while treatment of established anaemia requires individual clinical assessment. ^[8]

Food Sources of Iron

Haem-iron sources include:

Meat.
Poultry.
Fish.

Non-haem-iron sources include:

Lentils.
Beans.
Chickpeas.
Soy foods.
Dark-green vegetables.
Seeds.
Nuts.
Iron-fortified cereals.
Iron-fortified flour products.
Dried fruit in appropriate portions.

Iron absorption varies.

Useful strategies may include:

Pairing plant iron with vitamin-C-rich food.
Including fruit or vegetables with meals.
Separating tea or coffee from an iron-rich meal or prescribed iron when advised.
Reviewing calcium timing when it interferes with prescribed iron.
Using culturally familiar foods.

Food can support iron intake.

It may not correct moderate or severe iron-deficiency anaemia quickly enough.

Do Not Treat Anaemia by Diet Alone When Medicine Is Needed

Treatment may involve:

Oral iron.
A different oral preparation.
A modified dosing schedule.
Intravenous iron.
Transfusion in selected urgent situations.
Treatment of folate or vitamin B12 deficiency.
Investigation of another cause.

The route depends on:

Haemoglobin.
Ferritin.
Symptoms.
Gestational age.
Rate of change.
Time before birth.
Oral tolerance.
Absorption.
Ongoing blood loss.
Medical comorbidity.
Clinical urgency.

No patient-specific dose should be copied from a webpage.

Investigate the Cause of Anaemia

Possible causes include:

Iron deficiency.
Folate deficiency.
Vitamin B12 deficiency.
Haemoglobinopathy.
Inflammation.
Kidney disease.
Bleeding.
Haemolysis.
Multiple pregnancy.
Another condition.

WHO’s current framework emphasises that anaemia has multiple causes and should not be reduced to iron deficiency alone. ^[9]

A low haemoglobin result requires interpretation—not automatic high-dose supplementation.

Folate

Folate supports maternal blood formation and fetal development.

Sources include:

Leafy vegetables.
Pulses.
Beans.
Citrus fruit.
Avocado.
Fortified grains.
Fortified cereals.

Food does not replace recommended pregnancy folic-acid supplementation.

A higher prescribed dose may be required for a separate recognised indication.

Fibroids alone do not determine the dose.

Vitamin B12

Vitamin B12 is found mainly in:

Meat.
Fish.
Eggs.
Dairy.
Fortified foods.

Risk of deficiency may be higher with:

Vegan diets.
Limited animal-source intake.
Malabsorption.
Previous gastric or bowel surgery.
Metformin.
Certain acid-suppressing medicines.
Previous deficiency.

Folate supplementation can partially correct blood-count changes while neurological vitamin B12 deficiency persists.

Testing and treatment should be individualised.

Vitamin D

Vitamin D supports:

Bone health.
Calcium metabolism.
Maternal musculoskeletal health.

Sources and contributors include:

Sun exposure according to skin and safety.
Fortified foods.
Eggs.
Oily fish.
Prescribed or recommended supplements.

Vitamin D deficiency should be treated according to local pregnancy guidance and laboratory findings.

High-dose vitamin D has not been shown to shrink fibroids safely during pregnancy.

Calcium

Calcium sources may include:

Milk.
Yoghurt.
Cheese.
Calcium-set tofu.
Fortified plant drinks.
Selected fish with edible bones.
Sesame products.
Other culturally appropriate foods.

The plan should account for:

Lactose intolerance.
Vegan diet.
Low dairy intake.
Vitamin D status.
Kidney disease.
Prescribed iron timing.

Calcium restriction does not treat fibroids.

Unnecessary restriction may weaken the maternal diet.

Iodine

Iodine supports thyroid hormone production.

Sources vary by country and may include:

Iodised salt.
Dairy.
Fish.
Eggs.
Fortified products.

The plan should consider:

Thyroid disease.
Vegan diet.
Type of salt used.
Prenatal supplement content.
Excess iodine from seaweed or kelp products.

More is not always better.

High-dose iodine or kelp supplements should not be used without clinical advice.

Omega-3 Fats

Sources include:

Oily fish that meets pregnancy-safety guidance.
Walnuts.
Chia seeds.
Flaxseed.
Selected fortified foods.

Omega-3 fats are part of a balanced diet.

They have not been shown to dissolve fibroids.

Fish choices should follow local advice about:

Mercury.
Food safety.
Portion and species.
Raw or undercooked products.

Fibre

Fibroids and pregnancy may both contribute to:

Constipation.
Pelvic pressure.
Haemorrhoids.
Pain with bowel movements.

Fibre sources include:

Vegetables.
Fruit.
Pulses.
Whole grains.
Nuts.
Seeds.

Increase fibre gradually when intake has been low.

Rapid increase without enough fluid may worsen:

Bloating.
Cramping.
Constipation.

Severe pain, vomiting, marked distension or inability to pass stool or gas requires assessment rather than more fibre.

Hydration

Hydration supports:

Circulation.
Bowel function.
Recovery from vomiting.
Tolerance of some medicines.
Prevention of dehydration-related uterine irritability.

Needs vary with:

Climate.
Body size.
Vomiting.
Fever.
Activity.
Kidney or heart disease.
Diabetes.
Intravenous-fluid use.

The goal is regular fluid intake and normal hydration.

Excessive water intake does not treat fibroids and can be harmful.

Nausea and Vomiting

When nausea limits intake, consider:

Small frequent meals.
Dry or bland food when tolerated.
Protein-containing snacks.
Cooler foods if smells trigger symptoms.
Sips of fluid.
Oral rehydration when appropriate.
Prescribed antiemetics.
Review of iron timing or preparation.
Thiamine assessment with prolonged vomiting according to clinical care.

Seek prompt assessment with:

Inability to keep fluids down.
Reduced urine.
Dizziness.
Weight loss.
Blood in vomit.
Severe pain.
Fever.
Feeling seriously unwell.

Vomiting should not be attributed automatically to fibroid pressure.

Reflux and Early Fullness

Strategies may include:

Smaller meals.
Avoiding lying flat immediately after eating.
Identifying individual trigger foods.
Eating earlier in the evening.
Prescribed pregnancy-compatible treatment.
Separating large drinks from meals if fullness is severe.

Do not remove entire food groups without a nutritional replacement.

Persistent vomiting, difficulty swallowing, bleeding or significant weight loss requires assessment.

Constipation During Iron Treatment

Constipation may worsen with:

Oral iron.
Opioid analgesia.
Reduced activity.
Dehydration.
Low-fibre intake.
Mechanical pressure.

The plan may include:

Fluid.
Gradual fibre.
Fruit and vegetables.
Pulses or whole grains when tolerated.
Movement when clinically safe.
A pregnancy-compatible stool softener or laxative when prescribed.
Review of the iron preparation or schedule.

Do not stop prescribed iron without discussing the reason and an alternative.

Gestational Diabetes

A woman with fibroids can also develop gestational diabetes.

Nutrition should then support:

Adequate pregnancy intake.
Glucose targets.
Regular carbohydrate distribution.
Protein and fibre.
Fetal-growth assessment.
Medication when needed.

A diabetes plan should not become an unnecessarily restrictive fibroid diet.

Avoiding all fruit, grains or dairy is rarely a balanced solution.

Hypertension and Preeclampsia Risk

A balanced eating pattern may support general cardiovascular health.

It does not replace:

Blood-pressure checks.
Urine testing.
Laboratory assessment.
Prescribed aspirin when indicated for a separate preeclampsia-risk pathway.
Antihypertensive treatment.
Fetal surveillance.
Timely birth when required.

Fibroids alone are not a universal indication for aspirin.

Diet should not delay evaluation of severe headache, visual symptoms or upper-abdominal pain.

Salt

Salt advice should reflect:

Blood pressure.
Kidney disease.
Dietary pattern.
Climate.
Processed-food intake.
Local guidance.

Extreme sodium restriction is not a fibroid treatment.

Routine pregnancy hydration should not be combined with unmonitored salt-loading remedies.

Sugar

Sugar does not directly feed a fibroid in a way that allows the tumour to be starved by removing all carbohydrate.

A high-sugar, low-nutrient diet may displace:

Protein.
Fibre.
Iron-rich foods.
Micronutrients.

The goal is proportion—not fear.

Fruit does not need to be removed solely because fibroids are present.

Dairy

Dairy does not need to be removed because of fibroids unless there is:

Allergy.
Intolerance.
Personal choice.
Another medical reason.

When removed, replace:

Calcium.
Protein.
Iodine where relevant.
Vitamin B12.
Vitamin D where fortified.

A dairy-free label does not make a product nutritionally equivalent.

Soy

Soy foods can provide:

Protein.
Iron.
Calcium when set or fortified.
Useful options for vegetarian and vegan diets.

Ordinary food portions of soy do not need to be banned because fibroids are hormone responsive.

Concentrated extracts or high-dose supplements are different from food and should be reviewed separately.

Red Meat

Red meat may provide:

Iron.
Protein.
Vitamin B12.
Zinc.

It is not compulsory.

It also does not need to be forbidden solely because fibroids are present.

The choice should consider:

Dietary preference.
Anaemia.
Portion.
Preparation.
Overall dietary pattern.
Food safety.

Vegetarian iron and protein strategies can also be effective.

Gluten

Gluten does not need to be removed because of fibroids.

A gluten-free diet is appropriate for:

Confirmed coeliac disease.
Wheat allergy with appropriate avoidance.
Another valid medical indication.

Unnecessary gluten restriction may:

Increase cost.
Reduce fibre.
Reduce fortified-grain intake.
Complicate hospital food.
Create avoidable anxiety.

Symptoms after wheat require proper assessment rather than a self-diagnosed fibroid diet.

“Anti-Inflammatory” Diet Claims

A balanced pattern rich in:

Vegetables.
Fruit.
Pulses.
Whole grains.
Nuts.
Seeds.
Appropriate fish.
Unsaturated fats.

may support general health.

The phrase anti-inflammatory diet should not be used to promise:

Fibroid shrinkage.
Pain prevention.
Reduced haemorrhage.
Avoidance of surgery.
A specific pregnancy outcome.

Inflammatory markers during acute pain require medical interpretation.

Green Tea and EGCG Products

Green tea as an ordinary beverage and concentrated green-tea extracts are not the same exposure.

Concentrated products may contain:

High catechin doses.
Caffeine.
Multiple herbal ingredients.
Uncertain purity.
Unclear pregnancy safety.

They have been marketed for fibroid reduction outside pregnancy.

They should not be used as a fibroid treatment during pregnancy without specialist review.

A supplement trial in non-pregnant adults cannot be assumed safe or effective in pregnancy.

Herbal and Traditional Remedies

Products marketed to:

Shrink fibroids.
Clean the uterus.
Balance hormones.
Improve blood flow.
Dissolve tumours.
Prevent caesarean birth.

may contain:

Undeclared medicines.
Uterotonic ingredients.
Anticoagulant ingredients.
Liver-toxic substances.
Heavy metals.
Variable doses.
Contamination.

The woman should be invited to disclose products without fear of judgement.

The clinician should assess:

Ingredients.
Dose.
Frequency.
Source.
Interactions.
Adverse effects.

Castor-Oil Packs and Abdominal Treatments

Castor-oil packs, abdominal massage, heat devices and topical remedies are promoted online for fibroids.

During pregnancy:

They have not been shown to shrink fibroids.
Strong abdominal pressure may be uncomfortable or unsafe.
Excessive heat may cause burns.
Castor oil taken orally may cause diarrhoea and dehydration.
Topical ingredients may cause skin reactions.

Persistent pain needs diagnosis—not masking by home treatment.

Detoxes, Fasts and Juice Cleanses

These may lead to:

Inadequate energy.
Low protein.
Electrolyte disturbance.
Dehydration.
Glucose instability.
Diarrhoea.
Delayed medical assessment.

They do not remove fibroids.

Pregnancy is not a time for a medically unsupervised detox or prolonged fast.

Religious fasting should be discussed respectfully with the maternity team so that maternal health, gestation, diabetes, anaemia and hydration can be considered.

High-Dose Vitamins

High doses can cause harm.

Examples include:

Excess vitamin A in retinol form.
Excess vitamin D.
Excess iodine.
Excess iron.
Excess vitamin B6.
Multiple overlapping prenatal products.

Review the label of every:

Prenatal vitamin.
Anaemia product.
Hair supplement.
Immunity supplement.
Protein powder.
Herbal product.
Fertility supplement.

The total dose matters.

Food Safety

Pregnancy food safety remains important.

Review local guidance about:

Unpasteurised foods.
Raw or undercooked eggs.
Raw or undercooked meat.
Raw fish and shellfish.
High-mercury fish.
Refrigerated ready-to-eat foods.
Food storage.
Reheating.
Kitchen hygiene.

Fibroids do not alter the need to prevent foodborne illness.

An infection may cause fever, dehydration and contractions that complicate pain assessment.

Weight Monitoring

Weight should be interpreted with:

Pre-pregnancy body mass index.
Gestational age.
Vomiting.
Oedema.
Fibroid burden.
Fetal growth.
Multiple pregnancy.
Diabetes.
Dietary intake.
Clinical condition.

A fibroid uterus may enlarge the abdomen without reflecting maternal nutritional gain.

Weight should not be used alone to judge fetal growth.

Low Maternal Weight or Poor Gain

Assessment should consider:

Reduced appetite.
Early fullness.
Vomiting.
Food avoidance.
Pain.
Depression or anxiety.
Food insecurity.
Gastrointestinal disease.
Thyroid disease.
Diabetes.
Fetal growth.

The response may include:

Dietetic review.
Small frequent meals.
Energy-dense foods.
Oral nutrition products when appropriate.
Treatment of nausea or pain.
Laboratory testing.
Growth assessment.

The answer is not automatic bed rest or high-calorie supplementation without assessment.

Higher Maternal Weight

Care should remain respectful.

The plan may address:

Nutrient density.
Glucose.
Blood pressure.
Thrombosis risk.
Anaesthetic planning.
Ultrasound limitations.
Appropriate activity.
Weight gain according to local guidance.

Weight stigma can delay pain and emergency assessment.

Severe symptoms should never be dismissed as body size or fibroid discomfort.

Movement

When the pregnancy is stable, appropriate physical activity may support:

Bowel function.
Circulation.
Sleep.
Mood.
General fitness.

During an acute pain episode, temporary reduction may be reasonable.

Activity should be individualised with:

Bleeding.
Preterm labour.
Placental disease.
Severe anaemia.
Pain.
Previous uterine surgery.
Another contraindication.

Exercise does not shrink fibroids.

Routine prolonged bed rest is not a treatment.

Nutrition During an Acute Pain Episode

When pain or nausea limits food, priorities may include:

Hydration.
Small tolerated meals.
Protein-containing foods.
Easily digested carbohydrate.
Prescribed antiemetics.
Bowel management.
Monitoring urine output.
Avoiding unverified herbal analgesics.

Seek reassessment if:

Intake remains poor.
Vomiting persists.
Urine falls.
Fever develops.
Pain worsens.
Bleeding, contractions or reduced fetal movements occur.

Nutrition supports recovery.

It does not establish the diagnosis.

Nutrition Before Possible Surgery or Caesarean Birth

Preparation may include:

Correcting anaemia.
Maintaining protein and energy.
Reviewing diabetes.
Reviewing fasting instructions.
Planning postoperative food.
Identifying allergies.
Reviewing supplements that affect bleeding.
Ensuring safe oral nutrition products when needed.

The hospital plan should not begin after surgery.

A woman with anaemia and limited intake needs a documented pre-birth strategy.

Hospital Food Planning

A long admission for pain, induction or surgery may disrupt intake.

The plan should identify:

Dietary pattern.
Allergies.
Diabetes.
Vegetarian or vegan requirements.
Iron-rich options.
Protein sources.
Safe snacks.
Out-of-hours food.
Family support where permitted.

Poor hospital intake should not be accepted as inevitable.

Postpartum Nutrition Begins Antenatally

Preparation should anticipate:

Blood loss.
Anaemia.
Wound healing.
Breastfeeding.
Constipation.
Opioid use.
Reduced time to prepare food.
Follow-up iron treatment.
Reassessment of fibroid-related heavy bleeding after cycles return.

The postpartum plan will be detailed later.

The antenatal record should already state what nutrition and laboratory follow-up may be needed.

What Nutrition Can Realistically Achieve

Nutrition can help:

Prevent avoidable deficiency.
Treat deficiency alongside prescribed care.
Improve iron and protein intake.
Support hydration.
Reduce constipation.
Maintain maternal weight.
Support recovery.
Prepare for blood loss.
Support fetal growth when intake has been inadequate.

Nutrition cannot guarantee:

Fibroid shrinkage.
Absence of pain.
Vaginal birth.
Normal placental function.
No haemorrhage.
No preterm birth.
A particular fetal position.
A particular pregnancy outcome.

Dr Tania’s Nutrition Framework

I ask six questions:

1. Is intake adequate?

Review:

Energy.
Protein.
Meal frequency.
Appetite.
Vomiting.
Early fullness.

2. Is maternal reserve adequate?

Review:

Haemoglobin.
Ferritin.
Weight.
Vitamin B12.
Folate.
Vitamin D when indicated.
Other targeted results.

3. Is a symptom preventing nutrition?

Review:

Pain.
Nausea.
Reflux.
Constipation.
Urinary pressure.
Anxiety.

4. Has the diet become unnecessarily restrictive?

Review avoidance of:

Gluten.
Dairy.
Soy.
Fruit.
Grains.
Pulses.
Other food groups.

5. Are supplements safe and necessary?

Review:

Indication.
Dose.
Duplication.
Interactions.
Pregnancy safety.
Laboratory monitoring.

6. Is the plan preparing for birth and recovery?

Review:

Anaemia treatment.
Protein.
Hospital food.
Diabetes.
Postpartum follow-up.
Possible operative birth.

Nutrition does not shrink fibroids during pregnancy. Its clinical value is to protect haemoglobin, iron reserve, protein intake, hydration, bowel function, maternal weight and recovery while the obstetric plan manages anatomy and risk.

The next part will address red degeneration and pain management, including pregnancy-stage limits on anti-inflammatory medicines, escalation for persistent pain and the rare circumstances in which surgery may be considered.

Red Degeneration and Pain Management

Red degeneration is one possible cause of pain in a pregnancy with fibroids.

It is not diagnosed safely by:

Fibroid size alone.
Pain location alone.
A telephone description.
One previous episode.
Temporary improvement after analgesia.
A normal ultrasound alone.
The absence of vaginal bleeding.

The first responsibility is to exclude:

Maternal instability.
Miscarriage.
Ectopic pregnancy when pregnancy location is uncertain.
Placental abruption.
Placenta praevia with bleeding.
Preterm labour.
Ruptured membranes.
Uterine rupture after previous surgery.
Urinary infection or obstruction.
Kidney stone.
Appendicitis.
Gallbladder disease.
Pancreatitis.
Ovarian torsion.
Bowel obstruction.
Another medical or surgical emergency.

Once urgent alternatives have been considered and maternal and fetal assessments are reassuring, treatment is usually conservative. ^[1]

The Goals of Treatment

The aims are to:

Control pain.
Treat nausea or vomiting.
Restore hydration.
Maintain nutrition.
Support sleep.
Preserve mobility.
Prevent constipation.
Reassess the diagnosis when recovery does not follow the expected course.
Protect maternal and fetal wellbeing.
Avoid unnecessary surgery.
Avoid medicines that are unsuitable for the pregnancy stage.

Treatment should not be used to hide deterioration.

Assess Pain Properly

Document:

Site.
Onset.
Character.
Severity.
Radiation.
Constant or intermittent pattern.
Relationship to movement.
Relationship to contractions.
Relationship to urination or bowel movements.
Associated bleeding.
Fluid leakage.
Fever.
Vomiting.
Fetal movements.
Previous episodes.
Medicines already taken.
Response to treatment.

Repeated pain scoring can help show whether treatment is working.

Pain score alone does not establish the diagnosis.

Confirm Maternal Stability

Monitor according to severity:

Blood pressure.
Pulse.
Temperature.
Respiratory rate.
Oxygen saturation.
Hydration.
Urine output.
Abdominal examination.
Bleeding.
Ability to eat, drink and mobilise.

Escalate with:

Tachycardia.
Hypotension.
Fever.
Hypoxia.
Reduced urine.
Fainting.
Generalised guarding.
Increasing abdominal distension.
Heavy bleeding.
Clinical deterioration.

Assess the Fetus According to Gestation

Assessment may include:

Fetal viability.
Fetal heart rate.
Fetal movements.
Cardiotocography.
Contractions.
Ultrasound.
Placenta.
Amniotic fluid.
Cervix.
Fetal presentation.

The method depends on gestation and symptoms.

A reassuring fetal assessment supports conservative care.

It does not remove the need to reassess worsening maternal symptoms.

Initial Conservative Care

When the woman and fetus are stable, care may include:

Rest from activities that worsen acute pain.
Comfortable positioning.
Oral or intravenous fluids according to clinical need.
Pregnancy-compatible analgesia.
Antiemetic treatment when required.
Bowel care.
Small tolerated meals.
Monitoring.
Repeat examination.
Clear return precautions.

Routine prolonged bed rest is not treatment.

Activity should increase again as symptoms allow.

Paracetamol or Acetaminophen

Paracetamol is generally the first-line analgesic and antipyretic during pregnancy when used appropriately.

ACOG, SMFM and RCOG continue to support its use for pain and fever during pregnancy under clinical guidance. ^[7]

The plan should consider:

Total dose from all products.
Liver disease.
Alcohol exposure.
Low body weight.
Malnutrition.
Combination cold or pain medicines.
Duration of use.
Response.

Do not take more than one paracetamol-containing product unknowingly.

No patient-specific dose should be copied from this page.

Treat Pain Rather Than Endure It Without Review

Significant untreated pain may contribute to:

Poor sleep.
Reduced intake.
Dehydration.
Immobility.
Distress.
Delayed recognition of another condition when the woman avoids care.

Pain deserves treatment.

Persistent or worsening pain deserves diagnosis and reassessment—not simply repeated medication.

Non-Steroidal Anti-Inflammatory Medicines

Non-steroidal anti-inflammatory medicines include:

Ibuprofen.
Naproxen.
Diclofenac.
Indomethacin.
Ketorolac.
Celecoxib.
Other medicines in the same class.

These medicines may reduce inflammatory fibroid pain.

They are not suitable for unsupervised self-treatment in pregnancy.

The decision depends on:

Gestational age.
Diagnosis.
Expected benefit.
Duration.
Maternal kidney function.
Gastrointestinal risk.
Bleeding risk.
Blood pressure.
Fetal condition.
Amniotic fluid.
Other medicines.

The 20-Week NSAID Warning Matters

The United States Food and Drug Administration advises avoiding NSAIDs at around 20 weeks of pregnancy or later unless specifically recommended by a healthcare professional because fetal kidney dysfunction and reduced amniotic fluid can occur. ^[6]

When an NSAID is considered necessary between 20 and 30 weeks, the FDA advises:

The lowest effective dose.
The shortest possible duration.
Consideration of amniotic-fluid monitoring if treatment continues beyond 48 hours.
Discontinuation if oligohydramnios develops. [6]

NSAIDs should generally be avoided after 30 weeks because of additional fetal and birth-related risks. ^[6]

The woman should not begin ibuprofen, naproxen, diclofenac or another NSAID from a pharmacy or home supply without obstetric advice.

First-Trimester NSAID Use

Evidence about first-trimester NSAID exposure and miscarriage or congenital outcomes is conflicting and may be affected by the underlying illness and other factors.

This uncertainty does not mean that NSAIDs should be used casually.

The prescribing clinician should consider:

Why treatment is needed.
Available alternatives.
Duration.
Previous exposure.
Maternal risk factors.

An accidental exposure should be discussed with the maternity team rather than treated as proof that harm has occurred.

Low-Dose Aspirin Is a Different Clinical Pathway

Low-dose aspirin may be prescribed to reduce preeclampsia risk or for another recognised obstetric or medical indication.

It should not be:

Started because fibroids are present.
Stopped because this page discusses NSAIDs.
Used as treatment for red degeneration.
Increased to an analgesic dose without medical advice.

The indication, dose and stop plan should remain documented by the prescribing clinician.

Maternal Risks of NSAIDs

Potential maternal concerns include:

Gastritis.
Ulceration.
Gastrointestinal bleeding.
Kidney injury.
Fluid retention.
Blood-pressure effects.
Asthma sensitivity.
Platelet effects.
Medicine interactions.
Allergy.

Risk may be greater with:

Dehydration.
Kidney disease.
Hypertension.
Anticoagulation.
Gastrointestinal disease.
Significant bleeding.
Repeated or prolonged use.

A medicine that helped a previous pain episode may not be appropriate later in the same pregnancy.

Opioid Analgesia

A short course of prescribed opioid analgesia may be considered for severe acute pain when:

Non-opioid treatment is inadequate.
The diagnosis has been assessed.
Maternal and fetal monitoring are appropriate.
Benefits and risks have been discussed.

Pregnancy should not be a reason to leave severe acute pain untreated, but opioids require careful prescribing and follow-up. ^[10]

The plan should consider:

Sedation.
Nausea.
Vomiting.
Constipation.
Respiratory depression.
Falls.
Interaction with other sedatives.
Previous opioid use.
Substance-use disorder.
Duration.
Neonatal effects with repeated or late-pregnancy exposure.

Take only the prescribed medicine, dose and duration.

Opioid Use Disorder or Long-Term Opioid Treatment

A woman taking methadone, buprenorphine or long-term prescribed opioids requires coordinated care.

Do not:

Stop treatment suddenly.
Withhold acute pain relief.
Assume drug-seeking.
Prescribe an opioid agonist-antagonist without reviewing the maintenance treatment.
Ignore neonatal planning.

Care may involve:

Obstetrics.
Anaesthesia or pain medicine.
Addiction medicine.
Pharmacy.
Neonatology.
Mental-health support.

The acute fibroid-pain plan should be written clearly.

Antiemetic Treatment

Nausea and vomiting may result from:

Severe pain.
Opioids.
Fibroid pressure.
Gastrointestinal disease.
Urinary disease.
Pregnancy nausea.
Another emergency.

Pregnancy-compatible antiemetics may be prescribed according to:

Gestation.
Severity.
Previous response.
Other medicines.
Electrolytes.
Cardiac risk.
Diagnosis.

Persistent vomiting requires assessment of:

Hydration.
Urine output.
Electrolytes.
Weight.
Thiamine risk with prolonged vomiting.
Alternative diagnoses.

Fluids

Oral fluids may be sufficient when:

Vomiting is absent or mild.
Hydration is reassuring.
The woman can drink.
Maternal observations are stable.

Intravenous fluids may be required with:

Persistent vomiting.
Dehydration.
Reduced intake.
Hypotension.
Kidney impairment.
Planned procedure.
Another clinical indication.

Fluid treatment should be individualised with:

Preeclampsia.
Heart disease.
Kidney disease.
Severe anaemia.
Diabetes.
Risk of fluid overload.

Intravenous fluid does not replace nutrition during a prolonged admission.

Heat and Cold

Some women obtain temporary comfort from:

A warm bath.
A warm—not excessively hot—pack.
A cool pack.
Supportive positioning.

Avoid:

Burns.
Prolonged high heat.
Sleeping on an electric heat source.
Strong abdominal pressure.
Delaying assessment because a home method partially helps.

Heat does not treat abruption, labour, torsion, rupture or infection.

Positioning

Comfort may improve with:

Side lying.
Support under the abdomen.
Pillows between the knees.
Avoiding direct pressure on a tender mass.
Gradual position changes.

A woman with breathlessness, faintness or late-pregnancy supine symptoms should avoid remaining flat on her back.

Positioning is supportive.

It does not replace clinical assessment.

Mobility

During severe pain, short-term reduced activity may be needed.

As symptoms improve, gradual mobilisation helps reduce:

Thrombosis risk.
Constipation.
Muscle loss.
Deconditioning.
Loss of independence.

Prolonged immobility should trigger review of:

Venous-thromboembolism risk.
Hydration.
Mechanical prophylaxis.
Pharmacological prophylaxis when separately indicated.
Physiotherapy.
Home support.

Fibroids alone do not create an automatic anticoagulation indication.

Constipation Prevention

Pain medicines, especially opioids, may worsen constipation.

The plan may include:

Fluids.
Gradual fibre.
Fruit.
Vegetables.
Pulses.
Movement as tolerated.
A pregnancy-compatible laxative or stool softener when prescribed.
Review of iron treatment.
Review of bowel obstruction warning signs.

Seek reassessment for:

Persistent vomiting.
Severe distension.
Inability to pass stool or gas.
Generalised pain.
Fever.
Peritoneal signs.

Antibiotics Are Not Routine Treatment

Red degeneration is not automatically an infection.

Antibiotics should be used when there is evidence or strong suspicion of:

Urinary infection.
Pyelonephritis.
Chorioamnionitis.
Surgical infection.
Sepsis.
Another bacterial condition.

A raised white-cell count or inflammatory marker alone does not prove infection in pregnancy.

Unnecessary antibiotics may cause:

Adverse effects.
Resistance.
Diarrhoea.
Allergy.
Diagnostic confusion.

Steroids Are Not Fibroid-Pain Treatment

Corticosteroids may be given for:

Fetal lung maturation when preterm birth risk meets criteria.
Maternal autoimmune disease.
Another recognised indication.

They should not be prescribed routinely to treat fibroid degeneration.

Antenatal corticosteroids do not shrink fibroids.

Progesterone Is Not Routine Treatment for Degeneration

Progesterone may be prescribed for a separate recognised indication such as a selected preterm-birth-prevention pathway.

It is not a pain medicine.

It does not treat red degeneration.

It should not be started solely because:

Fibroids are present.
Pain occurred.
The uterus feels irritable.
A previous loss occurred.

Tocolysis Is Not Routine Fibroid Treatment

Tocolytic medicine may be considered when true preterm labour meets the local clinical pathway.

It should not be used simply because:

Pain is severe.
The uterus is tender.
Fibroids are present.
Sporadic tightenings occur.
Red degeneration is suspected.

The team should establish:

Gestation.
Contraction pattern.
Cervical findings.
Membrane status.
Bleeding.
Infection.
Fetal condition.

Placental abruption and infection may make tocolysis inappropriate.

Thrombosis Prevention Is a Separate Assessment

Hospital admission, severe pain and reduced mobility may increase thrombosis risk.

Review:

Previous venous thromboembolism.
Thrombophilia.
Body mass index.
Age.
Multiple pregnancy.
Infection.
Dehydration.
Surgery.
Immobility.
Bleeding.
Other risk factors.

Mechanical or pharmacological prevention should follow the validated maternity thrombosis pathway.

It should not be given automatically because a fibroid is large.

Laboratory Monitoring

Depending on the presentation, tests may include:

Full blood count.
C-reactive protein.
Kidney function.
Electrolytes.
Liver tests.
Urinalysis.
Urine culture.
Coagulation.
Fibrinogen.
Other targeted tests.

Repeat testing may be needed when:

Symptoms worsen.
Fever develops.
Bleeding occurs.
Vomiting persists.
Kidney function is at risk.
Surgery is considered.
The diagnosis remains uncertain.

Laboratory tests support the clinical assessment.

They do not diagnose degeneration on their own.

Imaging During an Acute Episode

Ultrasound may assess:

Fetal wellbeing.
Placenta.
Cervix.
Amniotic fluid.
Fibroid location.
Adnexa.
Urinary tract.
Free fluid.
Alternative findings.

MRI may be useful when:

Ultrasound is inconclusive.
Appendicitis or torsion is considered.
A mass is uncertain.
Lower-segment anatomy is difficult.
Surgery is being considered.

Imaging should answer a defined question.

Maternal or fetal instability should not wait for non-essential imaging.

When Outpatient Care May Be Reasonable

Outpatient care may be considered when:

Maternal observations are stable.
Fetal assessment is reassuring for gestation.
Pain is controlled with an appropriate oral plan.
The woman can drink and eat.
Vomiting is controlled.
There is no significant bleeding.
There is no evidence of labour or ruptured membranes.
Urinary and surgical emergencies are unlikely.
Reliable follow-up and transport are available.
Clear return precautions are understood.

The decision must reflect gestation, history and local resources.

When Admission May Be Appropriate

Admission may be needed with:

Severe or uncontrolled pain.
Diagnostic uncertainty.
Need for intravenous treatment.
Persistent vomiting.
Dehydration.
Fever.
Bleeding.
Contractions.
Reduced fetal movements.
Abnormal fetal assessment.
Urinary retention or obstruction.
Falling haemoglobin.
Previous deep myomectomy with unexplained pain.
Significant medical comorbidity.
Inability to manage safely at home.

Admission should have defined goals and reassessment criteria.

Reassess the Diagnosis

Reconsider degeneration when:

Pain worsens.
Pain becomes generalised.
Maternal observations change.
Fever rises.
Vomiting persists.
Haemoglobin falls.
Bleeding develops.
Contractions become regular.
The cervix changes.
Fluid leakage occurs.
Fetal movements reduce.
Fetal monitoring becomes abnormal.
Kidney or liver tests worsen.
The woman fails to improve within the expected period.
A new focal symptom appears.

A diagnosis is not protected from revision because it was written once.

Expected Course

Pain from degeneration often improves with conservative care.

The duration varies.

Recovery should be judged by:

Pain trend.
Reduced tenderness.
Stable observations.
Improved mobility.
Oral intake.
Urine output.
Absence of new bleeding or contractions.
Reassuring fetal assessment.

A fixed number of hours cannot guarantee that the episode is over.

Recurrence

Pain may recur:

In the same fibroid.
In another fibroid.
At another gestation.
With dehydration or intercurrent illness.
Without an obvious trigger.

A previous confirmed episode may help interpretation.

It should not be used to self-diagnose every later episode.

The written plan should state:

Which symptoms require immediate assessment.
Which medicine may be used.
Which medicine must not be self-started.
Where to seek care.
Whether previous uterine surgery lowers the threshold for review.

Persistent Pain

Persistent pain may require:

Repeat examination.
Repeat fetal assessment.
Specialist ultrasound.
MRI.
Surgical review.
Urology review.
Gastrointestinal or medical review.
Pain-service input.
Review of the original diagnosis.

Long-term opioid escalation without diagnostic reassessment is not an adequate plan.

Chronic Pain

Some women have recurrent or chronic pain related to:

Fibroids.
Endometriosis.
Adenomyosis.
Adhesions.
Pelvic-girdle pain.
Back pain.
Neuropathic pain.
Previous surgery.
Another chronic condition.

A multidisciplinary plan may involve:

Obstetrics.
Pain medicine.
Physiotherapy.
Mental-health support.
Gastroenterology.
Urology.
Gynaecology.
Pharmacy.

The aim is function and safety—not dismissal or automatic opioid treatment.

Surgery During Pregnancy

Myomectomy during pregnancy is uncommon.

It may be considered only in selected situations such as:

Torsion of a pedunculated fibroid.
Persistent severe pain despite appropriate conservative management.
Severe compression of urinary or bowel structures.
Rapid change with diagnostic concern.
A fibroid obstructing necessary access or treatment.
Another specific surgical indication. [1]

The decision requires:

Senior obstetric review.
Experienced gynaecological surgery.
Anaesthetic input.
Imaging.
Blood preparation.
Gestational-age assessment.
Fetal assessment.
Neonatal planning when relevant.
Informed consent.

Potential Risks of Antepartum Myomectomy

Possible risks include:

Severe haemorrhage.
Transfusion.
Pregnancy loss.
Preterm contractions.
Preterm birth.
Fetal compromise.
Uterine scar.
Adhesions.
Infection.
Anaesthetic complications.
Need for more extensive surgery.
Hysterectomy in an extreme emergency.

The benefit must outweigh these risks.

Successful published cases do not create a routine recommendation.

Timing of Surgery

When surgery is not an emergency, the team may consider:

Gestational age.
Placental location.
Fibroid type.
Surgical access.
Uterine size.
Fetal viability.
Blood-loss risk.
Available expertise.
Whether conservative care remains safe.

There is no universal gestational age at which myomectomy becomes safe.

Emergency surgery follows the maternal and fetal condition.

Surgical Approach

The approach may be:

Laparoscopic.
Open abdominal.
Another specialist technique.

Choice depends on:

Fibroid size.
Pedunculation.
Location.
Number.
Uterine size.
Gestation.
Previous surgery.
Surgeon expertise.
Need for rapid access.
Haemorrhage risk.

The least invasive label is not always the safest operation.

Blood Preparation for Surgery

Preparation may include:

Current haemoglobin.
Platelets.
Blood group.
Antibody screen.
Crossmatched blood.
Massive-haemorrhage protocol.
Cell-salvage planning according to local practice.
Senior surgical support.
Urology support when urinary anatomy is affected.
Intensive-care planning in selected cases.

Anaemia should be treated before planned surgery when time and clinical condition allow.

After Surgery During Pregnancy

Postoperative care may include:

Maternal observations.
Pain relief.
Thrombosis assessment.
Fetal assessment.
Contraction monitoring.
Bleeding assessment.
Infection monitoring.
Nutrition and bowel care.
Scar and wound review.
A revised birth plan.

The operative note should document:

Fibroid removed.
Uterine incision.
Cavity entry.
Closure.
Blood loss.
Future pregnancy and birth advice.

This information may determine mode and timing of birth.

Do Not Promise Fibroid Removal at Caesarean Birth

A woman admitted with degeneration may ask whether every fibroid can be removed when the baby is born.

That decision belongs to later surgical planning.

Caesarean myomectomy is not routine.

It may increase:

Haemorrhage.
Transfusion.
Operative time.
Surgical complexity.

Selected removal may be considered by an experienced team when a fibroid:

Is pedunculated.
Prevents fetal delivery.
Prevents uterine closure.
Is otherwise strategically unavoidable.

The evidence remains uncertain, and removal should never be promised in advance from size alone. ^[5]

Discharge Planning

Before discharge after severe pain, document:

Working diagnosis.
Important alternatives considered.
Maternal status.
Fetal status.
Medicines.
Duration and stop plan.
NSAID restrictions when relevant.
Bowel plan.
Hydration and nutrition.
Mobility.
Follow-up.
Return precautions.
Emergency contact.
Whether repeat imaging is needed.
Whether birth planning has changed.

The woman should understand which symptoms are not expected.

Return Immediately For

Seek urgent maternity or emergency assessment for:

Heavy vaginal bleeding.
Sudden or severe worsening pain.
Fainting.
Persistent vomiting.
Fever.
Fluid leakage.
Regular contractions.
Reduced fetal movements.
Chest pain.
Significant breathlessness.
Inability to pass urine.
Severe flank pain.
Severe headache.
Visual disturbance.
Upper-abdominal pain.
Feeling seriously unwell.

Do not wait for a scheduled clinic appointment when these symptoms occur.

Dr Tania’s Pain-Management Framework

I ask seven questions:

1. Has an emergency been excluded?

Review:

Maternal stability.
Placenta.
Labour.
Membranes.
Urinary tract.
Gastrointestinal and surgical causes.
Previous uterine scar.

2. Is the fetus reassuring?

Assess according to gestation and the current symptoms.

3. What is the least risky effective treatment now?

Consider:

Paracetamol.
Fluids.
Antiemetic.
Positioning.
Bowel care.
Selected prescription analgesia.

4. Is an NSAID appropriate at this gestation?

Review:

Gestational age.
Duration.
Amniotic fluid.
Kidney function.
Bleeding risk.
Other medicines.

5. Is pain improving as expected?

Use:

Repeat examination.
Pain trend.
Oral intake.
Mobility.
Maternal observations.
Fetal assessment.

6. Does persistent pain require a new diagnosis or surgical opinion?

Do not repeat the same treatment indefinitely when the course is atypical.

7. Is there a safe written plan for home?

Include:

Medicines.
Restrictions.
Follow-up.
Transport.
Emergency symptoms.
Maternity contact.

Red degeneration is usually managed conservatively, but conservative care is active care: confirm stability, exclude emergencies, treat pain safely for the pregnancy stage, maintain hydration and nutrition, reassess the course and escalate when the diagnosis no longer fits.

The next part will assess the relationship between fibroids, placenta, cervix and fetal growth, then translate previous myomectomy details into a pregnancy and birth-risk plan.

Placenta, Cervix and Fetal Growth

A fibroid pregnancy should not be monitored by repeatedly measuring tumours while ignoring the structures that determine obstetric care.

The clinically important map includes:

Placenta.
Internal cervical opening.
Cervical length when indicated.
Lower uterine segment.
Fetal anatomy.
Fetal growth.
Amniotic fluid.
Fetal presentation.
Doppler when a recognised indication exists.
Previous uterine scars.

The purpose is to identify a current complication—not to predict one from the word fibroid alone.

Begin With Placental Location

The routine mid-trimester ultrasound should identify placental location and its relationship to the internal cervical opening. ^[11,12]

In a pregnancy with multiple or large fibroids, the report should additionally describe:

Whether the placenta is separate from the dominant fibroids.
Whether it lies beside a fibroid.
Whether it partly overlies a fibroid.
Whether a fibroid lies behind the placenta.
Whether the placental bed appears distorted.
Whether lower-segment anatomy is difficult to assess.
Whether a previous uterine scar lies beneath the placenta.
Whether imaging is technically limited.

A placenta beside a fibroid is not automatically abnormal.

The relationship becomes more clinically important when there is:

Bleeding.
Pain.
Hypertension.
Fetal-growth concern.
Abnormal Doppler.
Placenta praevia.
Suspicion of placental separation.
Previous full-thickness uterine surgery.
Another placental risk factor.

Do Not Call Every Adjacent Fibroid Retroplacental

A fibroid should be described as retroplacental only when it is genuinely located behind the placental implantation site.

A fibroid may instead be:

Near the placental edge.
Beneath part of the placenta.
In the same uterine wall but not behind the placental bed.
Separated by normal myometrium.
Difficult to localise because of uterine distortion.

Precise language matters because retroplacental can imply a closer placental relationship than is actually demonstrated.

Fibroid–Placenta Relationships Can Be Difficult to Compare

The uterus changes shape during pregnancy.

Comparison between scans may be affected by:

Placental development.
Uterine expansion.
Fibroid compression.
Different probe angles.
Different operators.
Fetal position.
Acoustic shadowing.
Incomplete visualisation.

The placenta does not literally migrate.

Its lower edge may become farther from the cervix as the lower uterine segment develops.

Its relationship to a fibroid should be described at the time of each clinically relevant assessment.

Placenta Praevia Is a Separate Diagnosis

Placenta praevia means the placenta covers the internal cervical opening.

A low-lying placenta is close to—but does not cover—the opening according to the measurement and definition used in the relevant clinical pathway.

Fibroids may be associated with placenta praevia at a population level. ^[1,2]

The diagnosis should still be made by placental imaging.

A lower-segment fibroid does not itself equal placenta praevia.

Follow-Up of a Low Placenta

When the placenta is low at the mid-trimester scan, follow-up should follow the placental pathway.

Assessment may include:

Transvaginal ultrasound.
Distance from the placental edge to the internal opening.
Placental side.
Bleeding history.
Fetal presentation.
Previous caesarean or uterine surgery.
Fibroid distortion.
Vasa-praevia assessment when indicated.
Placenta-accreta-spectrum assessment when indicated.

Transvaginal ultrasound may provide more accurate information than transabdominal assessment of the placental edge.

A fibroid should not prevent appropriate transvaginal assessment when clinically indicated.

Bleeding With a Low Placenta Requires Prompt Assessment

Seek urgent maternity care for:

Fresh vaginal bleeding.
Heavy bleeding.
Bleeding with pain.
Bleeding with contractions.
Dizziness.
Fainting.
Reduced fetal movements.
Fluid leakage.
Feeling seriously unwell.

Do not assume that bleeding is caused by:

Fibroid degeneration.
Cervical pressure.
A previous episode.
Intercourse.
A known low placenta without reassessment.

The woman’s blood group, antibody status and anti-D requirements should be considered according to local care.

Placenta Accreta Spectrum

Placenta accreta spectrum occurs when placental tissue attaches abnormally deeply to the uterine wall.

Risk assessment is particularly important with:

Placenta praevia.
Previous caesarean birth.
Previous myomectomy.
Previous full-thickness uterine surgery.
Hysteroscopic surgery.
Curettage.
Endometrial ablation.
Uterine-artery embolisation.
Other uterine surgical trauma.
Suspicious ultrasound findings.

The updated 2026 RCOG guideline recognises that placenta accreta spectrum can be associated with uterine procedures beyond caesarean birth, including myomectomy. ^[14]

A history of myomectomy does not automatically diagnose placenta accreta spectrum.

It identifies a reason to assess placental implantation carefully when other risk factors or suspicious findings are present.

Specialist Placental Imaging

Specialist imaging may be required when there is:

Placenta praevia with previous uterine surgery.
Placenta over a scar.
Loss of the normal placental–myometrial interface.
Abnormal placental vascularity.
Placental lacunae.
Myometrial thinning.
Bladder-wall concern.
Difficult anatomy because of fibroids.
Another suspicious feature.

The plan may use:

Specialist ultrasound.
Colour Doppler.
Transvaginal ultrasound.
MRI in selected cases.
Multidisciplinary review.

MRI should complement—not replace—expert ultrasound when it is likely to clarify anatomy or surgical planning.

Do Not Diagnose Accreta From One Non-Specific Feature

Placental lakes, fibroid-related distortion or a thin-looking uterine wall do not prove placenta accreta spectrum by themselves.

Diagnosis should consider:

Placental location.
Surgical history.
Multiple ultrasound signs.
Imaging quality.
Gestational age.
Specialist interpretation.

False reassurance and overdiagnosis can both cause harm.

Placental Abruption

Fibroids have been associated with placental abruption in observational evidence. ^[1,2]

Abruption remains a clinical diagnosis.

Possible features include:

Vaginal bleeding.
Abdominal or back pain.
Uterine tenderness.
Frequent contractions.
A tense uterus.
Reduced fetal movements.
Fetal-heart-rate abnormality.
Maternal instability.
Coagulopathy.

Ultrasound may not show the abruption.

A fibroid behind or near the placenta does not allow pain to be labelled degeneration without urgent assessment when abruption is possible.

Placental Function Cannot Be Judged From Location Alone

A placenta beside a large fibroid may function normally.

Concern about placental dysfunction is based on findings such as:

Fetal-growth restriction.
Abnormal umbilical-artery Doppler.
Hypertension or preeclampsia.
Reduced fetal movements.
Abnormal fetal testing.
Placental bleeding.
Oligohydramnios when clinically relevant.
Another maternal or fetal sign.

No scan can guarantee future placental performance.

The plan should respond to current evidence.

The Cervix

Cervical assessment should answer:

Is the cervix structurally visible?
Is a fibroid distorting or displacing it?
Is a fibroid cervical or paracervical?
Is a lower-segment fibroid close to the internal opening?
Is cervical-length measurement technically reliable?
Is there a separate indication for preterm-birth surveillance?
Is the cervix accessible for examination or procedure?
Could the presenting part engage?

A fibroid uterus may make the cervix difficult to identify.

The report should state when assessment is limited.

Cervical Fibroids

A cervical fibroid may affect:

Bladder emptying.
Ureteric anatomy.
Cervical access.
Cervical length.
Labour assessment.
Engagement of the presenting part.
Vaginal birth.
Caesarean surgical access.

Important details include:

Anterior or posterior position.
Size in three dimensions.
Distance from the internal opening when measurable.
Relationship to the bladder.
Relationship to the presenting part.
Change over time.
Symptoms.

A cervical fibroid does not automatically require early birth.

It may require later anatomical reassessment and specialist birth planning.

Lower-Segment Fibroids

A lower-segment fibroid may:

Displace the cervix.
Prevent engagement.
Contribute to malpresentation.
Occupy the likely caesarean-incision site.
Displace the bladder.
Distort placental assessment.
Complicate vaginal examination.
Affect fetal extraction during surgery.

The clinically useful question is not simply whether a fibroid is low.

The question is what lies between:

The fetus.
The cervix.
The bladder.
The placenta.
The planned birth route.

Cervical Length Is Not a Fibroid-Risk Score

Fibroids alone do not create a universal indication for serial cervical-length scans.

Cervical surveillance may be indicated because of:

Previous spontaneous preterm birth.
Previous mid-trimester loss.
Symptoms of preterm labour.
A short cervix found incidentally.
Cervical surgery.
Multiple pregnancy under the relevant pathway.
A cervical or lower-segment fibroid that makes anatomy clinically important.
Another recognised indication.

The timing and frequency should follow the preterm-birth pathway and the woman’s history.

Measure Cervical Length Correctly

When cervical length is clinically required, transvaginal ultrasound is generally preferred.

The report should state:

Measurement method.
Shortest valid closed cervical length.
Presence of funnelling when relevant.
Dynamic change.
Technical limitations.
Relationship to a fibroid.
Whether the cervix is displaced.

A transabdominal estimate should not be treated as equivalent when the cervix cannot be seen reliably.

Do Not Treat the Scan Instead of the Woman

A short cervix requires assessment within the correct pathway.

Possible management may include:

Vaginal progesterone.
Cerclage.
Repeat assessment.
Symptom review.
Another intervention.

These decisions depend on:

Gestational age.
Cervical length.
Previous preterm birth.
Previous loss.
Cervical dilatation.
Membranes.
Infection.
Bleeding.
Local guidance.

Fibroids do not create an automatic indication for progesterone or cerclage.

Preterm-Labour Symptoms Still Matter

Seek assessment for:

Regular painful contractions.
Pelvic pressure.
Backache.
Fluid leakage.
Vaginal bleeding.
Change in discharge.
Cervical symptoms.
Reduced fetal movements.

A previously normal cervical length does not exclude later preterm labour.

Fibroid pain and uterine irritability can mimic contractions.

True labour requires clinical assessment.

Fetal Anatomy

The routine mid-trimester scan should assess fetal anatomy and placental location. ^[11,12]

Multiple or large fibroids may:

Limit ultrasound windows.
Distort the uterus.
Cast acoustic shadows.
Restrict probe access.
Obscure selected fetal structures.
Make fetal position less favourable.

The report should distinguish:

Anatomy visualised and reassuring.
Anatomy not adequately visualised.
A suspected abnormality.
A need for repeat or specialist imaging.

Not seen does not mean abnormal.

It also does not mean normal.

Repeat Anatomy Imaging

A repeat scan may be needed when:

Essential views were incomplete.
Fetal position was unfavourable.
Fibroid shadowing obscured anatomy.
Maternal factors limited imaging.
A possible abnormality requires specialist review.

The repeat should have a defined purpose.

Repeated scans should not continue indefinitely without deciding whether another imaging approach or specialist opinion is required.

Fetal Growth Is Not Measured by Fundal Height Alone

Fundal height may be inaccurate because of:

Large fibroids.
Multiple fibroids.
Irregular uterine contour.
Maternal body habitus.
Multiple pregnancy.
Amniotic-fluid variation.
Fetal position.

NICE recommends fundal-height measurement after 24 weeks in singleton pregnancies unless regular growth scans are already being performed, with ultrasound when clinical measurement is concerning. ^[11]

In a substantially fibroid-distorted uterus, the team should state whether fundal height remains interpretable.

Fibroids Do Not Automatically Mean Fetal-Growth Restriction

Research about fetal-growth restriction in fibroid pregnancies is inconsistent.

A fetus may be:

Appropriately grown.
Constitutionally small.
Small for gestational age.
Growth restricted because of placental dysfunction.
Large because of diabetes or constitutional factors.
Difficult to measure technically.

Do not assume that:

A large fibroid compresses the fetus into growth restriction.
Every placenta beside a fibroid is insufficient.
Every small measurement is caused by fibroids.
Every stable pregnancy requires frequent scans.

The diagnosis should follow the fetal-growth pathway.

When Growth Ultrasound May Be Reasonable

A growth scan may be considered when:

Fundal height is unreliable.
The uterus is markedly distorted.
A large fibroid lies close to the placenta.
Fetal anatomy was technically limited.
Maternal weight gain is poor.
Significant anaemia persists.
Hypertension or diabetes is present.
Previous fetal-growth restriction occurred.
A current clinical measurement raises concern.
Reduced fetal movements occur.
Another recognised risk factor exists.

The schedule should be individualised.

More scans are not automatically safer.

What a Growth Scan Should Include

A clinically useful assessment may include:

Biparietal diameter.
Head circumference.
Abdominal circumference.
Femur length.
Estimated fetal weight.
Growth centile.
Comparison with prior measurements.
Amniotic fluid.
Placental location.
Fetal presentation.
Technical limitations.
Doppler when indicated.

ISUOG’s third-trimester ultrasound guidance includes placental location, fetal presentation, biometry, growth pattern, amniotic fluid and Doppler assessment as clinically appropriate components. ^[12]

Growth Velocity

One measurement provides a size estimate.

Serial measurements may help assess growth velocity.

Interpretation should consider:

Interval between scans.
Measurement error.
Different operators.
Different machines.
Fetal position.
Fibroid shadowing.
Maternal anatomy.
Gestational-age accuracy.

Scans performed too close together may produce apparent change that reflects measurement variation rather than true growth.

Small for Gestational Age and Fetal-Growth Restriction Are Not Identical

A small-for-gestational-age fetus may be constitutionally small.

Fetal-growth restriction suggests failure to reach growth potential and may involve placental dysfunction.

Assessment may consider:

Estimated fetal weight.
Abdominal circumference.
Growth velocity.
Umbilical-artery Doppler.
Amniotic fluid.
Maternal blood pressure.
Fetal movements.
Other maternal, fetal or placental findings.

The diagnosis should not be made from one label on one scan without interpretation.

When Fetal-Growth Restriction Is Diagnosed

SMFM defines fetal-growth restriction using estimated fetal weight or abdominal circumference below the 10th percentile and recommends umbilical-artery Doppler surveillance once the diagnosis is established. ^[13]

The plan may include:

Detailed ultrasound.
Review of gestational dating.
Maternal blood-pressure assessment.
Review of fetal anatomy.
Genetic or infection assessment when indicated.
Umbilical-artery Doppler.
Cardiotocography.
Repeat growth.
Timing-of-birth planning.

The fibroid remains part of the maternal anatomy.

It does not replace the fetal-growth-restriction pathway.

Umbilical-Artery Doppler

Umbilical-artery Doppler assesses resistance in the placental circulation.

It may be indicated with:

Fetal-growth restriction.
Suspected placental dysfunction.
Another recognised high-risk condition.

It is not indicated merely because:

A fibroid is large.
Several fibroids are present.
A fibroid is intramural.
The placenta lies near a fibroid.
The woman had one episode of degeneration.

A normal result is reassuring for the issue assessed at that time.

It does not guarantee the remainder of the pregnancy.

Other Doppler Studies

Depending on the clinical situation and local pathway, the team may use:

Middle-cerebral-artery Doppler.
Ductus-venosus Doppler.
Uterine-artery Doppler.
Cerebroplacental ratio.

These tests have defined roles in selected conditions.

They should not be used as an unvalidated fibroid circulation panel.

Amniotic Fluid

Amniotic-fluid assessment may be clinically relevant with:

Suspected fetal-growth restriction.
Reduced fetal movements.
Ruptured membranes.
Diabetes.
Hypertension.
Fetal anomaly.
Post-dates pregnancy.
NSAID exposure requiring assessment.
Another indication.

Fibroids do not directly determine fluid volume in every pregnancy.

An abnormal result requires its own clinical pathway.

Fetal Presentation

Fibroids may contribute to:

Breech presentation.
Transverse lie.
Oblique lie.
Unstable lie.
Failure of the presenting part to engage.

The likelihood may depend on:

Fibroid size.
Fibroid location.
Lower-segment anatomy.
Placental location.
Parity.
Amniotic fluid.
Fetal factors.
Gestational age.

Presentation should be reassessed near birth.

A breech or transverse fetus in mid-pregnancy does not determine the final birth route.

External Cephalic Version

When the fetus remains breech near term, external cephalic version may be discussed according to the usual pathway.

The decision may be influenced by:

Fibroid location.
Uterine shape.
Placenta.
Amniotic fluid.
Fetal condition.
Previous uterine surgery.
Previous caesarean.
Ability to monitor and perform emergency birth.
Maternal preference.

Fibroids are not a single universal yes-or-no rule.

The team should assess whether the procedure is technically and clinically appropriate.

Reduced Fetal Movements

After the gestation at which movement awareness is advised, the woman should contact maternity services promptly if movements reduce or change.

NICE advises assessment whenever there are concerns about fetal movements after 24 weeks. ^[11]

Do not wait because:

A fibroid may cushion movement.
The placenta is anterior.
The woman has felt less movement before.
A growth scan was recently normal.
A home Doppler detects a heartbeat.

A home Doppler does not assess fetal wellbeing.

When Fibroids Limit Fetal Assessment

The report should say:

Which measurements are reliable.
Which views are limited.
Whether a different probe or position was attempted.
Whether specialist imaging is needed.
Whether MRI has a role for a separate defined question.
Whether surveillance should use another parameter.

Do not create false precision from technically difficult images.

Reassuring Findings

Reassuring features may include:

Placenta clear of the cervix.
No suspicious accreta-spectrum feature.
Fibroids separate from the placental bed.
Cervix reassuring when assessed for a valid indication.
Complete fetal anatomy.
Appropriate growth.
Normal amniotic fluid.
Cephalic presentation near term.
Normal Doppler when indicated.
No bleeding or preterm-labour symptoms.
Reassuring fetal movements.

These findings support proportionate care.

They do not provide an outcome guarantee.

Findings That May Change Care

The plan may change with:

Placenta praevia.
Suspicion of placenta accreta spectrum.
Recurrent bleeding.
Suspected placental abruption.
Short cervix within a recognised pathway.
Fetal-growth restriction.
Abnormal Doppler.
Oligohydramnios.
Persistent malpresentation.
A lower-segment fibroid obstructing the presenting part.
Technically incomplete fetal assessment.
Reduced fetal movements.
Another maternal or fetal complication.

The condition driving risk should determine the intervention.

Dr Tania’s Placenta–Cervix–Growth Framework

I ask seven questions:

1. Where is the placenta?

Document:

Site.
Distance from the cervix when relevant.
Relationship to fibroids.
Relationship to uterine scars.
Imaging limitations.

2. Is placental implantation reassuring?

Review:

Bleeding.
Accreta-spectrum risk.
Abruption concern.
Specialist imaging when indicated.

3. Can the cervix and lower segment be defined?

Review:

Cervical or lower-segment fibroids.
Cervical accessibility.
Bladder displacement.
Reliability of cervical measurement.

4. Is fetal anatomy complete?

Separate:

Normal visualised anatomy.
Incomplete views.
Suspected abnormality.

5. Is growth assessment technically and clinically appropriate?

Review:

Fundal-height reliability.
Growth risk.
Measurement quality.
Need for serial assessment.

6. Is placental surveillance indicated?

Use:

Growth.
Doppler.
Amniotic fluid.
Fetal movements.
Maternal condition.

Do not use fibroid count as the surveillance plan.

7. Will the anatomy change birth planning?

Review:

Placenta praevia.
Accreta-spectrum concern.
Fetal presentation.
Lower-segment obstruction.
Previous uterine scars.
Anticipated surgical access.

The obstetric map is not complete until it shows the placenta, cervix, lower uterine segment, fetal growth and presentation. Fibroid measurements matter only when they help explain or anticipate a specific maternal, fetal, placental or surgical issue.

The next part will translate previous hysteroscopic, laparoscopic, robotic or open myomectomy details into a scar-specific pregnancy and birth plan without relying on an unvalidated universal scar-thickness or cavity-entry rule.

Pregnancy After Myomectomy

A pregnancy after myomectomy is not defined by the word scar alone.

Myomectomy may have been:

Hysteroscopic.
Laparoscopic.
Robot assisted.
Open abdominal.
Vaginal.
Combined.
Converted from minimally invasive to open surgery.
Performed during a previous caesarean birth.
Performed during pregnancy in an exceptional emergency.

The operation may have removed:

One superficial pedunculated fibroid.
One deep intramural fibroid.
Several fibroids through one incision.
Several fibroids through multiple incisions.
A submucosal fibroid from inside the uterine cavity.
A lower-segment fibroid.
A fundal or cornual fibroid.
A fibroid close to the placenta in a previous pregnancy.

These operations do not create identical uterine scars.

The safest pregnancy plan reconstructs what was cut, how deeply, where, how it was closed and whether the endometrial cavity was entered or unintentionally perforated.

Retrieve the Operative Note

The operative note is often the most valuable document.

It may record:

Date.
Surgical approach.
Number of fibroids removed.
Size of each fibroid.
Location.
FIGO type when documented.
Number of uterine incisions.
Depth of myometrial dissection.
Full-thickness entry.
Endometrial-cavity entry.
Cornual or fundal involvement.
Lower-segment involvement.
Use of electrosurgery.
Method of haemostasis.
Number of closure layers.
Suture material.
Whether the uterine wall was reconstructed.
Haematoma.
Blood loss.
Transfusion.
Conversion to open surgery.
Postoperative infection.
Surgeon’s advice about conception and birth.

A discharge summary may omit most of this information.

The full operative note should be requested whenever possible.

Review the Pathology Report

Pathology may confirm:

Leiomyoma.
Cellular leiomyoma.
Degenerative change.
Adenomyoma.
Another benign diagnosis.
Atypical or uncertain features requiring follow-up.

The current pregnancy should not be managed from an imprecise memory that a tumour was removed.

The histological diagnosis matters when the original mass was unusual.

Identify the Surgical Route

Hysteroscopic myomectomy

Hysteroscopic surgery removes intracavity or cavity-projecting fibroids through the cervix.

It usually does not create the same outer full-thickness uterine-wall scar as laparoscopic or open myomectomy.

Important exceptions include:

Deep intramural extension.
Uterine perforation.
Extensive myometrial resection.
Repeat procedures.
Thermal injury.
Incomplete operative documentation.
Subsequent intrauterine adhesions.

Hysteroscopic myomectomy should not automatically be treated as an indication for planned caesarean birth.

The actual procedure and complications should be reviewed.

Laparoscopic or robotic myomectomy

A minimally invasive abdominal approach may involve:

Superficial serosal removal.
Deep intramural dissection.
Multiple uterine incisions.
Cavity entry.
Extensive electrosurgery.
Single-layer or multilayer closure.
Morcellation of the removed fibroid.

A small skin incision does not mean a small uterine incision.

The external approach alone cannot determine labour safety.

Open abdominal myomectomy

An open operation may involve:

One superficial fibroid.
Multiple deep fibroids.
Several uterine incisions.
Cavity entry.
Extensive reconstruction.
Significant blood loss.
Adhesiolysis.

An open operation is not automatically more or less secure than a laparoscopic operation.

The uterine details matter more than the abdominal route.

Vaginal myomectomy

A vaginal approach is uncommon and may be used for selected:

Cervical fibroids.
Prolapsed submucosal fibroids.
Lower uterine lesions.

The operative note should clarify:

Whether the uterine wall was entered.
Whether the cervix was reconstructed.
Whether there was perforation.
Whether a later pregnancy or birth restriction was advised.

Number and Location of Uterine Incisions

The plan should identify:

One incision or several.
Anterior, posterior, fundal, lateral or cornual location.
Lower-segment involvement.
Whether an incision crossed most of the myometrial thickness.
Whether more than one uterine surface was entered.
Whether a caesarean scar also exists.

A fundal scar, lower-segment scar and superficial pedunculated-fibroid scar may not carry the same practical considerations.

Evidence does not provide a validated risk calculator that converts these features into an exact individual rupture probability.

Endometrial-Cavity Entry

Cavity entry is often treated as an important surgical detail.

It may indicate:

Deep dissection.
Full-thickness uterine entry.
Need for endometrial and myometrial closure.
Potential placental implantation over a scar.
A reason for more cautious birth planning.

Cavity entry alone is not a perfectly validated yes-or-no rule for:

Uterine rupture.
Planned caesarean birth.
Timing of birth.
Placenta accreta spectrum.
Future fertility.

The information should be considered with the entire operation.

Closure Technique

The operative record may describe:

Single-layer closure.
Double-layer closure.
Multilayer closure.
Interrupted sutures.
Continuous sutures.
Barbed suture.
Haemostatic sutures.
Serosal closure.
No closure for a superficial pedunculated lesion.

No closure description can guarantee scar strength.

The absence of detailed documentation does not prove that closure was inadequate.

It increases uncertainty and may influence how cautiously the pregnancy is managed.

Electrosurgery and Thermal Injury

Electrosurgery may have been used for:

Uterine incision.
Fibroid dissection.
Haemostasis.
Treatment of the fibroid bed.

The operative note rarely quantifies thermal injury precisely.

Concern may be greater with:

Extensive coagulation.
Difficult haemostasis.
Limited suturing.
Deep tissue damage.
Postoperative haematoma.

There is no clinically validated threshold of electrosurgery use that predicts rupture for an individual woman.

Postoperative Complications

Review:

Fever.
Infection.
Wound complication.
Pelvic collection.
Haematoma.
Readmission.
Reoperation.
Transfusion.
Delayed healing.
Uterine fistula.
Intrauterine adhesions.
Persistent pain.
Abnormal imaging.

Complications may affect:

Confidence in healing.
Placental assessment.
Adhesion risk.
Surgical planning.
Future fertility.

They should be documented rather than assumed from the surgical route.

Interval From Myomectomy to Conception

Women are often told to wait:

Three months.
Six months.
Twelve months.
Longer.

The evidence does not establish one universal minimum interval that prevents uterine rupture.

A systematic review found insufficient evidence to recommend a specific minimum time between myomectomy and conception. ^[15]

Preconception advice may still consider:

Extent of surgery.
Healing.
Anaemia.
Infection.
Repeat imaging.
Fertility and age.
Surgeon’s recommendation.
Other medical conditions.

A short interval should be documented and discussed.

It should not be used alone to predict that rupture will occur.

Pregnancy Before the Recommended Interval

When conception occurs earlier than advised:

Do not assume the pregnancy cannot continue safely.
Retrieve the operative details.
Review symptoms.
Establish placental location.
Plan specialist obstetric review.
Discuss uncertainty honestly.
Create an emergency-symptom plan.
Avoid unsupported claims that one scan can certify the scar.

The woman should not be blamed.

The plan should focus on the current pregnancy.

Uterine Rupture Is Rare but Serious

Uterine rupture after myomectomy is uncommon.

It may occur:

Before labour.
During labour.
Before term.
At term.
With few warning symptoms.
With sudden maternal or fetal deterioration.

A systematic review reported an overall rupture incidence below 1% in the available pregnancy-after-myomectomy literature and found that several reported ruptures occurred before labour and before 36 weeks. ^[15]

These estimates come from limited and heterogeneous evidence.

They should not be presented as an exact personal risk.

Trial-of-Labour Evidence

The same systematic review reported a rupture risk of approximately 0.5% among women who underwent a trial of labour after myomectomy. ^[15]

This does not mean that:

Every woman should labour.
Every woman should have a caesarean birth.
The risk is identical after every operation.
The review can identify which individual scar will rupture.
Labour is the only period of risk.

The review did not identify reliable operative risk factors from the variables available. ^[15]

Counselling should acknowledge both the low absolute reported risk and the uncertainty of individual prediction.

Do Not Use Approach Alone to Decide Mode of Birth

Avoid rules such as:

Laparoscopic means caesarean.
Open means labour is safe.
Robotic means the scar is stronger.
Hysteroscopic always means no scar issue.
One fibroid means vaginal birth.
Several fibroids mean caesarean.

The decision should consider:

Operative details.
Number and depth of incisions.
Cavity entry.
Fibroid location.
Closure.
Postoperative complications.
Current placental location.
Current remaining fibroids.
Fetal presentation.
Other uterine scars.
Maternal preferences.
Local expertise and emergency access.

Do Not Use Fibroid Size Removed as the Only Rule

A large pedunculated fibroid may require little uterine-wall reconstruction.

A smaller deep intramural fibroid may require full-thickness dissection.

The size removed should be interpreted with:

Depth.
Location.
Number of incisions.
Cavity entry.
Closure.
Surgeon’s description.

There is no universal removed-fibroid diameter that determines birth route.

Ultrasound Cannot Certify Scar Strength

Ultrasound may occasionally visualise:

Myometrial thickness.
Scar contour.
Defect.
Dehiscence.
Placental relationship.
Residual fibroids.

There is no universally validated ultrasound scar-thickness threshold that proves a myomectomy scar is safe for labour or predicts rupture.

A reassuring-looking scar does not guarantee integrity.

A thin-looking area does not automatically establish impending rupture.

Imaging should be interpreted by specialists within the full clinical context.

MRI Cannot Certify Scar Strength

MRI may help define:

Complex anatomy.
Placental relationship.
A suspected defect.
Lower-segment or fundal anatomy.
Residual fibroids.
Another pelvic diagnosis.

It cannot provide a validated guarantee that labour is safe.

Routine MRI solely to measure every myomectomy scar is not supported.

Use it when the result is likely to answer a defined clinical question.

Symptoms That Require Urgent Assessment

Seek urgent maternity or emergency care for:

Sudden severe abdominal pain.
Persistent unexplained pain.
Pain different from previous degeneration.
Vaginal bleeding.
Fainting.
Maternal collapse.
Shoulder-tip pain with abdominal symptoms.
New breathlessness.
Reduced fetal movements.
Regular contractions.
Fluid leakage.
Abnormal fetal-heart-rate concern.
Severe scar-site tenderness.
Feeling seriously unwell.

Uterine rupture does not always present with a classic symptom pattern.

A previous myomectomy should lower the threshold for obstetric assessment when severe unexplained pain occurs.

Pain Is Not Automatically Scar Pain

Possible causes still include:

Fibroid degeneration.
Placental abruption.
Preterm labour.
Urinary disease.
Appendicitis.
Gallbladder disease.
Ovarian torsion.
Musculoskeletal pain.
Adhesion-related pain.
Another medical or surgical condition.

The previous scar is important.

It must not replace a complete acute-pain assessment.

Placental Location After Myomectomy

The pregnancy plan should document:

Placental site.
Relationship to each known uterine scar.
Relationship to residual fibroids.
Placenta praevia.
Suspicious accreta-spectrum features.
Imaging limitations.

The updated RCOG placenta praevia and placenta accreta spectrum guidance recognises myomectomy among forms of uterine surgical trauma associated with placenta accreta spectrum risk. ^[14]

Risk is not determined by myomectomy alone.

It becomes especially important when the placenta is low, over a scar or has suspicious imaging features.

Low Placenta Over a Uterine Scar

When a low placenta or placenta praevia overlies a uterine scar, assessment may include:

Specialist ultrasound.
Colour Doppler.
Transvaginal imaging.
MRI in selected cases.
Referral to an accreta-spectrum centre when suspected.
Multidisciplinary birth planning.

NICE recommends specialist accreta assessment when a low or praevia placenta occurs with a previous uterine scar from caesarean or other surgery. ^[14]

Fibroids may make imaging more difficult.

Difficulty should be documented rather than converted into false reassurance.

Intrauterine Adhesions

Hysteroscopic or cavity-entering surgery may contribute to intrauterine adhesions.

Possible implications include:

Infertility.
Implantation difficulty.
Abnormal placentation.
Retained placenta.
Menstrual change before pregnancy.
Difficulty interpreting the uterine cavity.

A history of adhesions should be recorded.

It does not automatically predict one pregnancy outcome.

Residual or Recurrent Fibroids

Pregnancy after myomectomy may still include:

Residual fibroids.
New fibroids.
Fibroids too small to remove previously.
A dominant lesion in another wall.
Lower-segment fibroids.
Placenta-adjacent fibroids.

The current anatomy must be mapped separately from the surgical scar.

A previous myomectomy does not mean the current uterus is fibroid free.

Combined Myomectomy and Caesarean Scars

Some women have:

Previous myomectomy.
Previous caesarean birth.
More than one caesarean.
A classical or unusual uterine incision.
A previous extension or repair.

Birth planning should identify each scar.

The plan should not assume that the usual vaginal-birth-after-caesarean pathway alone covers a deep myomectomy scar.

Specialist review is required.

Previous Uterine Rupture or Dehiscence

A history of:

Complete uterine rupture.
Scar dehiscence.
Incomplete separation.
Surgical repair.
Haemoperitoneum.

requires highly individualised specialist management.

Review:

Operative report.
Location and extent.
Repair.
Gestation.
Whether labour was present.
Current placental site.
Current symptoms.

This history is different from uncomplicated myomectomy.

Fertility Treatment After Myomectomy

Assisted reproduction may add considerations such as:

Precise embryo-transfer dating.
Multiple pregnancy.
Placental risk.
Maternal age.
Infertility diagnosis.
Previous implantation failure.
Anxiety after treatment.

The mode of conception does not determine scar strength.

It should be included in the overall pregnancy risk assessment.

Cervical and Lower-Segment Surgery

When myomectomy involved:

Cervix.
Lower uterine segment.
Broad-ligament region.
Bladder dissection.
Ureteric dissection.

the current plan should assess:

Cervical anatomy.
Bladder displacement.
Ureteric anatomy.
Lower-segment access.
Presenting-part engagement.
Potential uterine incision.
Need for urology or senior surgical support.

These questions may be more important than general scar-thickness measurement.

Fundal and Cornual Surgery

Fundal or cornual surgery may be relevant because:

The scar is outside the usual lower-segment caesarean area.
Rupture may occur before labour.
The placenta may implant near the scar.
Pain location may be atypical.
Surgical access at caesarean may differ.

The operative note should clarify whether:

The uterine cavity was entered.
The tube or cornua was involved.
A wedge-type resection occurred.
Another ectopic-pregnancy surgery was performed.

Do not combine all fundal scars into one risk category without detail.

Myomectomy During a Previous Caesarean Birth

When a fibroid was removed at caesarean birth, retrieve the operative note.

Clarify:

Which fibroid was removed.
Whether it was pedunculated.
Whether the lower segment was entered separately.
Whether the caesarean incision was extended.
Whether an additional uterine incision was made.
Blood loss.
Closure.
Complications.
Future-birth advice.

The woman may have more than one uterine scar from the same operation.

Caesarean Myomectomy in the Current Pregnancy

Previous successful caesarean myomectomy does not mean that current fibroids should also be removed at birth.

The decision depends on current:

Fibroid anatomy.
Placenta.
Uterine incision.
Surgical access.
Blood-loss risk.
Haemoglobin.
Team experience.
Need for removal to deliver the fetus or close the uterus.
Future fertility.

The evidence remains uncertain. ^[5]

No promise should be made antenatally that all fibroids will be removed.

Conception After Uterine-Artery Embolisation or Ablation

These procedures are not myomectomy.

They may alter:

Uterine blood supply.
Myometrial tissue.
Endometrium.
Fibroid tissue.
Placental implantation.

The pregnancy requires specialist review of:

Procedure type.
Treated area.
Imaging.
Placenta.
Fetal growth.
Remaining fibroids.
Symptoms.
Birth planning.

Do not apply myomectomy counselling automatically to embolisation, radiofrequency ablation or focused-ultrasound treatment.

Antenatal Surveillance Is Not One Universal Schedule

Previous myomectomy does not automatically prescribe:

Weekly scans.
Routine scar measurements.
Repeated MRI.
Early cardiotocography.
Bed rest.
Admission.
Steroids.
Aspirin.
Heparin.

Surveillance should reflect:

Operative uncertainty.
Placental site.
Residual fibroids.
Fetal growth.
Maternal symptoms.
Other medical or obstetric risk.

The detailed surveillance framework will follow in Part 4C.

Birth Planning Should Begin Before Labour

The plan should be documented before term.

It should state:

Whether the operative note was reviewed.
What type of myomectomy occurred.
Whether cavity entry or full-thickness surgery was documented.
Number and location of uterine incisions.
Other uterine scars.
Placental location.
Residual fibroid map.
Fetal presentation.
Whether labour is being considered.
Whether planned caesarean birth is advised.
Level of maternity unit required.
Blood and surgical preparation.
What to do if labour or membrane rupture occurs earlier.

The detailed timing and mode-of-birth decisions will be discussed later.

When Operative Records Cannot Be Obtained

Record exactly what is known:

Country and hospital.
Year.
Surgical route recalled.
Number and approximate size of fibroids.
Whether the woman was told the cavity was entered.
Whether she was advised to avoid labour.
Postoperative hospital stay.
Complications.
Abdominal scars.
Any later imaging.
Any previous birth after the surgery.

Uncertainty should be acknowledged.

It should not be replaced by invented certainty.

A more cautious plan may be reasonable when surgery appears extensive and records remain unavailable.

The Woman’s Preferences Matter

Counselling should explore:

Desire for vaginal birth.
Concern about uterine rupture.
Concern about repeat surgery.
Previous birth trauma.
Recovery needs.
Future pregnancies.
Blood-transfusion preferences.
Distance from emergency care.
Understanding of uncertainty.

Shared decision-making does not mean presenting all options as equally appropriate.

It means explaining:

What is known.
What is uncertain.
What the team recommends.
Why.
What alternatives exist.
What may change the plan.

Avoid False Reassurance

Do not say:

The scar is completely healed because six months passed.
The scar is safe because ultrasound looks normal.
A laparoscopic scar cannot rupture.
An open scar is always stronger.
No cavity entry means no risk.
A planned caesarean removes all rupture risk.
A previous vaginal birth proves the scar will remain intact.

Risk may be low.

It is not zero.

Avoid Automatic Caesarean Counselling Without Review

Do not say:

Every myomectomy requires caesarean birth.
Hysteroscopic surgery requires caesarean birth.
One removed fibroid prohibits labour.
Cavity entry is the only fact that matters.
A patient cannot participate in the decision.

Some women may be candidates for planned vaginal birth after specialist review.

Others may be advised planned caesarean birth because the operation involved extensive or deep uterine surgery or because records are concerning or uncertain.

The recommendation should be individualised.

Dr Tania’s Myomectomy Framework

I ask eight questions:

1. What operation was actually performed?

Define:

Route.
Date.
Fibroids removed.
Uterine incisions.
Cavity entry.
Closure.
Complications.

2. Where is the scar?

Identify:

Fundal.
Cornual.
Anterior.
Posterior.
Lateral.
Lower segment.
Cervical.
Multiple sites.

3. Is the placenta related to the scar?

Review:

Placental location.
Low placenta or praevia.
Accreta-spectrum features.
Specialist imaging.

4. What is the current uterine anatomy?

Map:

Residual fibroids.
Lower-segment obstruction.
Cervix.
Bladder.
Fetal presentation.

5. Are there symptoms that could represent scar complication?

Review:

Severe pain.
Bleeding.
Maternal instability.
Fetal-heart-rate concern.
Preterm labour.
Reduced fetal movements.

6. Can individual rupture risk be quantified reliably?

Usually not precisely.

Explain the limited evidence and avoid unvalidated scar-thickness or surgery-type formulas.

7. What birth options are clinically appropriate?

Consider:

Operative details.
Other scars.
Placenta.
Presentation.
Emergency resources.
Maternal preferences.

The detailed recommendation belongs in the later birth-planning section.

8. Is the emergency plan clear?

Document what to do with:

Pain.
Bleeding.
Labour.
Membrane rupture.
Reduced fetal movements.
Maternal deterioration.

Pregnancy after myomectomy requires scar reconstruction, not scar mythology. The operative note, incision depth and location, cavity entry, closure, placental relationship, residual fibroids and current symptoms should be read together—without pretending that one surgical label or ultrasound thickness can predict uterine rupture.

The next part will create the risk-stratified Maternal and Fetal Surveillance plan, distinguishing stable treated anatomy from pregnancies requiring closer review because of pain, placental disease, fetal-growth concern, lower-segment obstruction or a significant uterine scar.

Maternal and Fetal Surveillance

Surveillance should follow the risk that is present.

It should not follow the fibroid label alone.

A woman with:

Several stable fibroids.
No significant pain.
Reassuring haemoglobin.
A placenta clear of the cervix.
Complete fetal anatomy.
Appropriate fetal growth.
Cephalic presentation later in pregnancy.
No important myomectomy scar.
No other maternal or obstetric condition.

may require routine antenatal care with selected anatomical reassessment.

A woman may require closer monitoring when there is:

Recurrent or severe pain.
Low maternal weight or poor weight gain.
Persistent anaemia.
Heavy bleeding.
Placenta praevia.
Placenta accreta spectrum concern.
Placental abruption concern.
Fetal-growth restriction.
Reduced fetal movements.
Abnormal Doppler.
Oligohydramnios.
Persistent malpresentation.
A cervical or lower-segment fibroid.
Urinary obstruction.
Previous extensive myomectomy.
An uncertain uterine scar.
Hypertension.
Diabetes.
Multiple pregnancy.
Another recognised high-risk condition.

The plan should state:

What is being monitored.
Why it is being monitored.
How often.
Who will review the result.
What finding will change care.

Routine Care May Be Appropriate

Routine care may remain appropriate when:

Fibroids are incidental.
Anatomy is well defined.
The placenta is reassuring.
The cervix is not obstructed.
Fetal anatomy is complete.
Fundal-height assessment remains interpretable or an alternative growth plan is documented.
Maternal symptoms are absent or mild.
Haemoglobin and iron reserve are adequate.
No previous deep uterine surgery exists.
No other obstetric risk is present.

Routine care does not mean ignoring the diagnosis.

It means avoiding unnecessary testing while preserving:

Symptom review.
Blood-pressure care.
Anaemia prevention.
Fetal-movement advice.
Reassessment of presentation and lower-segment anatomy when clinically relevant.
A written birth plan before labour.

There Is No Universal Fibroid Scan Schedule

Multiple or large fibroids do not automatically require:

Scans every two weeks.
Monthly fibroid measurement.
Weekly Doppler.
Routine cardiotocography.
Routine biophysical profiles.
Repeated magnetic resonance imaging.
Repeated scar-thickness measurement.
Hospital admission.
Bed rest.

The number of scans should be determined by:

Reliability of fundal height.
Fibroid location.
Placental relationship.
Maternal symptoms.
Fetal-growth risk.
Previous obstetric history.
Myomectomy details.
Fetal presentation.
Lower-segment anatomy.
Another maternal or fetal condition.

A test should be repeated only when the result may change care.

Map Once, Then Reassess Strategically

After a detailed baseline map, later scans may focus on:

The placenta.
The cervix or lower uterine segment.
Fetal growth.
Fetal presentation.
Amniotic fluid.
Doppler when indicated.
A dominant fibroid affecting birth access.
A fibroid associated with recurrent symptoms.
A previous uterine scar when a defined abnormality is suspected.

Not every small fibroid requires serial measurement.

The dominant and strategically located fibroids matter most.

Maternal Symptom Review

At each relevant contact, review:

Abdominal or pelvic pain.
Vaginal bleeding.
Contractions.
Fluid leakage.
Urinary symptoms.
Urinary retention.
Flank pain.
Constipation.
Vomiting.
Fever.
Breathlessness.
Dizziness.
Fainting.
Fetal movements after the appropriate gestation.
Ability to eat and drink.
Mobility.
Medicine use.

Symptoms may change the surveillance plan more quickly than a routine scan date.

Pain Surveillance

A woman with recurrent pain should have a written plan that states:

Which symptoms may be managed initially at home.
Which medicine is permitted.
Which medicine must not be self-started.
When to contact maternity triage.
When to attend urgently.
Whether previous myomectomy lowers the threshold for review.
Whether a known pedunculated fibroid is present.
Whether urinary obstruction has occurred.
Whether placental disease has been excluded.

Surveillance should not normalise severe pain.

Each new episode must be assessed on its own features.

Bleeding Surveillance

Any bleeding should be assessed according to:

Gestational age.
Amount.
Pain.
Placental location.
Maternal observations.
Fetal condition.
Contractions.
Cervical findings.
Blood group.
Antibody status.
Haemoglobin.
Previous uterine surgery.

Recurrent bleeding may require:

Repeat placental imaging.
Anaemia review.
Fetal-growth assessment.
Admission.
Corticosteroids when preterm birth risk meets the clinical pathway.
Birth-planning review.

Fibroids should not be used as a default explanation.

Maternal Weight and Intake

Review:

Pre-pregnancy weight.
Weight trend.
Appetite.
Early fullness.
Vomiting.
Pain limiting food.
Dietary restriction.
Food insecurity.
Protein intake.
Hydration.
Bowel function.

Closer nutritional review may be needed with:

Weight loss.
Poor gain.
Recurrent admission.
Persistent vomiting.
Severe pressure symptoms.
Anaemia.
Diabetes.
Planned complex surgery.

Weight does not measure fetal growth reliably.

It is one part of maternal assessment.

Haemoglobin and Iron Reserve

A surveillance plan may include:

Full blood count.
Ferritin.
Response to oral iron.
Response to intravenous iron.
Symptoms.
Ongoing bleeding.
Time before birth.
Expected surgical complexity.
Previous transfusion.

Testing frequency should reflect:

Initial severity.
Treatment.
Gestation.
Symptoms.
Blood loss.
Planned birth.

The objective is to enter birth with the best achievable haemoglobin and iron reserve.

A normal early-pregnancy result does not exclude later deficiency.

Anaemia Escalation

Escalate review when there is:

Falling haemoglobin.
Severe fatigue.
Breathlessness.
Palpitations.
Dizziness.
Fainting.
Poor response to oral treatment.
Oral intolerance.
Late gestation with inadequate correction.
Recurrent bleeding.
Anticipated complex surgery.
Another cause of anaemia.

The plan may require:

Different oral treatment.
Intravenous iron.
Haematology review.
Investigation of another deficiency or haemoglobinopathy.
Blood-bank planning.
Transfusion in selected urgent circumstances.

The treatment route should be individualised.

Blood Pressure and Preeclampsia Surveillance

Fibroids do not replace routine blood-pressure care.

At antenatal contacts, assess according to the maternity pathway:

Blood pressure.
Symptoms.
Urine protein when indicated.
Platelets.
Kidney function.
Liver tests.
Fetal growth.
Fetal movements.

Seek urgent assessment with:

Severe headache.
Visual disturbance.
Upper-abdominal pain.
Sudden swelling with other symptoms.
Marked breathlessness.
Reduced fetal movements.
Feeling seriously unwell.

Do not attribute upper-abdominal pain to a fundal fibroid until hypertensive disease has been considered.

Diabetes Surveillance

When diabetes is present, surveillance may include:

Glucose review.
Medication adjustment.
Fetal growth.
Amniotic fluid.
Blood pressure.
Fetal surveillance.
Birth timing.
Neonatal planning.

The fibroid plan and diabetes plan should be integrated.

One condition should not obscure the other.

Urinary Surveillance

Closer review may be required with:

Lower-segment fibroids.
Cervical fibroids.
Lateral pelvic fibroids.
Previous retention.
Hydronephrosis.
Recurrent urinary infection.
Flank pain.
Altered kidney function.

Assessment may include:

Urinalysis.
Urine culture.
Creatinine.
Bladder scan.
Post-void residual.
Renal ultrasound.
Urology review.

Seek prompt care for:

Inability to pass urine.
Fever.
Severe flank pain.
Reduced urine.
Vomiting.
Feeling seriously unwell.

Bowel Function

Monitor:

Constipation.
Opioid use.
Iron treatment.
Hydration.
Fibre tolerance.
Abdominal distension.
Passage of stool and gas.
Vomiting.

Persistent vomiting, severe distension or inability to pass stool or gas requires assessment for obstruction.

Do not continue adding fibre when bowel obstruction is possible.

Thrombosis Risk

Reassess venous-thromboembolism risk with:

Admission.
Reduced mobility.
Surgery.
Dehydration.
Infection.
Obesity.
Multiple pregnancy.
Preeclampsia.
Postpartum haemorrhage.
Another risk factor.

The plan may include:

Mobilisation.
Hydration.
Mechanical prevention.
Pharmacological prevention when indicated.

Fibroid size or number alone is not an anticoagulation indication.

Review of Medicines

At each clinically relevant point, review:

Analgesics.
Non-steroidal anti-inflammatory medicines.
Aspirin.
Anticoagulants.
Antiemetics.
Iron.
Laxatives.
Antihypertensives.
Diabetes medicines.
Herbal products.
Over-the-counter medicines.
Combination cold or pain products.

The review should identify:

Indication.
Gestational-age suitability.
Duration.
Duplication.
Side effects.
Monitoring.
Stop plan.

A medicine that was acceptable earlier in pregnancy may not remain appropriate later.

Fetal Anatomy Completion

If the routine anatomy scan was incomplete because of fibroid shadowing or fetal position, document:

Structures not seen.
Repeat-scan plan.
Specialist referral.
Whether the repeat remains technically limited.
Whether another modality is appropriate for a defined question.

Surveillance should not proceed as though anatomy was complete when essential views remain missing.

The record should state the final status clearly.

Growth Surveillance

Growth assessment may be reasonable when:

Fundal height is unreliable.
The uterus is markedly distorted.
A dominant fibroid lies close to the placental bed.
Maternal weight gain is poor.
Significant anaemia persists.
Hypertension or diabetes is present.
Previous fetal-growth restriction occurred.
Current clinical assessment raises concern.
Fetal movements reduce.
Another recognised risk exists.

NICE recommends ultrasound for fetal growth and wellbeing when fundal-height measurement raises concern, with urgency influenced by findings such as reduced fetal movements or raised blood pressure. ^[11]

A fibroid-distorted uterus may make clinical measurement unreliable.

The plan should state whether growth ultrasound is replacing fundal-height surveillance.

Timing of Growth Scans

The interval should allow meaningful assessment of growth velocity.

The schedule depends on:

Gestational age.
Previous measurements.
Severity of concern.
Doppler.
Maternal condition.
Technical quality.
Local fetal-growth pathway.

Scans performed too close together may exaggerate measurement noise.

A routine fixed interval should not be copied to every fibroid pregnancy.

What to Document on Growth Ultrasound

A useful scan may include:

Fetal viability.
Presentation.
Placental location.
Biometry.
Estimated fetal weight.
Abdominal circumference.
Growth centiles.
Comparison with previous measurements.
Amniotic fluid.
Doppler when indicated.
Dominant lower-segment fibroid.
Technical limitations.

ISUOG’s third-trimester ultrasound guidance includes placental location, fetal presentation, biometry, growth pattern, amniotic-fluid assessment and Doppler when clinically appropriate. ^[12]

Fetal-Growth Restriction

When fetal-growth restriction is diagnosed, the plan should move into a recognised fetal-growth-restriction pathway.

SMFM recommends:

Definition using estimated fetal weight or abdominal circumference below the 10th percentile.
Umbilical-artery Doppler surveillance after diagnosis.
Increased monitoring with more severe Doppler abnormalities.
Cardiotocography after viability according to severity and comorbidity.
Birth timing based on gestation, fetal size, Doppler and the complete clinical picture. ^[13]

Fibroids may be part of the maternal background.

They do not replace this pathway.

Small for Gestational Age

A fetus may be small but otherwise reassuring.

Assessment should distinguish:

Constitutionally small fetus.
Fetal-growth restriction.
Dating uncertainty.
Measurement limitation.
Placental dysfunction.
Fetal condition.

Do not diagnose placental insufficiency from fibroids alone.

Do not dismiss poor growth because fibroids can distort ultrasound.

Doppler Surveillance

Umbilical-artery Doppler is appropriate when fetal-growth restriction or another recognised placental indication exists.

It is not a routine test merely because:

Several fibroids are present.
A fibroid is large.
A fibroid is intramural.
The placenta lies near a fibroid.
A degeneration episode occurred.
A myomectomy scar exists.

Doppler frequency should follow the fetal condition and local pathway.

Cardiotocography and Biophysical Profile

Antenatal fetal testing may be indicated with:

Fetal-growth restriction.
Abnormal Doppler.
Reduced fetal movements.
Hypertension.
Diabetes.
Recurrent bleeding.
Another recognised condition.

Stable fibroids alone do not automatically require:

Weekly cardiotocography.
Twice-weekly non-stress tests.
Routine biophysical profiles.

Testing should begin when its result can change care.

A normal test is reassuring for the period assessed.

It does not guarantee future wellbeing.

Fetal Movements

The woman should receive clear local advice about:

Her baby’s usual movement pattern.
What constitutes a reduction or change.
Where to call.
When to attend.
Not waiting until the next day when concerned.

NICE advises assessment whenever there are concerns about fetal movements after 24 weeks. ^[11]

Do not delay because:

The placenta is anterior.
A fibroid may cushion movement.
A scan was recently reassuring.
A home Doppler detects a heartbeat.
Previous episodes were reassuring.

A home Doppler cannot assess fetal wellbeing.

Amniotic Fluid

Amniotic-fluid assessment may be relevant with:

Fetal-growth restriction.
Reduced fetal movements.
Ruptured membranes.
Diabetes.
Hypertension.
Post-dates pregnancy.
Fetal anomaly.
NSAID exposure requiring review.
Another clinical indication.

Fibroids do not create a universal fluid-surveillance schedule.

An abnormal result requires its own assessment and follow-up.

Fetal Presentation

Presentation should be reassessed late enough to influence birth planning.

Document:

Cephalic.
Breech.
Transverse.
Oblique.
Unstable lie.
Presenting part relative to the cervix.
Presenting part relative to lower-segment fibroids.
Engagement.
Placenta.
Amniotic fluid.

A mid-pregnancy presentation should not determine final mode of birth.

A persistent non-cephalic or unstable lie may change:

External-cephalic-version counselling.
Admission.
Membrane-rupture advice.
Cord-prolapse precautions.
Mode of birth.

External Cephalic Version Planning

When external cephalic version is being considered, assess:

Fibroid map.
Lower-segment anatomy.
Placental location.
Amniotic fluid.
Fetal wellbeing.
Previous myomectomy.
Other uterine scars.
Ability to perform urgent birth.
Maternal preference.

Fibroids are not an automatic universal contraindication.

A large strategically located fibroid may make the procedure unsuitable or technically difficult.

Placenta Praevia Surveillance

When a placenta remains low or praevia, follow the placental pathway.

Surveillance may include:

Transvaginal localisation.
Bleeding review.
Fetal growth when indicated.
Accreta-spectrum assessment.
Haemoglobin.
Blood-bank planning.
Birth timing and setting.

Fibroids may complicate imaging and surgical access.

They do not change the definition of placenta praevia.

Placenta Accreta Spectrum Surveillance

When accreta spectrum is suspected, care should move to a specialist pathway.

Planning may involve:

Expert ultrasound.
MRI in selected cases.
Multidisciplinary review.
Anaesthesia.
Blood bank.
Senior pelvic surgery.
Urology.
Neonatology.
Critical care.
Planned birth at an appropriate centre.

Repeated routine fibroid scans are not the central surveillance strategy.

The placental diagnosis drives care.

Recurrent Bleeding

Recurrent bleeding may change:

Admission threshold.
Anaemia monitoring.
Corticosteroid planning.
Fetal surveillance.
Birth timing.
Blood preparation.
Place of care.

Each episode should be documented with:

Amount.
Pain.
Maternal observations.
Fetal status.
Placental assessment.
Haemoglobin.
Management.

The absence of bleeding between episodes does not erase the history.

Previous Myomectomy

Surveillance after myomectomy should be individualised.

Review:

Operative-note certainty.
Depth and number of uterine incisions.
Cavity entry.
Scar location.
Closure.
Placental relationship.
Residual fibroids.
Symptoms.
Other uterine scars.

Routine serial scar-thickness measurement is not a validated guarantee of rupture risk.

A normal measurement should not override severe symptoms.

Severe Pain After Myomectomy

Seek urgent assessment for:

Sudden severe pain.
Persistent unexplained pain.
Pain different from previous degeneration.
Vaginal bleeding.
Maternal instability.
Fetal-heart-rate concern.
Reduced fetal movements.
Labour symptoms.
Fluid leakage.

Surveillance should not consist of waiting for a scheduled scan when a scar emergency is possible.

Lower-Segment and Cervical Fibroids

Later-pregnancy reassessment may need to define:

Whether the presenting part can enter the pelvis.
Whether the cervix is accessible.
Whether the fibroid obstructs the birth canal.
Whether the bladder is displaced.
Whether the fibroid lies in the expected caesarean-incision site.
Whether the placenta is nearby.
Whether an alternative surgical approach may be needed.

This may require:

Specialist ultrasound.
Transvaginal ultrasound.
MRI in selected cases.
Senior surgical review.
Anaesthetic review.

The aim is surgical and obstetric planning—not repeated measurement for its own sake.

Urinary Obstruction

When a fibroid causes or may cause urinary obstruction, monitoring may include:

Symptoms.
Urine output.
Kidney function.
Bladder emptying.
Hydronephrosis.
Infection.
Pain.
Urology input.

The plan should state:

When to decompress the bladder.
When to repeat imaging.
When intervention is required.
Whether anatomy changes birth planning.

Maternal kidney protection takes priority over avoiding intervention.

Admission Does Not Replace a Surveillance Plan

When a woman is admitted, document:

Reason.
Maternal observations.
Fetal monitoring.
Pain plan.
Fluid and nutrition plan.
Thrombosis prevention.
Investigations.
Review frequency.
Escalation criteria.
Discharge criteria.
Birth-plan implications.

Hospitalisation without clear goals can increase anxiety and immobility without improving care.

Outpatient Review

Outpatient review may address:

New symptoms.
Anaemia.
Weight and nutrition.
Fibroid map.
Placenta.
Fetal growth.
Presentation.
Myomectomy scar history.
Birth planning.
Emergency advice.

Appointment frequency should reflect active risk.

A woman with stable findings should not be burdened by visits that do not alter care.

A woman with evolving risk should not be left on a routine schedule.

Multidisciplinary Review

A multidisciplinary meeting may be useful with:

Placenta accreta spectrum.
Placenta praevia.
Complex lower-segment anatomy.
Previous extensive myomectomy.
Multiple uterine scars.
Severe anaemia.
Urinary-tract displacement.
Anticipated difficult caesarean birth.
Significant medical comorbidity.
Refusal of blood products.
Another high-risk issue.

Possible participants include:

Maternal-fetal medicine.
Obstetric surgery.
Gynaecology.
Anaesthesia.
Radiology.
Haematology.
Blood bank.
Urology.
Neonatology.
Critical care.
Dietetics.

The meeting should produce one written plan.

Anaesthetic Review

Antenatal anaesthetic review may be appropriate with:

Anticipated complex surgery.
Severe anaemia.
Previous major haemorrhage.
Difficult airway.
Spinal disease.
Significant obesity.
Anticoagulation.
Placenta accreta spectrum.
Unusual abdominal or uterine incision.
Possible intensive-care need.

The plan may address:

Neuraxial or general anaesthesia.
Vascular access.
Monitoring.
Blood availability.
Postoperative pain.
Thrombosis prevention.
Critical-care support.

Blood-Bank Review

Antenatal blood planning may be needed with:

Severe anaemia.
Red-cell antibodies.
Rare blood group.
Previous transfusion reaction.
Placenta praevia.
Accreta-spectrum concern.
Previous major haemorrhage.
Anticipated difficult caesarean birth.
Refusal of blood products.

The plan may include:

Repeat antibody testing.
Compatible units.
Crossmatch.
Cell salvage according to local practice.
Massive-haemorrhage protocol.
Iron correction.
Haematology input.

Not every large fibroid requires crossmatched blood.

Risk should be assessed explicitly.

Psychological Surveillance

Repeated pain, bleeding and discussion of rupture or haemorrhage may cause:

Anxiety.
Hypervigilance.
Sleep disturbance.
Avoidance of activity.
Fear of fetal movement changes.
Fear of labour.
Previous trauma symptoms.

Care should include:

Clear explanations.
Written plans.
Consistent messages.
Mental-health assessment when needed.
Avoidance of catastrophic language.
Respect for the woman’s priorities.

Reassurance should remain honest.

No clinician can guarantee the outcome.

Remote Monitoring and Home Devices

Home devices cannot replace clinical assessment.

Do not rely on:

Home fetal Doppler.
Consumer contraction monitor.
Wearable oxygen monitor.
Home blood-pressure result without appropriate technique or follow-up.
Symptom-tracking app.
Home ultrasound service.

Home blood-pressure monitoring may be useful within a clinician-led pathway.

A detected fetal heartbeat does not exclude fetal compromise.

A Written Surveillance Schedule

The record should state:

Routine appointment schedule.
Maternal laboratory plan.
Growth-scan plan.
Placental follow-up.
Presentation reassessment.
Fetal-movement advice.
Myomectomy-scar considerations.
Anaesthetic review.
Blood-bank plan.
Multidisciplinary review.
Birth-planning date.
Emergency symptoms.

Avoid vague wording such as:

Extra scans.
Close monitoring.
High risk.
Watch the scar.
Review later.

A written schedule reduces contradictory advice.

When Surveillance Should Escalate

Escalate when there is:

New heavy bleeding.
Recurrent bleeding.
Severe or persistent pain.
Maternal instability.
Fever.
Reduced fetal movements.
Abnormal fetal testing.
Falling growth centile.
Fetal-growth restriction.
Abnormal Doppler.
Oligohydramnios.
Hypertension or preeclampsia.
Persistent malpresentation.
Urinary retention or obstruction.
Worsening anaemia.
Suspicious placental imaging.
New concern about a uterine scar.
Another maternal or fetal complication.

Escalation may involve:

Earlier review.
Admission.
Specialist imaging.
Additional fetal surveillance.
Multidisciplinary planning.
Birth-timing review.

When Surveillance Can Remain Proportionate

Routine or less intensive care may remain appropriate when:

Symptoms are stable.
Maternal observations are reassuring.
Haemoglobin is adequate.
Placental location is reassuring.
Fetal anatomy is complete.
Growth is appropriate.
Movements are reassuring.
Presentation is cephalic near birth.
Lower-segment anatomy is unobstructed.
No major scar concern exists.
No other condition requires escalation.

Reducing unnecessary testing is not neglect.

It is evidence-based proportional care.

Dr Tania’s Surveillance Framework

I ask eight questions:

1. Is maternal health stable?

Review:

Pain.
Bleeding.
Haemoglobin.
Weight.
Blood pressure.
Urinary and bowel symptoms.
Mobility.

2. Is the placenta reassuring?

Review:

Location.
Bleeding.
Fibroid relationship.
Previous uterine scars.
Accreta-spectrum risk.
Abruption concern.

3. Is fetal anatomy complete?

Identify:

Completed views.
Technical limitations.
Need for specialist reassessment.

4. Is fetal growth surveillance indicated?

Use:

Fundal-height reliability.
Maternal condition.
Placental concern.
Previous history.
Current growth findings.

Do not use fibroid count alone.

5. Is Doppler or fetal testing indicated?

Use the recognised condition:

Fetal-growth restriction.
Hypertension.
Diabetes.
Reduced fetal movements.
Another obstetric indication.

6. Is presentation or lower-segment anatomy changing the birth route?

Review:

Cephalic, breech or transverse lie.
Engagement.
Cervix.
Obstructing fibroid.
Placenta.
Bladder.
Likely uterine incision.

7. Does a previous myomectomy require additional planning?

Review:

Operative note.
Scar location.
Symptoms.
Placenta.
Birth recommendation.
Emergency access.

8. Will every planned test change care?

If not, reconsider whether it is necessary.

Surveillance should follow maternal symptoms, placental findings, fetal growth, presentation, lower-segment anatomy and uterine-scar history—not the number of fibroids on the report. The safest schedule is written, risk stratified and linked to decisions.

The next part will address Timing and Mode of Birth, then Labour, Haemorrhage and Postpartum Care, including vaginal-birth eligibility, myomectomy-scar planning, lower-segment obstruction, caesarean-incision strategy and haemorrhage preparedness.

Timing and Mode of Birth

Fibroids alone do not determine:

When birth should occur.
Whether labour should be induced.
Whether vaginal birth is possible.
Whether caesarean birth is required.
Whether birth must occur before term.
Whether the woman needs a tertiary centre.

The birth plan should be based on:

Placental location.
Placenta accreta spectrum risk.
Fetal presentation.
Fetal growth.
Doppler when indicated.
Lower-segment and cervical anatomy.
Whether the presenting part can engage.
Previous myomectomy details.
Other uterine scars.
Maternal symptoms.
Anaemia.
Previous haemorrhage.
Other medical and obstetric conditions.
The woman’s informed preferences.
Local maternity and surgical resources.

A woman with multiple or large fibroids may still have a vaginal birth.

A woman may require planned caesarean birth because one fibroid or one scar changes the anatomy.

The decision should identify the actual indication.

Fibroids Are Not an Automatic Indication for Early Birth

Do not recommend early birth solely because:

Several fibroids are present.
One fibroid is large.
A fibroid increased in size.
Red degeneration occurred earlier in pregnancy.
The uterus measures large.
The woman is anxious about haemorrhage.
A population study reports increased risk.

Early birth may be indicated because of:

Placenta praevia.
Placenta accreta spectrum.
Significant recurrent bleeding.
Fetal-growth restriction.
Abnormal Doppler.
Hypertension or preeclampsia.
Diabetes.
Reduced fetal movements with clinical concern.
Preterm labour.
Ruptured membranes.
Maternal deterioration.
Another recognised maternal or fetal condition.

The condition driving risk should determine timing.

Fibroids Are Not an Automatic Indication for Induction

Induction may be offered for ordinary or high-risk obstetric indications.

Before induction, assess:

Fetal presentation.
Placental location.
Cervical accessibility.
Whether a cervical or lower-segment fibroid obstructs the birth canal.
Whether the presenting part can descend.
Previous myomectomy.
Previous caesarean birth.
Fetal condition.
Maternal condition.
Likelihood that emergency caesarean birth can be performed safely.

A fibroid uterus may make vaginal examination or cervical assessment difficult.

Difficulty does not automatically make induction impossible.

The anatomy and uterine-scar history should be reviewed first.

Fibroids Are Not an Automatic Indication for Caesarean Birth

Population studies show a higher caesarean-birth rate in women with fibroids. ^[1,2]

Possible reasons include:

Breech or transverse presentation.
Placenta praevia.
Lower-segment obstruction.
Failure of the presenting part to engage.
Labour dystocia.
Fetal compromise.
Previous myomectomy.
Previous caesarean birth.
Anticipated surgical complexity.
Another obstetric indication.

The association does not mean that every fibroid pregnancy requires surgery.

A cephalic fetus, reassuring placenta, unobstructed lower segment and no scar-based contraindication may allow vaginal birth.

Vaginal Birth May Be Appropriate

Vaginal birth may be considered when:

The fetus is cephalic.
The placenta does not cover the cervix.
There is no suspected placenta accreta spectrum requiring planned surgery.
No fibroid obstructs the cervix or pelvic inlet.
The presenting part can engage.
Fetal growth and wellbeing are reassuring.
There is no separate obstetric contraindication.
Previous uterine surgery does not require planned caesarean birth.
Emergency obstetric care is available.
The woman understands the plan and uncertainty.

The presence of a large fundal or subserosal fibroid does not by itself make vaginal birth unsafe.

When Caesarean Birth May Be Recommended

Possible indications include:

Placenta praevia.
Suspected placenta accreta spectrum.
Persistent transverse lie.
Selected breech presentations.
A cervical or lower-segment fibroid obstructing the birth canal.
A fibroid preventing engagement or descent.
A previous uterine scar for which labour is not advised.
Fetal compromise.
Failed induction.
Labour obstruction.
Another recognised obstetric indication.

The documentation should state the specific reason.

Avoid recording only:

Multiple large fibroids—caesarean required.

Lower-Segment Obstruction

Late-pregnancy imaging should answer:

Is the fibroid below the presenting part?
Does it occupy the pelvic inlet?
Is the cervix displaced?
Can the head engage?
Is the fibroid anterior or posterior?
Is the bladder displaced?
Is the placenta nearby?
Where could a uterine incision be made if surgery is required?

A lower-segment fibroid may change:

Whether induction is appropriate.
Whether vaginal birth is anatomically possible.
The uterine incision.
The skin incision.
The need for senior surgical support.
Blood preparation.

The plan should be based on current late-pregnancy anatomy.

Malpresentation

Fibroids may contribute to:

Breech presentation.
Transverse lie.
Oblique lie.
Unstable lie.

Management should consider:

Gestational age.
Placenta.
Amniotic fluid.
Fibroid location.
Previous uterine surgery.
Fetal wellbeing.
External-cephalic-version suitability.
Cord-prolapse risk.
Emergency access.

A persistent transverse lie commonly requires caesarean birth.

A breech presentation should follow the recognised breech pathway.

Unstable Lie

An unstable lie may increase concern about:

Cord presentation.
Cord prolapse after membrane rupture.
Emergency birth.
Difficulty confirming presentation.

The plan may include:

Repeat presentation assessment.
Advice to attend immediately after membrane rupture.
Admission according to gestation, findings and local protocol.
Mode-of-birth planning.
Ultrasound before induction or labour procedures.

Fibroids are one possible contributor.

The actual fetal lie determines care.

External Cephalic Version

External cephalic version may be discussed for an eligible breech pregnancy.

Assessment should include:

Dominant fibroid location.
Lower-segment anatomy.
Placental site.
Amniotic fluid.
Fetal condition.
Previous myomectomy.
Previous caesarean birth.
Ability to monitor the fetus.
Ability to perform emergency caesarean birth.
Maternal preference.

Fibroids do not create one universal rule.

A large or strategically located fibroid may reduce feasibility or make the procedure inappropriate.

Birth After Myomectomy

Birth planning after myomectomy should begin before labour.

The plan should state:

Surgical route.
Number and location of uterine incisions.
Depth of myometrial dissection.
Whether the endometrial cavity was entered.
Closure.
Postoperative complications.
Whether operative records were reviewed.
Placental relationship to the scar.
Other uterine scars.
Remaining fibroids.
Whether labour is being considered.
What to do if contractions or membrane rupture occur before the planned date.

No validated calculator can convert these details into an exact individual rupture risk.

Labour After Myomectomy

Selected women may be considered for labour after specialist review.

The published evidence reports a low absolute rupture risk among women who labour after myomectomy, but the evidence is limited and cannot identify every high-risk scar. ^[15]

Labour may be less appropriate when there is:

Documented extensive full-thickness surgery.
Several deep uterine incisions.
Concerning fundal or cornual reconstruction.
A previous uterine rupture.
A surgeon’s clear recommendation to avoid labour based on operative findings.
Inability to provide urgent caesarean birth.
Another obstetric contraindication.

Cavity entry may influence counselling.

It should not be used as the only fact in isolation.

Planned Caesarean Birth After Myomectomy

When planned caesarean birth is recommended, timing should be individualised according to:

Operative details.
Scar location.
Concern about labour.
Previous symptoms.
Placenta.
Fetal condition.
Other obstetric indications.
Local specialist guidance.
Neonatal implications of earlier birth.

There is no one gestational week that applies to every myomectomy scar.

The plan should balance:

Avoiding spontaneous labour when clinically important.
Avoiding unnecessary early-term or preterm birth.
Maternal and fetal condition.
Emergency access.

If Labour Begins Before Planned Caesarean Birth

The written plan should state:

Where the woman should attend.
Whether she should come with the first regular contractions.
What to do after membrane rupture.
Whether continuous fetal monitoring is recommended.
Whether urgent caesarean birth is required.
Whether a brief period for assessment is appropriate.
Which surgical and anaesthetic teams should be contacted.
Blood preparation.

The woman should not be left to interpret the scar risk during labour.

Placenta Praevia

Placenta praevia generally requires caesarean birth.

Planning should include:

Bleeding history.
Placental location.
Fetal presentation.
Anaemia.
Blood bank.
Surgical expertise.
Possibility of placenta accreta spectrum.
Timing according to the placental pathway.
Emergency instructions for bleeding or labour.

Fibroids may affect surgical access.

They do not change the need to manage placenta praevia through a specialist pathway.

Placenta Accreta Spectrum

Suspected placenta accreta spectrum requires planned multidisciplinary care at an appropriate centre. ^[14]

The plan may involve:

Maternal-fetal medicine.
Experienced pelvic surgery.
Anaesthesia.
Blood bank.
Urology.
Interventional radiology according to local practice.
Neonatology.
Critical care.
A detailed haemorrhage plan.

The strategy should follow the accreta diagnosis.

Routine fibroid removal is not the priority.

Fetal-Growth Restriction

When fetal-growth restriction is present, birth timing should follow:

Estimated fetal weight.
Abdominal circumference.
Growth velocity.
Umbilical-artery Doppler.
Other fetal testing.
Amniotic fluid.
Gestational age.
Maternal condition.
Fetal movements.
Local fetal-growth pathway. ^[13]

Fibroids may be part of the maternal background.

They do not create a separate universal timing rule.

Recurrent Pain

Previous red degeneration does not automatically require induction or caesarean birth.

Birth timing may change when pain is:

Severe.
Persistent.
Recurrent despite treatment.
Associated with maternal deterioration.
Associated with urinary or bowel obstruction.
Associated with diagnostic uncertainty.
Preventing adequate nutrition or mobility.
Requiring repeated admission.
Related to a surgical complication.

The team should identify the current diagnosis and weigh continued pregnancy against birth at that gestation.

Anaemia

Anaemia usually changes preparation more than mode of birth.

The plan may include:

Oral or intravenous iron.
Investigation of another cause.
Repeat haemoglobin.
Anaesthetic review.
Blood-bank planning.
Cell-salvage planning according to local practice.
Postpartum follow-up.

Anaemia alone does not automatically require caesarean birth.

Severe symptomatic anaemia may influence timing or place of birth.

Place of Birth

An obstetric-led unit may be appropriate with:

Large or multiple fibroids affecting anatomy.
Lower-segment or cervical fibroid.
Persistent malpresentation.
Previous extensive myomectomy.
Placenta praevia.
Accreta-spectrum concern.
Severe anaemia.
Previous major haemorrhage.
Fetal-growth restriction.
Significant medical comorbidity.
Anticipated operative birth.
Need for specialist neonatal care.

A tertiary centre may be needed with:

Suspected placenta accreta spectrum.
Complex pelvic anatomy.
Anticipated difficult uterine entry.
Possible urological involvement.
Rare blood or significant antibodies.
Need for critical care.
Another highly specialised risk.

Not every large fibroid requires tertiary care.

Surgical Mapping Before Caesarean Birth

Before planned surgery, review:

Placental location.
Fetal presentation.
Dominant fibroids.
Anterior lower-segment fibroids.
Cervical fibroids.
Bladder displacement.
Previous abdominal incisions.
Previous uterine incisions.
Adhesion risk.
Possible accreta spectrum.
Blood vessels and urinary structures when anatomy is complex.

The surgeon should know which fibroid is likely to affect entry or fetal delivery.

Skin Incision

The skin incision may be:

Transverse.
Vertical.
Extended.
Another approach.

Choice depends on:

Uterine size.
Fibroid position.
Previous scars.
Placenta accreta spectrum.
Need for upper-abdominal access.
Fetal presentation.
Surgical urgency.
Surgeon judgement.

A vertical skin incision does not automatically mean a vertical uterine incision.

The two decisions are separate.

Uterine Incision

A standard lower-segment transverse incision may be possible.

An alternative may be needed when:

A large anterior fibroid occupies the lower segment.
The placenta occupies the intended incision site.
The lower segment is inaccessible.
Fetal lie complicates delivery.
Previous scars alter anatomy.
Placenta accreta spectrum is suspected.
The bladder is displaced.
Emergency access requires another approach.

Possible alternatives may include:

A higher transverse incision.
A J-shaped or extended incision.
A vertical or classical incision.
Another specialist incision.

The exact choice belongs to the operating surgeon after reviewing current anatomy.

Avoid Cutting Directly Through a Fibroid When Feasible

Incising a fibroid may cause:

Significant bleeding.
Difficulty extending the incision.
Difficulty delivering the fetus.
Difficulty closing the uterus.
Myometrial distortion.

Sometimes the anatomy makes contact unavoidable.

The surgical plan should identify:

A safer entry site.
Whether ultrasound mapping is useful immediately before surgery.
Blood preparation.
Whether myomectomy is required for delivery or closure.
Senior surgical support.

Intraoperative Ultrasound

In selected complex cases, ultrasound may help identify:

Placenta.
Dominant anterior fibroid.
Fetal position.
A potential uterine-incision site.

It is not required for every caesarean birth with fibroids.

The team should use it when it is likely to improve surgical planning.

Caesarean Myomectomy Is Not Routine

Removing fibroids during caesarean birth may increase:

Haemorrhage.
Transfusion.
Operative time.
Surgical complexity.
Need for additional uterine reconstruction.

The 2024 Cochrane review concluded that the evidence is very uncertain regarding the benefits and harms of caesarean myomectomy. ^[5]

Routine removal of every fibroid should not be promised.

When Caesarean Myomectomy May Be Considered

An experienced surgeon may consider selected removal when a fibroid:

Is pedunculated and readily accessible.
Prevents entry into the uterus.
Prevents delivery of the fetus.
Prevents uterine closure.
Produces uncontrollable bleeding at the incision.
Is otherwise surgically unavoidable.

The decision depends on:

Fibroid type.
Location.
Placenta.
Haemoglobin.
Blood availability.
Surgical experience.
Haemorrhage control.
Future fertility.
Maternal condition.

A large size alone is not an indication.

Hysterectomy

Hysterectomy is not planned because fibroids are present alone.

It may become necessary in an extreme emergency with:

Uncontrollable haemorrhage.
Placenta accreta spectrum.
Uterine rupture.
Irreparable uterine trauma.
Severe infection.
Another life-threatening condition.

When risk is foreseeable, counselling and blood planning should occur antenatally.

Emergency life-saving treatment should not be delayed.

The Birth Plan Must Be Written

Before birth, document:

Planned mode of birth.
Specific indication.
Planned gestational timing or decision pathway.
What to do if labour begins.
What to do if membranes rupture.
Place of birth.
Fetal-monitoring plan.
Anaesthetic plan.
Blood preparation.
Placental plan.
Fibroid map.
Previous uterine scars.
Surgical access.
Whether caesarean myomectomy is not planned or may be considered only if necessary.
Postpartum-haemorrhage plan.
Neonatal plan when relevant.

Avoid vague statements such as:

Elective caesarean.
High-risk birth.
Senior review.
Blood ready.
Scar watch.

The plan should be usable at night and in an emergency.

Dr Tania’s Birth-Planning Framework

I ask nine questions:

1. Is vaginal birth anatomically possible?

Review:

Cervix.
Lower segment.
Presenting part.
Placenta.
Fetal presentation.

2. Is labour appropriate for the uterine scar?

Review:

Myomectomy operative note.
Other scars.
Previous rupture.
Emergency access.
Maternal preference.

3. Is there a separate indication for earlier birth?

Review:

Placenta.
Bleeding.
Fetal growth.
Doppler.
Hypertension.
Diabetes.
Maternal symptoms.

4. Is the fetus likely to require caesarean birth?

Review:

Presentation.
Wellbeing.
Growth.
Another fetal indication.

5. Where should birth occur?

Match the unit to:

Surgical complexity.
Blood needs.
Placenta.
Neonatal needs.
Critical-care needs.

6. Where will the surgeon enter?

Map:

Skin.
Uterus.
Placenta.
Fibroids.
Bladder.
Previous scars.

7. Is fibroid removal expected?

Usually no.

Document that removal is selective and may occur only when necessary or clearly advantageous in the hands of an experienced surgeon.

8. Is haemorrhage preparation proportionate?

Review:

Haemoglobin.
Antibodies.
Blood availability.
Uterotonics.
Tranexamic-acid pathway.
Surgical escalation.
Cell salvage according to local practice.

9. Does the woman understand what may change?

Explain:

Labour before the planned date.
Bleeding.
Membrane rupture.
Fetal compromise.
Unexpected surgical anatomy.
Need for additional procedures.

Mode of birth should follow anatomy, placental risk, fetal presentation, uterine scars and current maternal–fetal findings. Multiple or large fibroids do not create an automatic caesarean indication, but one strategically located fibroid or one significant scar may change the entire birth route.

Labour, Haemorrhage and Postpartum Care

Fibroids can affect labour and the immediate postpartum period through:

Malpresentation.
Difficulty with engagement.
Labour dystocia.
Operative birth.
Uterine atony.
Retained placenta.
Surgical complexity.
Anaemia.
Postpartum pain.
Urinary or bowel pressure.

These possibilities justify preparation.

They do not mean that a complication will occur.

Admission in Labour

The initial assessment should review:

Contractions.
Membranes.
Vaginal bleeding.
Fetal movements.
Fetal presentation.
Fetal heart rate.
Maternal observations.
Pain different from contractions.
Placental location.
Lower-segment anatomy.
Previous myomectomy.
Planned birth route.
Haemoglobin and blood plan when relevant.

NICE recommends systematic maternal and fetal assessment on admission and continuing reassessment during labour. ^[3]

The written antenatal plan should be immediately available.

Confirm Presentation

Palpation may be difficult with:

Multiple fibroids.
Large fibroids.
Maternal body habitus.
Polyhydramnios.
An unengaged presenting part.

Ultrasound may be appropriate to confirm:

Cephalic presentation.
Breech.
Transverse or oblique lie.
Presenting part relative to a lower-segment fibroid.
Placenta.
Cord presentation when suspected.

Do not perform amniotomy before presentation and engagement are understood when cord-prolapse risk exists.

Place of Labour

Labour should occur where the team can manage the recognised risk.

An obstetric unit may be appropriate with:

Significant fibroid distortion.
Previous myomectomy.
Malpresentation.
High unengaged head.
Anaemia.
Placental risk.
Anticipated haemorrhage.
Another obstetric complication.

The plan should consider:

Operating theatre access.
Anaesthesia.
Blood bank.
Neonatal support.
Senior obstetric availability.

Eating and Drinking

NICE advises drinking according to thirst in labour and allows a light diet for women who wish to eat unless opioids have been given or risk factors make caesarean birth more likely. ^[3]

The individual plan should consider:

Likelihood of operative birth.
Opioid use.
Anaesthetic advice.
Diabetes.
Nausea.
Prolonged induction.
Local policy.

A long labour still requires hydration and an appropriate nutrition plan.

Overconsumption of water can be harmful.

Intravenous Access

Intravenous access may be reasonable when there is:

Significant anaemia.
Previous postpartum haemorrhage.
Placenta praevia.
Accreta-spectrum concern.
Anticipated complex surgery.
Recurrent bleeding.
Need for intravenous analgesia or fluids.
Another clinical indication.

The number and size of cannulas should reflect risk.

Every woman with fibroids does not require invasive preparation.

Blood Preparation

The labour or operative plan may include:

Current haemoglobin.
Blood group.
Antibody screen.
Crossmatch.
Availability of compatible blood.
Rare-blood planning.
Previous transfusion reaction.
Cell salvage according to local policy.
Massive-haemorrhage protocol.

Preparation should be escalated with:

Severe anaemia.
Placenta praevia.
Accreta-spectrum concern.
Previous major haemorrhage.
Anticipated difficult caesarean birth.
Multiple red-cell antibodies.
Refusal of blood products.

Fetal Monitoring in Labour

Fetal monitoring should follow the complete risk assessment.

Continuous cardiotocography may be recommended with:

Fetal-growth restriction.
Hypertension.
Diabetes.
Abnormal fetal testing.
Reduced fetal movements.
Meconium.
Significant bleeding.
Previous uterine surgery when labour is being undertaken under a scar-specific plan.
Another recognised risk factor.

Stable fibroids alone do not automatically require continuous monitoring.

NICE emphasises that fetal monitoring is one tool and should be interpreted with the developing maternal, fetal and labour picture. ^[3]

Labour After Myomectomy

When labour after myomectomy is planned:

The operative history should be documented.
The woman should labour in a unit able to perform urgent caesarean birth.
Maternal pain and observations should be assessed carefully.
Fetal monitoring should follow the scar-specific and obstetric plan.
Oxytocin and induction methods should be considered by the responsible obstetric team.
New pain outside expected contractions requires review.
A low threshold for senior assessment is appropriate.

No monitoring method can guarantee that rupture will not occur.

Pain in Labour

Pain should be assessed for:

Normal contractions.
Red degeneration.
Placental abruption.
Uterine rupture.
Urinary retention.
Obstructed labour.
Surgical abdomen.
Another cause.

Warning features include:

Pain that persists between contractions.
Sudden severe pain.
New focal scar pain.
Vaginal bleeding.
Maternal tachycardia or hypotension.
Abnormal fetal heart rate.
Loss of fetal station.
Cessation of contractions.
Maternal collapse.

The pattern may be incomplete.

Urgent review is required when concern exists.

Pain Relief in Labour

Fibroids do not prevent:

Nitrous oxide.
Opioid analgesia.
Epidural analgesia.
Spinal anaesthesia.
General anaesthesia when required.

The plan should consider:

Platelets.
Anticoagulation.
Severe anaemia.
Difficult airway.
Previous spinal surgery.
Surgical urgency.
Placenta accreta spectrum.
Maternal preference.

Early epidural discussion may be useful in a labour with higher operative risk.

It should not be mandatory solely because fibroids are present.

Labour Progress

Fibroids may contribute to:

Poor engagement.
Malposition.
Inefficient contractions.
Slow cervical dilatation.
Slow descent.
Obstructed labour.

Labour progress should be assessed with:

Contraction pattern.
Cervical change.
Fetal position.
Descent.
Maternal condition.
Fetal condition.
Bladder emptying.
Lower-segment anatomy.

Do not diagnose obstruction from fibroids without examining the complete labour pattern.

Do not persist with labour when there is evidence that a fibroid physically prevents descent.

Induction and Augmentation Medicines

Induction or augmentation should follow the responsible obstetric pathway.

The team should review:

Previous myomectomy.
Previous caesarean birth.
Cervical and lower-segment anatomy.
Fetal presentation.
Placenta.
Uterine activity.
Fetal monitoring.
Emergency access.

A specific medicine or dose cannot be prescribed from a general webpage.

Previous uterine surgery may restrict which methods are appropriate.

Amniotomy

Before artificial rupture of membranes, assess:

Presentation.
Engagement.
Cord risk.
Placenta.
Lower-segment fibroid.
Fetal heart rate.
Previous uterine surgery.
Availability of urgent intervention.

A high or mobile presenting part may increase cord-prolapse concern.

Fibroids may contribute to non-engagement.

Operative Vaginal Birth

Forceps or vacuum birth may be considered for ordinary obstetric indications when:

The cervix is fully dilated.
The fetal head position is known.
The head is sufficiently low.
No fibroid obstructs descent.
The procedure is clinically appropriate.
Caesarean backup is available.

Fibroids alone do not prohibit operative vaginal birth.

A lower-segment obstruction may make it unsafe or impossible.

Emergency Caesarean Birth

In an emergency, priorities are:

Maternal stabilisation.
Fetal assessment.
Rapid senior review.
Anaesthesia.
Blood preparation.
Surgical access.
Neonatal readiness.

The team should identify quickly:

Placenta.
Dominant anterior fibroid.
Previous uterine scars.
Fetal lie.
Bladder displacement.
Potential uterine-incision site.

Imaging should not delay life-saving birth when the clinical situation is clear.

Anticipate Difficult Fetal Delivery

Difficulty may arise from:

Transverse lie.
Impacted head.
High floating head.
Lower-segment fibroid.
Contracted uterine access.
Placenta in the incision path.
Unusual uterine incision.
Adhesions.
Multiple fibroids.

The senior surgeon may need:

Alternative uterine entry.
Breech extraction or another manoeuvre.
Extension of the incision.
Additional assistance.
Selective myomectomy when unavoidable.

The exact technique depends on the intraoperative findings.

Uterine Closure

Fibroids may distort:

Incision edges.
Myometrial thickness.
Uterine shape.
Haemostasis.
Suture placement.

The operative note should document:

Uterine incision.
Extensions.
Fibroids encountered.
Myomectomy if performed.
Closure.
Blood loss.
Haemostatic procedures.
Future-birth advice.

This record may determine management of a later pregnancy.

Prevention of Postpartum Haemorrhage

Fibroids are associated with increased postpartum-haemorrhage risk at a population level, particularly when fibroids are large. ^[1,2]

Prevention includes:

Correcting antenatal anaemia when possible.
Identifying placental risk.
Planning the place of birth.
Ensuring appropriate staff and resources.
Using a prophylactic uterotonic according to the local third-stage-of-labour protocol.
Monitoring uterine tone and blood loss.
Early escalation when bleeding develops.

The 2025 WHO consolidated guideline recommends effective uterotonic prevention for every birth within an appropriate clinical protocol. ^[16]

Preparation should be proportionate.

Measure Blood Loss

Visual estimation can underestimate bleeding.

The birth unit should use its current protocol for:

Objective blood-loss assessment.
Maternal vital signs.
Uterine tone.
Ongoing bleeding.
Laboratory testing.
Escalation.

WHO’s 2025 consolidated guidance emphasises earlier recognition using measured blood loss and abnormal maternal observations rather than waiting for severe deterioration. ^[16]

The clinical condition matters more than one numerical threshold.

Causes of Postpartum Haemorrhage

The team should assess the recognised causes:

Tone: uterine atony.
Tissue: retained placenta or placental tissue.
Trauma: genital-tract or surgical injury.
Thrombin: coagulation disorder.

Fibroids may contribute mainly through:

Reduced uterine contraction.
Distorted uterine anatomy.
Retained placenta.
Operative complexity.

They should not distract from another cause.

Uterine Atony

Atony means inadequate uterine contraction after birth.

Management may include according to the local emergency protocol:

Uterine massage.
Uterotonic medicines.
Emptying the bladder.
Intravenous access and fluids.
Tranexamic acid.
Examination for retained tissue or trauma.
Blood products.
Balloon tamponade.
Surgical haemorrhage control.
Hysterectomy when life-saving.

The 2025 WHO guideline supports rapid bundled treatment once postpartum haemorrhage is diagnosed. ^[16]

Treatment should not wait for the fibroid map to be reviewed in detail.

Uterotonic Medicines

Choice may be affected by:

Hypertension.
Asthma.
Cardiac disease.
Previous reaction.
Local availability.
Route of birth.
Severity of bleeding.

No one uterotonic is suitable for every woman.

The antenatal record should identify contraindications.

Fibroids do not replace the standard haemorrhage protocol.

Tranexamic Acid

Tranexamic acid is used within postpartum-haemorrhage treatment protocols.

It should be given promptly when clinically indicated according to the current local pathway. ^[16]

It is not:

A substitute for uterotonics.
A substitute for finding the bleeding source.
A routine home medicine.
A guarantee that transfusion or surgery will be avoided.

The team should consider contraindications and the full haemorrhage picture.

Retained Placenta

Fibroids may distort the uterine cavity and contribute to:

Delayed placental delivery.
Trapped placenta.
Retained tissue.
Difficulty with manual removal.
Haemorrhage.

Management may include:

Uterotonics according to protocol.
Controlled cord traction by trained staff.
Manual removal.
Ultrasound when useful.
Theatre.
Anaesthesia.
Antibiotics according to local policy.
Blood preparation.

A placenta that does not deliver requires timely assessment.

Placenta Accreta Spectrum at Birth

When accreta spectrum is suspected, forced placental removal may cause catastrophic bleeding.

The planned strategy should follow the specialist accreta pathway. ^[14]

Unexpected accreta may require:

Immediate senior help.
Haemorrhage activation.
Blood products.
Surgical escalation.
Urology or other specialist input.
Hysterectomy.

Routine fibroid management becomes secondary to maternal life-saving care.

Trauma and Surgical Bleeding

Bleeding may come from:

Cervical tear.
Vaginal tear.
Perineal trauma.
Uterine-incision extension.
Fibroid bed after myomectomy.
Broad-ligament haematoma.
Uterine rupture.
Bladder or pelvic injury.
Another surgical source.

A firm uterus does not exclude significant bleeding.

The genital tract and surgical field should be assessed.

Balloon Tamponade and Surgical Escalation

When medical treatment is insufficient, escalation may include:

Uterine balloon tamponade.
Compression sutures.
Uterine-artery or stepwise devascularisation procedures.
Interventional radiology according to local availability.
Laparotomy.
Hysterectomy.

Fibroid anatomy may affect:

Balloon position.
Suture placement.
Surgical access.
Effectiveness of compression.
Blood loss.

The haemorrhage team should select the method appropriate to the anatomy and urgency.

Cell Salvage

Intraoperative cell salvage may be considered according to local policy when major blood loss is anticipated.

It may be particularly relevant with:

Placenta accreta spectrum.
Severe anaemia.
Rare blood.
Antibodies.
Refusal of allogeneic blood components.
Complex pelvic surgery.

It is not required for every caesarean birth with fibroids.

The plan should involve anaesthesia, surgery and transfusion services.

Blood Transfusion

Transfusion decisions should consider:

Active bleeding.
Haemodynamic status.
Haemoglobin.
Symptoms.
Ongoing blood loss.
Coagulation.
Available alternatives.
Maternal preferences.
Emergency risk.

Fibroids do not prevent necessary transfusion.

A fixed haemoglobin number alone should not replace clinical judgement during haemorrhage.

Refusal of Blood Products

When a woman declines some or all blood products, antenatal planning should document:

Which products are acceptable.
Which are declined.
Iron treatment.
Haemoglobin optimisation.
Cell-salvage preferences.
Haemostatic medicines.
Surgical thresholds.
Senior review.
Legal and consent documentation.
Emergency plan.

The discussion should be respectful and specific.

It should occur before labour whenever possible.

Immediate Postpartum Monitoring

After birth, assess:

Maternal observations.
Blood loss.
Uterine tone.
Pain.
Bladder emptying.
Wound or perineum.
Haemoglobin when indicated.
Mobility.
Thrombosis risk.
Nausea and oral intake.
Breastfeeding and newborn care.

Women with significant fibroid burden, difficult surgery or haemorrhage may need closer observation.

Postpartum Pain

Pain may reflect:

Normal uterine involution.
Caesarean wound.
Perineal trauma.
Fibroid degeneration.
Haematoma.
Retained tissue.
Infection.
Urinary retention.
Bowel dysfunction.
Thrombosis.
Another condition.

Seek urgent review for:

Severe or worsening pain.
Fever.
Heavy bleeding.
Fainting.
Abdominal distension.
Vomiting.
Breathlessness.
Chest pain.
Leg swelling.
Feeling seriously unwell.

Fibroid pain remains a diagnosis of exclusion postpartum.

Postpartum Anaemia

Review:

Blood loss.
Haemoglobin.
Symptoms.
Ferritin when appropriate.
Oral tolerance.
Need for intravenous iron.
Need for transfusion.
Ongoing bleeding.
Follow-up.

Symptoms may include:

Fatigue.
Dizziness.
Palpitations.
Breathlessness.
Poor exercise tolerance.
Difficulty caring for the baby.

Postpartum exhaustion should not be used to dismiss significant anaemia.

Thrombosis Prevention After Birth

Reassess risk after:

Caesarean birth.
Haemorrhage.
Transfusion.
Surgery.
Infection.
Immobility.
Obesity.
Preeclampsia.
Multiple pregnancy.
Another risk factor.

Prevention may include:

Early mobilisation.
Hydration.
Mechanical measures.
Pharmacological prophylaxis when indicated.

Fibroids alone are not a thrombosis diagnosis.

Bladder and Urinary Care

Large lower-segment fibroids, prolonged labour, epidural analgesia and surgery may contribute to:

Urinary retention.
Bladder overdistension.
Catheter need.
Urinary infection.
Ureteric concern.

The plan may include:

Timed catheter removal.
Monitoring first void.
Post-void residual.
Kidney function.
Urology review when symptoms persist.

Inability to pass urine requires prompt assessment.

Bowel Care

Contributors to postpartum constipation include:

Opioids.
Iron.
Reduced mobility.
Dehydration.
Caesarean birth.
Perineal pain.
Fibroid pressure.

Care may include:

Fluids.
Gradual fibre.
Mobilisation.
Pregnancy- and breastfeeding-compatible laxatives when prescribed.
Review of iron treatment.

Severe distension, vomiting or inability to pass stool or gas requires urgent review.

Breastfeeding

Fibroids do not prevent breastfeeding.

Breastfeeding support should consider:

Maternal pain.
Anaemia.
Fatigue.
Caesarean recovery.
Positioning.
Medicine compatibility.
Infant feeding effectiveness.
Maternal preference.

Analgesia should be reviewed for breastfeeding compatibility.

Essential treatment should not be stopped without an appropriate alternative.

Do Fibroids Shrink After Birth?

Many fibroids reduce in size as:

Pregnancy hormones fall.
The uterus involutes.
Blood flow changes.

Some remain symptomatic.

Some are difficult to assess accurately in the early postpartum period.

A large pregnancy fibroid should not be assumed to require immediate surgery.

Reassessment should occur after appropriate recovery unless urgent symptoms require earlier review.

Postpartum Imaging

Imaging may be considered with:

Persistent pain.
Ongoing pressure.
Abnormal bleeding.
Urinary obstruction.
Uncertain mass.
Complex caesarean findings.
Planning of future treatment.
Planning another pregnancy.

The timing may allow:

Uterine involution.
Recovery from birth.
Correction of anaemia.
Clearer anatomical mapping.

Immediate routine imaging is not required for every woman.

Myomectomy After Birth

Postpartum fibroid treatment should be individualised.

Options outside pregnancy may include:

Observation.
Medical treatment for bleeding.
Hysteroscopic myomectomy.
Laparoscopic or robotic myomectomy.
Open myomectomy.
Uterine-artery embolisation.
Radiofrequency ablation.
Other procedures.
Hysterectomy when appropriate.

The decision should consider:

Symptoms.
Fibroid map.
Cavity distortion.
Anaemia.
Fertility plans.
Previous surgery.
Breastfeeding.
Recovery.
Access to expertise.

No procedure is automatically best because the pregnancy involved large fibroids.

Secondary Postpartum Haemorrhage

Heavy or abnormal bleeding after the first day may reflect:

Retained placental tissue.
Infection.
Subinvolution.
Coagulation disorder.
Fibroid-related uterine distortion.
Another cause.

Seek urgent assessment for:

Soaking pads rapidly.
Large clots with ongoing bleeding.
Dizziness.
Fainting.
Fever.
Offensive discharge.
Worsening abdominal pain.
Breathlessness.
Feeling seriously unwell.

The diagnosis requires examination and appropriate testing.

Menstruation After Pregnancy

When menstrual cycles return, fibroids may again contribute to:

Heavy bleeding.
Clots.
Pain.
Pressure.
Anaemia.

The timing of cycle return varies with:

Breastfeeding.
Hormonal contraception.
Individual recovery.

The woman should have a plan for:

Bleeding assessment.
Haemoglobin and ferritin.
Contraception.
Fibroid imaging.
Future treatment.

Contraception

Contraceptive counselling should consider:

Breastfeeding.
Heavy menstrual bleeding.
Anaemia.
Fibroid distortion of the uterine cavity.
Thrombosis risk.
Blood pressure.
Future fertility.
Previous treatment.
Personal preference.

A fibroid-distorted cavity may affect suitability or placement of an intrauterine method.

The choice should be individualised.

Future Pregnancy

Before another pregnancy, review:

Birth and operative notes.
Uterine incision.
Any caesarean myomectomy.
Haemorrhage.
Transfusion.
Placental pathology.
Remaining fibroids.
Postpartum imaging.
Anaemia.
Urinary or bowel complications.
Future treatment.
Recommended interpregnancy recovery.
Birth advice for the next pregnancy.

A caesarean or myomectomy performed during this birth may change future scar planning.

The record should be preserved.

Placental Pathology

Placental examination may be useful with:

Fetal-growth restriction.
Stillbirth.
Severe preeclampsia.
Placental abruption.
Preterm birth.
Suspected infection.
Accreta spectrum.
Another placental indication.

Routine placental pathology is not required solely because fibroids are present.

The result may help explain complications and plan a future pregnancy.

Operative Documentation

After caesarean birth, the operative note should state:

Skin incision.
Adhesions.
Bladder position.
Placental location.
Uterine incision.
Extensions.
Fibroids encountered.
Whether any fibroid was removed.
Fibroid-bed closure.
Uterine closure.
Blood loss.
Transfusion.
Haemostatic procedures.
Complications.
Future-birth recommendation.

The woman should receive or know how to obtain the operative record.

Psychological Recovery

A pregnancy complicated by pain, bleeding or fear of haemorrhage may be emotionally difficult.

Postpartum review should ask about:

Birth experience.
Anxiety.
Intrusive memories.
Sleep.
Mood.
Fear of future pregnancy.
Fear of fibroid growth.
Body image.
Sexual health.
Support.

Severe mental-health symptoms require prompt professional assessment.

Emotional symptoms should not be dismissed as an inevitable response to a difficult birth.

Dr Tania’s Labour–Haemorrhage–Postpartum Framework

I ask ten questions:

1. Is the antenatal plan visible and usable?

Confirm:

Mode of birth.
Scar plan.
Placenta.
Fibroid map.
Blood plan.
Surgical plan.

2. Is fetal presentation confirmed?

Do not rely on an old scan when lie is uncertain or the presenting part remains high.

3. Is labour progressing around the anatomy?

Assess:

Cervix.
Descent.
Position.
Lower-segment obstruction.
Maternal and fetal condition.

4. Is new pain ordinary labour pain?

Reconsider:

Abruption.
Rupture.
Degeneration.
Urinary retention.
Obstruction.
Another emergency.

5. Is operative birth becoming more likely?

Prepare early without performing surgery solely because fibroids are present.

6. Is haemorrhage prevention proportionate?

Review:

Haemoglobin.
Uterotonic plan.
Blood availability.
Placenta.
Surgical complexity.
Contraindications.

7. If bleeding occurs, is the full haemorrhage bundle activated?

Treat:

Tone.
Tissue.
Trauma.
Thrombin.

Escalate rapidly.

8. Has postpartum recovery been assessed beyond blood loss?

Review:

Anaemia.
Pain.
Bladder.
Bowel.
Thrombosis.
Nutrition.
Breastfeeding.
Mental health.

9. Is fibroid follow-up timed appropriately?

Reassess after recovery unless symptoms require earlier investigation.

10. Is the next-pregnancy record complete?

Preserve:

Operative details.
Placental findings.
Haemorrhage.
Fibroid treatment.
Future-birth advice.

Fibroid-aware birth care is not a prediction of haemorrhage or caesarean birth. It is a prepared system: confirm presentation and obstruction, understand every uterine scar, plan surgical entry, optimise haemoglobin, recognise bleeding early, treat postpartum haemorrhage rapidly and preserve the operative record for recovery and future pregnancy.

The next part will add the Frequently Asked Questions, one shared FAQ data source, exact FAQPage schema parity and the closing consultation section.

Frequently Asked Questions

A Specialist Consultation Should Produce a Written Plan

A high-risk consultation for multiple or large fibroids should clarify:

Which fibroids are strategically important.
Which findings are incidental.
Placental location and implantation risk.
Cervical and lower-segment anatomy.
Whether fetal-growth surveillance is indicated.
Whether a previous myomectomy changes labour or birth planning.
How pain will be assessed and treated.
How haemoglobin and iron reserve will be protected.
Which symptoms require urgent assessment.
Where and when birth should occur.
How haemorrhage preparation will remain proportionate.
What follow-up is needed after pregnancy.

Bring:

Ultrasound reports and accessible images.
Myomectomy and caesarean operative notes.
Pathology reports.
Previous pregnancy and birth records.
Blood group and antibody results.
Recent full blood count and ferritin.
A complete medicine and supplement list.
A timeline of pain, bleeding, urinary symptoms and hospital admissions.
Any previous advice about avoiding labour or planning caesarean birth.

The aim is not to predict a complication from fibroid size. It is to leave the consultation with an accurate anatomical map, a risk-stratified surveillance plan, safe pain and nutrition guidance, clear emergency thresholds and a birth strategy that can be used in routine care and in an emergency.

No general webpage can replace examination, imaging review or patient-specific obstetric advice.

The final part will add the four-paragraph Medical Disclaimer, the complete Evidence Base, citation-link validation and the 100-point publication audit while keeping the medical-review line withheld.

Evidence Base

The evidence below supports the general educational content on this page. It combines current professional guidance with systematic reviews and recent peer-reviewed evidence. Recommendations must still be interpreted for the individual woman, gestational age, symptoms, imaging, uterine-surgery history and local maternity pathway.

[1] Ramašauskaitė D, Purandare N, Diaz I, et al. Fibroids and pregnancy. International Journal of Gynecology & Obstetrics. First published online 6 November 2025. doi:10.1002/ijgo.70612.
Open the peer-reviewed review
[2] Li H, Hu Z, Fan Y, Hao Y. The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis. BMC Pregnancy and Childbirth. 2024;24:345. doi:10.1186/s12884-024-06545-5.
Open the 2024 meta-analysis
[3] National Institute for Health and Care Excellence. Intrapartum care. NICE guideline NG235. Published 29 September 2023; maintained online.
Open NICE intrapartum-care recommendations
[4] International Society of Ultrasound in Obstetrics and Gynecology. Uterine Fibroids. Patient Information Series. Updated August 2023.
Open the ISUOG fibroid resource
[5] Dey T, Cole MG, Brown D, et al. Caesarean myomectomy in pregnant women with uterine fibroids. Cochrane Database of Systematic Reviews. 2025;Issue 1:CD016119. doi:10.1002/14651858.CD016119.
Open the Cochrane review
[6] United States Food and Drug Administration. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. Drug Safety Communication. Issued 15 October 2020; updated 1 September 2022.
Open the FDA drug-safety communication
[7] Current professional statements on paracetamol or acetaminophen for pain and fever during pregnancy.
[8] World Health Organization. Daily iron and folic acid supplementation during pregnancy. WHO eLENA intervention guidance; based on WHO antenatal-care recommendations.
Open WHO iron and folic-acid guidance
[9] World Health Organization. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Geneva: World Health Organization; 2024. ISBN 978-92-4-008854-2.
Open the WHO anaemia guideline
[10] American College of Obstetricians and Gynecologists. Opioid Use and Opioid Use Disorder in Pregnancy. Committee Opinion No. 711. August 2017; maintained online.
Open the ACOG committee opinion
[11] National Institute for Health and Care Excellence. Antenatal care. NICE guideline NG201. Published 19 August 2021; maintained online.
Open NICE antenatal-care recommendations
[12] Khalil A, Sotiriadis A, D’Antonio F, et al. ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scan. Ultrasound in Obstetrics & Gynecology. 2024;63:131–147.
Open the ISUOG Practice Guideline
[13] Society for Maternal-Fetal Medicine. Consult Series #52: Diagnosis and management of fetal growth restriction. American Journal of Obstetrics & Gynecology. 2020;223:B2–B17.
Open the SMFM fetal-growth-restriction guidance
[14] Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta: Diagnosis and Management. Green-top Guideline No. 27a. Updated 30 June 2026.
Open RCOG Green-top Guideline No. 27a
[15] Evidence on pregnancy after myomectomy:
1. Gambacorti-Passerini Z, Gimovsky AC, Locatelli A, Berghella V. Trial of labor after myomectomy and uterine rupture: a systematic review. Acta Obstetricia et Gynecologica Scandinavica. 2016;95:724–734.
  Open the uterine-rupture systematic review
2. Margueritte F, Adam C, Fauconnier A, Gauthier T. Time to conceive after myomectomy: should we advise a minimum time interval? A systematic review. Reproductive BioMedicine Online. 2021;43:543–552.
  Open the conception-interval systematic review
[16] World Health Organization, International Federation of Gynecology and Obstetrics and International Confederation of Midwives. Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2025. ISBN 978-92-4-011563-7.
Open the 2025 WHO postpartum-haemorrhage guideline

Evidence and guidance evolve. Recommendations on medicines, surveillance, surgery, labour and haemorrhage care should be checked against the current local protocol and the woman’s individual clinical circumstances.

Medical Disclaimer

This page provides general educational information about multiple or large uterine fibroids in pregnancy. It is not a diagnosis, prescription, emergency service or substitute for examination, ultrasound review, laboratory testing or advice from the obstetric team responsible for an individual pregnancy. Fibroid number or size alone cannot predict a personal outcome, and no webpage can guarantee maternal or fetal safety.

Seek urgent maternity or emergency assessment for heavy bleeding, sudden or severe worsening pain, fainting, fever, persistent vomiting, fluid leakage, regular contractions, reduced fetal movements, inability to pass urine, severe breathlessness, chest pain, maternal collapse or feeling seriously unwell. After previous myomectomy or other uterine surgery, severe unexplained pain deserves a low threshold for urgent obstetric assessment.

Do not start, stop or change pain medicines, anti-inflammatory medicines, aspirin, anticoagulants, iron, vitamins, herbal products or other treatment on the basis of this page. Medicine suitability depends on gestational age, diagnosis, maternal conditions, fetal findings, other medicines and the treating clinician’s plan. Nutrition supports maternal reserve and recovery but has not been shown to shrink fibroids during pregnancy.

Clinical evidence and professional guidance change over time. Decisions about surveillance, hospital admission, induction, vaginal birth, caesarean birth, myomectomy, blood preparation and postpartum care must be individualised by appropriately qualified clinicians with access to the complete history, operative records, imaging and current local guidance.